| Excerpt | Reference |
|---|
| "The DNCB-method in malignant melanoma is yet in the experimental stage and is not recommended for general use in practice." | ( Djawari, D; Weidner, F, 1979) |
| "Malignant melanoma is rather uncommon in India." | ( Reddy, CR; Satyanarayana, BV; Sundareshwar, B; Yellama, A, 1976) |
| "As the frequency of malignant melanoma is increasing and, as a great proportion of the melanomata are localized to the extremities, these patients should be offered hyperthermic regional perfusion on removal of the primary tumour and also if recurrence occurs." | ( Andersson, AP; Drzewiecki, KT, 1992) |
| "Malignant melanoma is one of the most malignant froms of cancer, for which the prognosis is still very grave." | ( Ikegawa, S; Ishihara, K, 1985) |
| "Malignant melanoma is generally considered as a hormone-independent tumour." | ( Mouridsen, HT; Pedersen, L; Rose, C, 1985) |
| "Malignant melanoma is common among the whites of South Africa." | ( Isaacson, C; Spector, I, 1987) |
| "Primary cutaneous malignant melanomas are generally divided into 3 separate clinico-pathological variants, lentigo maligna melanoma (LMM), superficial spreading melanoma (SSM), and nodular melanoma (NM)." | ( Søndergaard, K, 1983) |
| "Malignant melanoma is appropriate for this investigative and diagnostic technique because of its superficial localization." | ( Dobiás, J; Dobrota, D; Kasparová, S; Liptaj, T; Péc, J; Péc, M; Prónayová, N; Salon, F, 1995) |
| "Malignant melanoma is among the malignant tumors which still have the poorest prognosis." | ( Asano, K; Ishihara, K; Yamazaki, N, 1993) |
| "Nonocular malignant melanoma is a rare but lethal disease increasing in incidence and mortality in western countries with improved survival if diagnosed and treated early." | ( Gujarathi, M; Joshi, S; Jussawalla, DJ; Krishnamurthy, S; Yeole, B, 1994) |
| "The incidence of malignant melanoma is much lower in Japanese than in Caucasians, and the commonest type of melanoma in Japanese is acral lentiginous melanoma (ALM)." | ( Kato, T; Kumasaka, N; Suetake, T; Sugiyama, Y; Tabata, N; Tagami, H, 1995) |
| "Malignant melanoma is a relatively uncommon cancer of increasing incidence." | ( Alonso, O; Bazzano, C; Delgado, L; Espasandin, J; Lago, G; Martinez, M; Mut, F; Saadoun, A; Touya, E, 1996) |
| "A case of malignant melanoma is presented, in which I-123 IMP scintigraphy was useful to visualize the bone metastases." | ( Fukunaga, M; Morita, K; Otsuka, N; Sone, T, 1996) |
| "Human malignant melanoma is notoriously resistant to pharmacological modulation." | ( Artuc, M; Fichtner, I; Henz, BM; Jurgovsky, K; Kern, MA; Kolde, G; Makki, A; Nürnberg, W; Pahl, HL; Rosenbach, T; Schadendorf, D; Stüting, S; von Stebut, E; Worm, M, 1996) |
| "Because malignant melanoma is a highly malignant neoplasm, correct diagnosis and appropriate treatment are essential to improve the prognosis." | ( Saida, T, 1997) |
| "Human malignant melanoma is characterised by unresponsiveness to conventional chemotherapy." | ( Berger, W; Elbling, L; Hauptmann, E; Kokoschka, EM; Micksche, M; Vetterlein, M, 1997) |
| "Malignant melanoma is a prime example of cancers that respond poorly to various treatment modalities including chemotherapy." | ( Brown, BD; Bryan, RN; Eichler, HG; Jansen, B; Müller, M; Pehamberger, H; Schlagbauer-Wadl, H; van Elsas, A; Wolff, K, 1998) |
| "Primary anorectal malignant melanoma is a fairly uncommon but highly malignant disease." | ( Haneji, H; Katayama, N; Kurihara, T; Nakatsuka, H; Ohmoto, T; Ojima, Y; Sadamoto, S; Taniyama, K, 1999) |
| "Malignant melanoma is well known for its primary unresponsiveness to chemotherapy." | ( Christmann, M; Dietel, M; Kaina, B; Kern, MA; Lage, H; Pick, M; Schadendorf, D, 1999) |
| "Cutaneous malignant melanoma is a life-threatening cancer with poor prognosis due to a high metastasis potential." | ( Bush, JA; Ho, VC; Li, G, 2000) |
| "Although malignant melanomas are often associated with cytotoxic lymphocyte infiltration, these cells are largely ineffective in inducing tumour cell kill, indicating that the melanoma cells have protective mechanisms." | ( Barral, AM; Källström, R; Rosén, A; Sander, B, 2000) |
| "Small cell malignant melanoma is postulated to be a distinct histopathological entity and a rare variant of naevoid melanoma." | ( Blessing, K; Coburn, P; Grant, JJ; Husain, A; Kennedy, MM; Sanders, DS, 2000) |
| "Malignant melanoma is resected with curative intent in 80-85% of the patients." | ( Franke, W; Neumann, NJ; Ruzicka, T; Schulte, KW, 2001) |
| "Malignant melanoma is increasing in frequency at a rapid rate in the United States." | ( Didolkar, MS; Eckardt, JR; Flaherty, LE; Samlowski, W; Sondak, VK; Taylor, SA; Unger, JM; Whitehead, RP, 2001) |
| "Malignant melanoma is a cancer whose incidence is rising rapidly, but the mechanism by which normal melanocytes become malignant in vivo is still little understood." | ( Geissinger, E; Schartl, M; Troppmair, J; Weisser, C; Wellbrock, C, 2002) |
| "Primary mucosal malignant melanomas are rare." | ( Cansiz, H; Karakullukçu, B; Ozek, H; Oztürk, O, 2001) |
| "Malignant melanoma is a skin tumour, which carries a very unfavourable prognosis." | ( Arndt, R; Hartleb, J, 2001) |
| "Malignant melanoma is heterogeneous in terms of its biological, immunological and metastatic properties, and melanoma cells exhibit a polymorphous expression of tumour markers." | ( Enk, CD; Gimon, Z; Hochberg, M; Lotem, M; Shiloni, E, 2002) |
| "Malignant melanoma is a tumor that responds poorly to a variety of apoptosis-inducing treatment modalities, such as chemotherapy." | ( Heere-Ress, E; Jansen, B; Lucas, T; Monia, BP; Pehamberger, H; Schlagbauer-Wadl, H; Thallinger, C; Wacheck, V; Wolff, K, 2002) |
| "The incidence of malignant melanoma is rising; it now has an incidence of ten per 100 000 per annum in the UK." | ( Hill, AD; O'Higgins, NJ; Prichard, RS; Skehan, SJ, 2002) |
| "Malignant melanoma is a rare malignant tumor arising within the melanocytes of the skin." | ( Jang Kim, S; Ju Kim, I; Ki Kim, Y; Won Seok, J, 2002) |
| "Malignant melanoma is rapidly increasing in the United States." | ( Chapman, RA; Doolittle, GC; Flaherty, LE; Hammond, N; Klein, CE; Kraut, EH; Mills, GM; Sondak, VK; Unger, JM; Whitehead, RP, 2002) |
| "Malignant melanoma is one of the tumors which may metastasize to the thyroid gland." | ( Aigner, RM; Nicoletti, R; Schwarz, T; Wolf, G, 2002) |
| "Malignant melanoma is one of those malignancies with worldwide increasing incidence." | ( Aigner, RM; Richtig, E; Schwarz, T, 2002) |
| "Malignant melanoma is a tumor known for its uncontrollable growth and aggressive metastatic behavior." | ( Limonta, P; Montagnani Marelli, M; Moretti, RM; Van Groeninghen, JC, 2002) |
| "Anorectal malignant melanoma is an uncommon tumour." | ( Fierlbeck, G; Metzger, S; Ulmer, A, 2002) |
| "Malignant melanoma is the most common tumor metastatic to the GI tract." | ( Horvath, W; Khosrowshahi, E, 2002) |
| "Anorectal malignant melanoma is relatively rare and its prognosis is very poor because of distant metastasis via the blood or lymphatic vessels." | ( Ebisui, C; Fujimoto, T; Fukuchi, N; Izawa, H; Kanai, T; Sakita, I; Souma, I; Yoshida, T, 2002) |
| "Malignant melanoma is one of the most rapidly increasing cancer types, and patients with metastatic disease have a very poor prognosis." | ( Bitisik, O; Camlica, H; Dalay, N; Duranyildiz, D; Kurul, S; Tas, F, 2003) |
| "Taking a biopsy of malignant melanoma is generally contraindicated because of the high risk of inducing metastasis." | ( Abe, K; Aoki, T; Hayashi, M; Kitamura, K; Koyanagi, Y; Mori, M; Saito, H; Sato, S; Tsuchida, A; Umezu, K; Yamagishi, T, 2003) |
| "The progression of malignant melanoma is characterized by overexpression of a number of matrix metalloproteinases (MMPs), especially MMP-2, which play a critical role in the degradation of basement membranes and the extracellular matrix." | ( Badary, OA; Drevs, J; Esser, N; Fichtner, I; Hamada, FM; Kratz, F; Mansour, AM; Unger, C, 2003) |
| "Malignant melanoma is rare before puberty." | ( NEWMAN, BA, 1957) |
| "Malignant melanoma is rare before puberty." | ( NEWMAN, BA, 1957) |
| "Malignant melanoma is rare before puberty." | ( NEWMAN, BA, 1957) |
| "Malignant melanoma is rare before puberty." | ( NEWMAN, BA, 1957) |
| "Malignant melanoma is one of the most worrisome tumors in terms of epidemiology, and incidence is increasing." | ( Khayat, D; Meric, JB; Rixe, O, 2003) |
| "Malignant melanoma is considered to be a chemotherapy-refractory tumour, and the commonly used anticancer drugs do not seem to modify the prognosis of metastatic disease." | ( Cannavò, E; D'Atri, S; Falchetti, R; Fuggetta, MP; Lanzilli, G; Ravagnan, G; Tricarico, M; Zambruno, G, 2004) |
| "Mucosal malignant melanomas are rare lesions, and they have different characteristics from their cutaneous counterparts." | ( Cansiz, H; Güzel, MZ; Karakullukçu, B; Ozek, H; Oztürk, O, 2005) |
| "Metastatic malignant melanoma is an extremely aggressive cancer, with no currently viable therapy." | ( Alworth, WL; Fitzpatrick, JE; Ghosh, R; Kumar, AP; Nadiminty, N; Slaga, TJ, 2005) |
| "Osteoid malignant melanoma is a rare type of melanoma described in humans and dogs with some areas of bone differentiation." | ( Estrada, M; Fontaine, JJ; Lagadic, M; Maliver, P; Manin, S; Mialot, M, 2004) |
| "Anorectal malignant melanoma is a rare tumor and there is no consensus on whether aggressive or local management is more appropriate." | ( Cemazar, M; Jancar, B; Rudolf, Z; Sersa, G; Snoj, M, 2005) |
| "Malignant melanoma is the seventh most common newly diagnosed cancer among Americans." | ( Alavi, A; Kumar, R, 2005) |
| "Malignant melanoma is well known for its poor response to chemotherapy, radiotherapy and its susceptibility to immunotherapy." | ( Jović, V; Konjević, G; Radomirović, V; Spuzić, I, 2002) |
| "Malignant melanoma is the most aggressive form of skin cancer and has proven to be highly resistant to conventional chemotherapy." | ( Niemetz, A; Pützer, BM; Racek, T; Schultz, J; Soengas, MS; Tuve, S, 2006) |
| "Malignant melanoma is the third most common skin cancer in the United States." | ( Ivry, GB; Ogle, CA; Shim, EK, 2006) |
| "Malignant melanomas are characterized by a high intrinsic resistance to chemotherapy." | ( Baker, B; Engel, JB; Halmos, G; Keller, G; Nagy, A; Schally, AV, 2006) |
| "Human malignant melanoma is a highly aggressive form of cancer; the 5-year survival rate in patients with stage III or IV disease is <5%." | ( Ekmekcioglu, S; Fok, JY; Mehta, K, 2006) |
| "Malignant melanoma is highly refractory to conventional radio- and chemotherapy." | ( Hei, TK; Ivanov, VN, 2006) |
| "Malignant melanoma is particularly resistant to conventional chemotherapy and radiotherapy." | ( Benassi, L; Bernardi, C; Bertazzoni, G; Coppi, A; Costi, MP; Gelain, A; Giannetti, A; Giudice, S; Gualdi, G; Magnoni, C; Rossi, T; Venturelli, A, 2007) |
| "Malignant melanoma is a common and frequently lethal disease." | ( Bosenberg, M; Bradbury, CM; Curley, DP; Duraisamy, S; Hobbs, C; Muthusamy, V; Nelson, B, 2006) |
| "Malignant melanoma is one of the most aggressive skin cancer and chemotherapeutic agents currently in use are still unsatisfactory." | ( Delogu, G; Dettori, MA; Fabbri, D; Loi, M; Mura, ME; Pagnan, G; Palmieri, G; Pisano, M; Ponzoni, M; Rozzo, C; Tilocca, MG, 2007) |
| "Metastatic malignant melanoma is a devastating disease with a poor prognosis." | ( Buzney, E; Fuhlbrigge, RC; Kupper, TS; Munoz, KN; Weishaupt, C, 2007) |
| "Malignant melanoma is a highly aggressive tumor which frequently resists chemotherapy, therefore, the search for new agents for its treatment is of great importance." | ( Bergman, M; Cohen, Y; Dovrat, S; Gottlieb, H; Grossman, S; Rozenblat, S, 2008) |
| "Malignant melanoma is a rare pathology: 1-4% of all melanomas occur before the age of 20 and 0." | ( Bouali, O; Galinier, P; Guitard, J; Lamant, L; Salazard, B, 2009) |
| "Cutaneous malignant melanoma is an aggressive type of skin cancer which causes disproportionate mortality in young and middle-aged adults." | ( Casanova, JM; Dolcet, X; Egido, R; Llobet, D; Llombart, A; Marti, RM; Matias-Guiu, X; Pérez de Santos, AM; Schoenenberger, JA; Soria, X; Sorolla, A; Vilella, R; Yeramian, A, 2008) |
| "Malignant melanoma is a potentially fatal skin cancer that is increasing in incidence." | ( Dutz, JP; Najar, HM, 2008) |
| "Malignant melanoma is one of the most lethal cancers." | ( Chammas, R; Donatti, L; Luvizon, AC; Mercadante, AF; Nakao, LS; Naliwaiko, K; Zanata, SM, 2008) |
| "Malignant melanoma is the most deadly form of skin cancer due to its highly metastatic nature." | ( Amin, S; Desai, D; Huh, SJ; Madhunapantula, SV; Robertson, GP; Sharma, A, 2008) |
| "Human malignant melanoma is notoriously resistant to currently available pharmacological modulation." | ( Geng, S; Li, X; Li, Z; Liu, Y; Pan, M; Peng, Z; Ren, J; Xiao, S, 2009) |
| "Twenty to 30% of malignant melanomas are associated with melanocytic nevi; however, sometimes it is difficult to distinguish the melanoma from the nevus by routine histology." | ( Kamino, H; Tam, S; Tapia, B; Toussaint, S, 2009) |
| "Malignant melanomas are highly resistant to chemotherapy." | ( Belohlavek, C; Christmann, M; Jöst, E; Kaina, B; Lennerz, V; Naumann, SC; Roos, WP; Schmidt, CW, 2009) |
| "Metastatic malignant melanoma is an incurable malignancy with extremely poor prognosis." | ( Erickson, LA; Farley, DR; Flotte, TJ; Jakub, JW; Kottschade, LA; Markovic, SN; McWilliams, RR; Olivier, KR; Pittelkow, MR; Pulido, JS; Quevedo, JF; Schild, SE; Sekulic, A; Stoian, I; Tran, NV; Vile, RG; Vuk-Pavlovic, S; Weenig, RH; Wiseman, GA, 2009) |
| "Malignant melanoma is one of the most aggressive human neoplasms and its incidence is still increasing." | ( Weinlich, G, 2009) |
| "Malignant melanoma is a highly metastatic cutaneous cancer and typically refractory to chemotherapy." | ( Mousavi-Shafaei, P; Zangemeister-Wittke, U; Ziaee, AA, 2009) |
| "Malignant melanomas are generally drug resistant and have a very poor prognosis." | ( Andersson, Y; Fodstad, Ø; Risberg, K, 2009) |
| "Malignant melanoma is resistant to almost all conventional forms of chemotherapy." | ( Akbari, M; Andrew, SE; Felton, KE; Keuling, AM; Parker, AA; Tron, VA, 2009) |
| "Malignant melanomas are intrinsically resistant to many conventional treatments, such as radiation and chemotherapy, for reasons that are poorly understood." | ( Cardarelli, CO; Chen, KG; Gottesman, MM; Hearing, VJ; Lai, B; Leapman, RD; Valencia, JC; Vieira, WD; Zhang, G, 2009) |
| "Malignant melanoma is a highly aggressive and drug-resistant cancer." | ( Aurelian, L; Colunga, AG; Laing, JM, 2010) |
| "The incidence of malignant melanoma is increasing at an alarming rate, doubling in women and growing by more 300% in men during the past 25 years." | ( Stadelmann, WK, 2010) |
| "Malignant melanoma is one of the most aggressive human neoplasms which develop from the malignant transformation of normal epithelial melanocytes and share the lineage with retinal cells." | ( Bazhin, AV; Dikov, B; Eichmüller, SB; Philippov, PP; Schadendorf, D; Tambor, V, 2010) |
| "The incidence of malignant melanoma is increasing at an alarming rate globally." | ( Chaudhuri, P; Sengupta, S; Soni, S, 2010) |
| "Primary pulmonary malignant melanoma is rare (0." | ( Bonnichon-Py, A; Foehrenbach, H; Le Floch, H; Mairovitz, A; Margery, J; Marotel, C; Pons, F; Rivière, F; Salles, Y; Staub, E; Vaylet, F, 2010) |
| "Malignant melanoma is one of the most lethal and aggressive human malignancies." | ( Jiang, G; Liu, YQ; Mao, LJ; Pei, DS; Wei, ZP; Zheng, JN, 2010) |
| "Malignant melanoma is an aggressive skin cancer with no effective therapies currently approved for advanced disease." | ( Binder, M; Erasim, C; Harmankaya, K; Hoos, A; Ibrahim, R; Koelblinger, C; Pehamberger, H, 2011) |
| "Malignant melanoma is rising faster in incidence than any other malignancy." | ( Boasberg, P; Hamid, O; O'Day, S, 2010) |
| "Malignant melanoma is a highly aggressive tumor that frequently resists chemotherapy, so the search for new agents for its treatment is of great importance." | ( Castello, G; De Marino, S; Festa, C; Ialenti, A; Ianaro, A; Iorizzi, M; Napolitano, M; Panza, E; Tersigni, M; Zollo, F, 2011) |
| "Disseminating malignant melanoma is a lethal disease highly resistant to radio- and chemotherapy." | ( Bao, W; Chen, M; Issaeva, N; Kumar, R; Selivanova, G; Spinnler, C; Strömblad, S; Thullberg, M; Zhao, X, 2011) |
| "Malignant melanoma is the most malignant of skin tumor." | ( Jiang, G; Liu, YQ; Pei, DS; Wei, ZP; Xin, Y; Zheng, JN, 2011) |
| "Malignant melanoma is the deadliest form of skin cancer, known for its drug resistance and high metastatic potential." | ( Amin, S; Chung, CY; Desai, D; Madhunapantula, SV; Robertson, GP, 2011) |
| "Malignant melanoma is well known for its propensity to spread to unpredictable sites." | ( Mudun, A; Ozkan, G; Sanli, Y; Turkmen, C; Yegen, G, 2011) |
| "Human malignant melanoma is highly resistant to chemotherapy and current immunotherapeutic approaches induce long term remission only in the minority of patients." | ( Busse, A; Keilholz, U, 2011) |
| "Cutaneous malignant melanoma is an aggressive disease of poor prognosis." | ( Angel, P; Blaber, M; Blaber, SI; Hess, J; Krenzer, S; Mauch, C; Peterziel, H, 2011) |
| "Malignant melanoma is an aggressive cancer of pigment-producing cells, derivates of the neural crest." | ( Heneberg, P, 2011) |
| "The incidence of malignant melanoma is growing rapidly worldwide and there is still no effective therapy for metastatic disease." | ( Li, W; Melton, DW, 2012) |
| "The incidence of malignant melanoma is rising faster than that of any other cancer in the United States." | ( Barkey, NM; De Silva, CR; Gillies, RJ; Hruby, VJ; Josan, JS; Morse, DL; Sill, KN; Tafreshi, NK; Vagner, J, 2011) |
| "Malignant melanoma is known by its rapid progression and poor response to currently applied treatments." | ( Sevko, A; Umansky, V, 2012) |
| "Malignant melanoma is a disease with high mortality rate caused by rapid metastasis." | ( Ciołczyk-Wierzbicka, D; Gil, D; Laidler, P, 2012) |
| "Malignant melanoma is a deadly type of metastatic skin cancer with increased incidence over the past 30 years." | ( Arruda, DC; Farias, CF; Favero, OA; Ferreira, MJ; Figueiredo, CR; Girola, N; Lago, JH; Massaoka, MH; Matsuo, AL; Romoff, P; Scutti, JA; Travassos, LR, 2012) |
| "Malignant melanoma is a relatively rare but potentially aggressive tumor in children and adolescents." | ( Abasq, C; Charles-Pétillon, F; Coat, C; De Braekeleer, M; Marcorelles, P; Quintin-Roué, I; Talagas, M; Uguen, A, 2012) |
| "The incidence of malignant melanoma is increasing worldwide, despite our best efforts in prevention and early detection." | ( Arenbergerová, M; Puzanov, I, 2012) |
| "Malignant melanoma is difficult to treat due to its resistance to chemotherapeutic regimens." | ( Adams, E; Hailey, S; McLane, MA; Penn, R; Wong, A, 2013) |
| "Metastatic malignant melanoma is highly resistant to chemotherapy, and the average survival rate is under 1 year." | ( Anvekar, RA; Asciolla, JJ; Belbin, G; Chipuk, JE; Elkholi, R; Floros, KV; Izadmehr, S; Lopez-Rivera, E; Sikora, AG, 2012) |
| "The prognosis for malignant melanoma is poor; therefore, new diagnostic methods and treatment strategies are urgently needed." | ( Inui, M; Morita, H; Murata, T; Okumura, K; Shimizu, K; Tagawa, T, 2013) |
| "Invasive malignant melanoma is the most common fatal form of skin cancer." | ( Glatz, K; Itin, P; Ivanova, K; Nicolas, G; Zippelius, A, 2012) |
| "Malignant melanoma is one of the most lethal and aggressive human malignancies." | ( Cheng, Q; Jiang, AJ; Jiang, G; Li, LT; Tian, H; Zheng, JN, 2013) |
| "Malignant melanoma is a highly-aggressive type of malignancy with considerable metastatic potential and frequent resistance to cytotoxic agents." | ( Brors, B; Enk, A; Helmbold, P; Penzel, R; Schirmacher, P; Skorokhod, A, 2013) |
| "The incidence of malignant melanoma is increasing annually." | ( Nathan, PD; Shaw, HM, 2013) |
| "Malignant melanoma is notorious for its high resistance to chemotherapy, and new anti-melanoma drugs are urgently needed." | ( Albeck, A; Lellouche, MB; Levinger, S; Sharabi-Ronen, Y, 2014) |
| "Malignant melanoma is the most aggressive form of skin cancer." | ( Cao, Z; Guo, P; Liu, R; Pan, Y; Yang, P; Zhang, G; Zhou, Q, 2013) |
| "Malignant melanoma is a highly aggressive tumor with increasing incidence and high mortality." | ( Dundr, P; Dvořák, P; Dvořánková, B; Kodet, O; Krajsová, I; Krejčí, E; Lacina, L; Smetana, K; Štork, J; Szabo, P, 2013) |
| "Malignant melanomas are characterized by the ability of early metastatic dissemination to regional lymph nodes and the detection of sentinel lymph node metastases serves as an important prognostic parameter." | ( Bianchini, F; Calorini, L; Contena, C; Peppicelli, S; Tombaccini, D, 2013) |
| "Human malignant melanoma is one of the most aggressive forms of skin cancer with an exceptionally bad prognosis." | ( Lázár, V, 2013) |
| "The incidence of malignant melanoma is continuously rising, but the therapy of advanced melanoma remains insufficient." | ( Liszkay, G, 2013) |
| "Malignant melanoma is refractory to various chemotherapeutics including antitubulin agents such as paclitaxel." | ( Akasaka, T; Inoue, T; Kasai, S; Maesawa, C; Masuda, T; Shibazaki, M; Takahashi, K; Watanabe, A; Yasuhira, S, 2013) |
| "Canine malignant melanomas are highly aggressive and fatal neoplasms." | ( Bonkobara, M; Hiroi, T; Ito, K; Iwata, T; Kobayashi, M; Kuroki, S; Kuroki, T; Mori, K; Nakagawa, T; Ono, K; Ozawa, Y; Sasaki, Y; Tetsuka, M; Washizu, T; Yamamoto, H, 2013) |
| "Malignant melanoma is an aggressive skin cancer and it is reported to be the most treatment-resistant human cancer." | ( Aliwaini, S; Blanckenberg, A; Mapolie, S; Prince, S; Swarts, AJ, 2013) |
| "The risk for malignant melanoma is higher than expected in Parkinson's disease (PD)." | ( Augustine, EF; Auinger, P; Constantinescu, R; Elm, J; Khadim, L; Kieburtz, K; Sharma, S, 2014) |
| "Malignant melanoma is highly aggressive, and always resistant to conventional chemo-radiotherapy, which results in poor prognosis." | ( Cui, H; Liu, Y; Yi, L; Zhang, Y; Zhu, S, 2014) |
| "Malignant melanoma is responsible for approximately 75% of skin cancer-related deaths." | ( Afaq, F; Athar, M; Ballestas, ME; Elmets, CA; Katiyar, SK; Pal, HC; Sharma, S; Strickland, LR, 2014) |
| "Malignant melanoma is the most aggressive and deadliest form of skin cancer due to its highly metastatic potential, which calls for new and improved therapies." | ( Berge, G; Camilio, KA; Ravuri, CS; Rekdal, O; Sveinbjørnsson, B, 2014) |
| "Malignant melanoma is characterized by the development of chronic inflammation in the tumor microenvironment, which leads to a strong immunosuppression associated with a rapid tumor progression." | ( Bazhin, AV; Shevchenko, I; Umansky, V; Utikal, J, 2014) |
| "Malignant melanoma is one of the most aggressive forms of cancer and its incidence is rapidly increasing." | ( Alili, L; Brenneisen, P; Das, S; Gupta, A; Karaman, E; Sack, M; Seal, S, 2014) |
| "Malignant melanoma is the most lethal form of skin cancer, with a high propensity to metastasize to the brain." | ( Bjerkvig, R; Dale, HA; Daphu, I; Horn, S; Skaftnesmo, KO; Spriet, E; Stieber, D; Thorsen, F; Varughese, JK, 2014) |
| "Malignant melanoma is the most deadly type of skin cancer." | ( Costa, VM; Diniz, C; Fresco, P; Soares, AS, 2015) |
| "The incidence of malignant melanoma is increasing worldwide." | ( Berrocal, A; Cabañas, L; Espinosa, E; Fernández-de-Misa, R; Martín-Algarra, S; Martínez-Cedres, JC; Ríos-Buceta, L; Rodríguez-Peralto, JL, 2014) |
| "Malignant melanoma is an aggressive form of skin cancer with limited effective therapeutic options." | ( Anant, S; Jensen, RA; Kaushik, G; Kwatra, D; Mammen, JM; Subramaniam, D, 2014) |
| "Malignant melanoma is the deadliest form of skin cancer; the treatment of advanced and recurrent forms remains a challenge." | ( Block, NL; Cai, RZ; Klukovits, A; Krishan, A; Popovics, P; Rick, FG; Schally, AV; Szalontay, L; Vidaurre, I; Zarandi, M, 2014) |
| "Malignant melanoma is the most aggressive and deadly form of skin cancer." | ( Jiang, G; Li, RH; Liu, YQ; Sun, C; Zheng, JN, 2014) |
| "Malignant melanoma is an aggressive and deadly form of skin cancer, and despite recent advances in available therapies, is still lacking in completely effective treatments." | ( Aziz, F; Fu, YS; Liu, JW; Shan, X; Wang, XQ; Yan, Q, 2014) |
| "Malignant melanoma is a form of skin cancer associated with significant mortality once it has spread beyond the skin." | ( Apalla, Z; Chan, AW; Kyrgidis, A; Mocellin, S; Pilati, P; Tzellos, T, 2014) |
| "Malignant melanoma is an aggressive tumor with poor prognosis that can have widespread metastases at presentation." | ( Bal, A; Dey, P; Jung, RS; Kapoor, R; Mittal, BR; Shukla, J, 2015) |
| "Malignant melanoma is a destructive and lethal form of skin cancer with poor prognosis." | ( Aziz, F; Liu, JW; Shan, X; Tian, LL; Wang, XQ; Yan, Q, 2015) |
| "Malignant melanoma is a melanocytic tumor with a high potential of invasion and metastasis." | ( Li, YQ; Lv, YT; Wang, JM; Zhang, YP, 2015) |
| "Malignant melanoma is a highly aggressive form of skin cancer with a high mortality rate if not discovered in early stages." | ( Faião-Flores, F; Fruet, AC; Maria, DA; Maria-Engler, SS; Pardi, PC; Quincoces Suarez, JA, 2015) |
| "Early diagnosis of malignant melanoma is important for patient survival." | ( Chang, CC; Chang, CH; Chen, CL; Lin, MH; Liu, RS; Shen, CC; Wang, HE, 2015) |
| "Malignant melanoma is a highly aggressive cancer, and the incidence of this disease is increasing worldwide at an alarming rate." | ( Anderson, CJ; Beaino, W; Nedrow, JR, 2015) |
| "Malignant melanoma is the most dangerous type of skin cancer." | ( Arnér, ES; Brodin, B; Campbell, J; Drummond, CJ; Higgins, M; Laín, S; McCarthy, AR; Sachweh, MC; Stafford, WC, 2015) |
| "Malignant melanoma is a highly aggressive tumor which may occur in the skin, eye, and mucous membranes." | ( Agliano, F; Morabito, S; Oteri, R; Teti, D; Venza, I; Venza, M; Visalli, M, 2015) |
| "Malignant melanoma is a type of skin cancer with accelerated evolution and a high metastatic potential, thus being the most aggressive type of skin tumor." | ( Blendea, A; Brănişteanu, DE; Costache, A; Georgescu, CV; Ţolea, I, 2015) |
| "The incidence of malignant melanoma is increasing, and up to 5 % of patients will experience in-transit metastases." | ( Bagge, AS; Belgrano, V; Ben-Shabat, I; Olofsson Bagge, R, 2016) |
| "Malignant melanoma is an aggressive, highly lethal dermatological malignancy." | ( Chen, YP; Feng, SX; Hou, XY; Jiang, G; Jiang, XX; Liu, YQ; Xu, XF; Yang, CS; Yang, M, 2016) |
| "Malignant melanoma is an aggressive tumor of the skin and seems to be resistant to current therapeutic approaches." | ( Candido, S; Cavalieri, S; Libra, M; McCubrey, JA; Motta, S; Nicoletti, F; Pappalardo, F; Pennisi, M; Russo, G, 2016) |
| "Malignant melanoma is the leading cause of death from skin cancer." | ( Beretta, G; Casati, L; Comitato, R; Festuccia, C; Gravina, GL; Limonta, P; Marzagalli, M; Montagnani Marelli, M; Moretti, RM, 2016) |
| "Malignant melanoma is the most aggressive form of skin carcinoma, which possesses fast propagating and highly invasive characteristics." | ( Guo, G; Mei, Z; Niu, T; Tian, Y, 2016) |
| "Malignant melanoma is one of the most dangerous skin cancer originating from melanocytes." | ( Kobiela, T; Lekka, M; Milner-Krawczyk, M; Sobiepanek, A, 2017) |
| "Malignant melanoma is a fast growing form of skin cancer with increasing global incidence." | ( Finocchiaro, LME; Glikin, GC; Rossi, UA, 2017) |
| "Incidence of malignant melanoma is increasing globally." | ( Dvořánková, B; Kodet, O; Kolář, M; Krejčí, E; Lacina, L; Naňka, O; Šedo, A; Smetana, K; Strnad, H; Szabo, P, 2017) |
| "Cutaneous malignant melanoma is among the deadliest human cancers, broadly resistant to most clinical therapies." | ( Merlino, G; Mishra, PJ, 2016) |
| "Malignant melanoma is a highly aggressive tumor resistant to chemotherapy." | ( Guo, XL; Jiang, BP; Liang, H; Shen, XC; Wang, Y; Zhang, L; Zhu, Y, 2017) |
| "Malignant melanoma is the deadliest form of all skin cancers." | ( Li, D; Liang, G; Liu, M; Liu, W; Mei, H; Shen, Y; Wang, Q, 2017) |
| "Malignant melanoma is a highly aggressive neoplasia of melanocytic origin." | ( Hu, G; Jiang, MJ; Li, FJ; Li, LM; Long, J; Xu, C; Zhang, RH; Zhou, P, 2017) |
| "Malignant melanoma is the most invasive and fatal form of cutaneous cancer." | ( Cheng, W; Han, X; Lin, J; Ni, J; Song, Z; Zhang, Y; Zhao, G, 2017) |
| "Malignant melanoma is a lethal form of skin cancer and highly metastatic tumor with poor prognosis; BEL β-trefoil, a lectin, obtained by our group, possesses the ability to act specifically on malignant cells." | ( Bovi, M; Cavallini, C; Cheri, S; Dalle Carbonare, L; Innamorati, G; Mori, A; Perduca, M; Scupoli, MT; Valenti, MT, 2017) |
| "Anorectal malignant melanoma is often misdiagnosed as either hemorrhoids or benign anorectal conditions in inflammatory bowel disease." | ( Kim, SE; Moon, W; Park, MI; Park, SJ; Seo, KI, 2017) |
| "Stage III malignant melanoma is a heterogeneous disease where those cases deemed marginally resectable or irresecatble are frequently incurable by surgery alone." | ( Ben-Ami, E; Ben-Betzalel, G; Goitein, D; Markel, G; Nissan, A; Schachter, J; Schneebaum, S; Shapira-Frommer, R; Zippel, D, 2017) |
| "Malignant melanoma is the most dangerous form of skin cancer, with a rapidly increasing incidence rate." | ( Carsten, B; Dyshlovoy, SA; Ermakova, SP; Gunhild, VA; Ivanchina, NV; Kicha, AA; Malyarenko, OS; Malyarenko, TV; Stonik, VA, 2017) |
| "Malignant melanoma is one of the most common malignant diseases of the gastrointestinal tract." | ( Choi, CW; Kang, DH; Kim, HJ; Kim, HW; Kim, SJ; Lee, JS; Park, SB; Yeo, CW, 2017) |
| "Malignant melanoma is the leading cause of mortality among the skin‑associated diseases because of its highly metastatic nature and lethality." | ( Li, TH; Yan, HX, 2018) |
| "Malignant melanoma is highly metastatic, and melanoma patients can develop chemotherapeutic resistance against conventional melanoma therapies." | ( Choi, KC; Heo, JR; Hwang, KA; Kim, GS; Lee, GA, 2018) |
| "Malignant melanoma is among the most aggressive cancers and its incidence is increasing worldwide." | ( Borgognoni, L; Deng, X; Gagliardi, S; Gray, NS; Pandolfi, S; Rovida, E; Stecca, B; Tubita, A; Tusa, I; Urso, C; Wang, J, 2018) |
| "Malignant melanoma is a devastating skin cancer due to its severe drug resistance and prompt metastasis." | ( Gao, T; Lei, Q; Song, X; Xiong, J; Yao, Y; Zhang, L, 2018) |
| "Malignant melanoma is an important type of cancer worldwide due to its aggressiveness and poor survival rate." | ( Antony, LP; Calcagno, DQ; de Arruda Cardoso Smith, M; de Lucas Chazin, E; de Vasconcellos, MC; do Nascimento Pedrosa, T; Dos Santos Barbosa, G; Montenegro, RC; Ralph, ACL; Vasconcelos, TRA; Vasconcelos, ZS, 2018) |
| "Malignant melanoma is the most commonly diagnosed skin cancer associated with a high rate of metastasis." | ( Kalafatis, M; Manouchehri, JM; Turner, KA, 2018) |
| "Malignant melanoma is an agressive tumour related to the overproduction of melanin, which provides colors of skin, eyes and hair." | ( Aytemir, MD; Ercan, A; Karakaya, G; Oncul, S, 2018) |
| "Malignant melanomas are amongst the most aggressive cancers." | ( Bu, CN; Dong, YL; Li, QS; Lin, MX; Ruan, BF; Shao, Q; Wang, TH; Xu, HJ; Zhang, Q; Zhou, BG, 2018) |
| "The incidence of malignant melanoma is increasing." | ( Abramov, I; Khochenkov, D; Prokofieva, A; Ryabaya, O; Stepanova, E; Zasedatelev, A, 2018) |
| "Malignant melanoma is an aggressive form of cancer which is highly resistant to chemotherapy." | ( Gao, Y; Liang, L; Liu, J; Qin, X; Zeng, W; Zhang, Z; Zhao, P, 2018) |
| "Malignant melanoma is developed from pigment-containing cells, melanocytes, and primarily found on the skin." | ( Chi, PL; Chiang, YC; Hsu, LF; Ko, HH; Ko, MI; Lee, CW; Lee, MH; Peng, KT; Tsai, CL, 2018) |
| "Malignant melanoma is a highly aggressive form of skin cancer responsible for the majority of skin cancer-related deaths." | ( Agostinis, P; Alexopoulos, LG; Antoranz, A; Guttà, C; Kulms, D; Pliaka, V; Podder, B; Rehm, M; Rožanc, J; Rufo, N; Sakellaropoulos, T; Sauter, T; Vetma, V, 2019) |
| "Malignant melanoma is an aggressive skin cancer with limited therapeutic options." | ( de Carvalho Lima, EN; Maria, DA; Piqueira, JRC, 2018) |
| "Malignant melanoma is very rare in childhood." | ( Büyükkapu Bay, S; Kebudi, R; Zülfikar, B, 2019) |
| "Malignant melanoma is a highly lethal disease, and advanced stages of melanoma have proven to be resistant to many chemotherapeutic drugs including temozolomide and paclitaxel." | ( Han, B; Sun, B; Wang, YB, 2018) |
| "BACKGROUND Malignant melanoma is recalcitrant to most existing chemotherapies, and aberrant expression of miR-211 plays prominent roles in progression of melanoma." | ( Lee, D; Li, N; Liu, Y; Pang, H; Xiao, Z; Zhou, Y, 2019) |
| "Malignant melanoma is a highly aggressive skin cancer that is highly resistant to chemotherapy." | ( Aizawa, S; Hara, H; Harada, T; Makita, K; Nakayama, T; Ochiai, Y; Okamoto, Y; Sano, E; Ueda, T; Yoshino, A, 2019) |
| "Malignant melanoma is the deadliest form of skin cancer and highly chemoresistant." | ( Baek, SB; Jung, HJ; Lim, HN, 2019) |
| "Malignant melanoma is a highly aggressive skin cancer and metastases rapidly extend to the regional lymph nodes (stage 3) and to distal organs (stage 4)." | ( Appelqvist, R; Baldetorp, B; Berge, E; Betancourt, LH; Burestedt, E; Corthals, G; Doma, V; Eriksson, J; Gil, J; Horvath, Z; Horvatovich, P; Ingvar, C; Jönsson, G; Karpati, S; Kim, Y; Knudsen, B; Kuras, M; Kwon, HJ; Lee, B; Lindberg, H; Lundgren, L; Malm, J; Marko-Varga, G; Miliotis, T; Murillo, JR; Németh, IB; Nishimura, T; Olsson, H; Oskolas, H; Pawłowski, K; Pla, I; Rezeli, M; Sanchez, A; Sugihara, Y; Szasz, AM; Timar, J; Welinder, C; Wieslander, E, 2019) |
| "Malignant melanoma is one of the most difficult cancers to treat due to its resistance to chemotherapy." | ( Arulananda, S; Behren, A; Cebon, J; Dobrovic, A; Evangelista, M; Fairlie, WD; Gunasingh, G; Haass, NK; Harris, TJ; Herold, MJ; Hobbs, C; John, T; Lee, EF; Mariadason, JM; Ramnac, C; Rohrbeck, L; Segal, D; Strasser, A; Tran, S; Zhu, H, 2019) |
| "Human malignant melanoma is one of the most aggressive cancers, accompanied with poor prognosis, metastatic evolution and high mortality." | ( Fasoli, S; Gotte, G; Menegazzi, M; Prodomini, S; Raineri, A, 2019) |
| "Malignant melanoma is the leading cause of death from skin disease, due in large part to its propensity to metastasize." | ( Li, CY; Li, G; Shen, S; Wang, Q; Wang, X; Wei, X, 2019) |
| "Malignant melanoma is a rare disease in the pediatric population and there are no recommendations regarding its management in children, while the current standard of care in metastatic or unresectable melanoma in adult patients includes immunotherapy (anti-CTLA-4 and anti-PD-1 antibodies)." | ( Galazka, P; Marjanska, A; Marjanski, M; Styczynski, J; Wysocki, M, 2019) |
| "Malignant melanoma is the most aggressive and lethal form of skin cancer." | ( Chodurek, E; Pilawa, B; Zdybel, M, 2019) |
| "Malignant melanoma is a high aggressive malignancy in humans and causes 60-80% of deaths from skin cancer." | ( Beberok, A; Respondek, M; Rok, J; Rzepka, Z; Wrześniok, D, 2020) |
| "Malignant melanoma is the most aggressive type of skin cancer and is closely associated with the development of brain metastases." | ( Aasen, SN; Bjerkvig, R; Feng, Z; Hoang, T; Knappskog, S; Parajuli, H; Roy, K; Stokke, K; Thorsen, F; Wang, J, 2019) |
| "Malignant melanoma is an aggressive type of cancer and the deadliest form of skin cancer." | ( Aplak, E; Berning, L; Brenneisen, P; Reichert, AS; Scharf, L; Stahl, W; Stucki, D; von Montfort, C, 2019) |
| "Malignant melanoma is one of the most leading forms of skin cancer associated with a low patient survival rate." | ( Fan, P; Fang, M; Li, Z; Zuo, C, 2020) |
| "Malignant melanoma is the most aggressive form of skin cancer; a substantial percentage of patients present with distant metastases." | ( Hong, J; Oh, E; Yun, CO, 2019) |
| "Cutaneous malignant melanoma is a neoplasm whose incidence and mortality are dramatically increasing." | ( Baldari, S; Baratto, L; Iagaru, A; Laudicella, R; Minutoli, F, 2020) |
| "Malignant melanoma is an aggressive skin cancer with poor survival outcomes for patients diagnosed at an advanced stage." | ( Burnett, K; Callan, B; Callan, JF; Dhillon, SK; Matin, RN; McHale, AP; McKaig, T; Nesbitt, H; Porter, SL; Rizk, N; Sheng, Y; White, B, 2020) |
| "Malignant melanoma is the most aggressive form of skin cancer, and once it becomes metastatic the prognosis is very poor." | ( Aplak, E; Brenneisen, P; Haasler, L; Reichert, AS; Stahl, W; Steckel, B; Stucki, D; von Montfort, C, 2020) |
| "Malignant melanoma is one of the most invasive tumours." | ( Chen, X; Guo, J; Liang, L; Liu, H; Liu, J; Liu, N; Peng, C; Qi, M; Su, J; Zhang, J; Zhao, S, 2020) |
| "Malignant melanoma is a devastating disease." | ( Alimohammadi, M; Bekeschus, S; Golpur, M; Hadavi, S; Niaki, HA; Rafiei, A; Sohbatzadeh, F; Valadan, R, 2020) |
| "Malignant melanoma is an emerging problem worldwide due to the high degree of lethalness." | ( Brzózka, Z; Chudy, M; Lamch, Ł; Piechota, B; Tokarska, K; Wilk, KA; Żukowski, K, 2020) |
| "Malignant melanoma is a kind of highly invasive and deadly diseases." | ( Chen, Y; Li, X; Liu, X; Rao, M; Shi, B; Sun, X; Wang, Y; Yuan, Y; Zhang, M, 2020) |
| "Malignant melanoma is a common form of skin cancer that contains different cell types recognized by various cell surface markers." | ( Jobani, BM; Mohebi, E; Najafzadeh, N, 2020) |
| "Malignant melanoma is the deadliest skin cancer, due to its propensity to metastasize." | ( Allegra, M; Busà, R; De Cicco, P; Ercolano, G; Formisano, C; Ianaro, A; Taglialatela-Scafati, O, 2021) |
| "Malignant melanoma is the most aggressive form of skin cancer with high metastatic capacity." | ( Benedicto, A; Hernandez-Unzueta, I; Márquez, J; Sanz, E, 2021) |
| "Malignant melanoma is a life-threatening form of skin cancer with a low response rate to single-agent chemotherapy." | ( Chen, S; Liu, C; Song, M; Tao, Z; Xia, W; Zhang, W; Zhu, B, 2021) |
| "Malignant melanoma is a critical and aggressive skin tumor with a steeply rising incidence and a less favorable prognosis due to the lack of efficient treatment." | ( Fang, J; Huang, X; Liang, X; Liu, J; Wang, X; Yang, Y, 2021) |
| "Canine malignant melanoma is highly aggressive and generally chemoresistant." | ( Bonkobara, M; Kurita, S; Michishita, M; Miyamoto, R; Nagashima, T; Noguchi, S; Tamura, K; Tani, H; Yayoshi, N, 2021) |
| "Malignant melanoma is one of the most devastating types of cancer with rapid relapse and low survival rate." | ( Hu, L; Li, Q; Liu, G; Mu, Z; Sun, F; Wu, X; Zhang, D; Zhang, M; Zhang, W, 2021) |
| "Malignant melanoma is a well-known diagnostic pitfall, given its propensity to metastasize to different sites and mimic various entities." | ( Lajara, S; Landau, M, 2021) |
| "Malignant melanoma is a highly aggressive skin cancer characterized by an elevated grade of tumor cell plasticity." | ( Andreucci, E; Biagioni, A; Bianchini, F; Calorini, L; Del Rosso, M; Fibbi, G; Fucci, L; Guida, M; Laurenzana, A; Margheri, F; Nediani, C; Peppicelli, S; Ruzzolini, J; Serrat, S, 2022) |
| "Malignant melanoma is considered the most aggressive skin carcinoma with invasive growth patterns." | ( Du, Y; Gu, Y; Jiang, L; Liu, J; Tang, X; Wu, X, 2021) |
| "Malignant melanoma is an aggressive tumor with a high potential for distant metastases." | ( Amaya, S; Minami, T; Mitsui, T; Munemoto, Y; Nakanuma, Y; Saito, K; Shimada, M; Takashima, Y; Terada, T; Yamagishi, Y, 2021) |
| "Malignant melanoma is responsible for the majority of skin cancer-related deaths." | ( Banach, K; Beberok, A; Kowalska, J; Rok, J; Rzepka, Z; Wrześniok, D, 2021) |
| "Malignant melanoma is the most aggressive of skin cancers and the 19th most common cancer worldwide, with an estimated age-standardized incidence rate of 2." | ( Abbatepaolo, C; Arezzo, F; Bellitti, E; Cazzato, G; Cimmino, A; Colagrande, A; Cormio, G; Foti, C; Ingravallo, G; Lettini, T; Loizzi, V; Lospalluti, L; Resta, L; Romita, P; Rossi, R; Sablone, S, 2021) |
| "Malignant melanoma is rare in the pediatric population and management is largely extrapolated from adult guidelines." | ( Aldrink, JH; Baertschiger, RM; Fahy, AS; Helenowski, I; Lautz, TB; Wayne, JD, 2022) |
| "Malignant melanoma is regarded as the most aggressive form of skin cancer, and is responsible for most death caused by skin cancer." | ( Bing, T; Chen, H; Jin, S; Li, W; Shangguan, D; Wang, R, 2021) |
| "Malignant melanoma is the deadliest form of skin cancer and NRF2 has been proposed as a main regulator of tumor cell malignancy." | ( Depke, M; Gschwendtner, A; Hengstschläger, M; Hundsberger, H; Mikula, M; Schmidt, F; Trautinger, F; Weitzenböck, HP; Wiesner, C, 2022) |
| "Cutaneous malignant melanoma is the fastest growing and the most aggressive form of skin cancer that is diagnosed." | ( Juszczak, AM; Končić, MZ; Tomczyk, M; Wöelfle, U, 2022) |
| "Malignant melanoma is an aggressive and deadly form of skin cancer and novel and improved therapeutic options are needed." | ( Albino, M; Correia, I; Côrte-Real, L; Gaspar, MM; Lopes, J; Matos, CP; Mendes, F; Pessoa, JC; Reis, CP; Tomaz, AI; Viana, AS, 2022) |
| "Malignant melanoma is a malignant tumor with a poor prognosis." | ( Di Guardo, L, 2022) |
| "Malignant melanoma is an aggressive skin tumor with a rapidly increasing incidence and there is not yet a successful treatment strategy." | ( Aras, S; Cansaran-Duman, D; Eskiler, GG; Yangın, S, 2022) |
| "Cutaneous malignant melanoma is fastest-growing cancer in white populations with a large majority of dermal cancer death." | ( Abdi, F; Arkan, E; Eidizadeh, M; Gamizgy, YH; Mansouri, K; Naseriyeh, T; Valipour, E, 2023) |
| "Early diagnosis of malignant melanoma is critical for effective treatment and reduced patient mortality." | ( Hara, H; Harada, T; Hirai, S; Katoh, Y, 2022) |
| "Malignant melanoma is among the tumor entities with the highest increase of incidence worldwide." | ( Benz, F; Groeber-Becker, FK; Junger, C; Leikeim, A; Monaghan, MG; Neto, NGB; Schilling, B; Schmidt, FF; Tiltmann, K; Wußmann, M, 2022) |
| "Malignant melanoma is a skin cancer characterized by rapid development, poor prognosis and high mortality." | ( Góralczyk, A; Grabarska, A; Marzęda, P; Wróblewska-Łuczka, P; Łuszczki, JJ, 2022) |
| "Malignant melanoma is an aggressive skin cancer, accounting for the majority of skin cancer deaths." | ( Leenutaphong, P; Nararatwanchai, T; Phetchengkao, W; Poommarapan, K; Rummaneethorn, P; Srihirun, S; Srisubat, A; Suriyachan, K; Suwanpidokkul, N; Tancharoen, S, 2023) |
| "Malignant melanoma is considered a deadly aggressive form of skin cancer that frequently metastasizes to various distal organs, which harbors mutations of the BRAF or NRAS which occur in 30 to 50% of melanoma patients." | ( Godugu, C; Nagula, S; Pooladanda, V; Thatikonda, S; Tokala, R, 2023) |
| "(1) Malignant melanomas are dangerous skin cancers, and the treatment of melanomas with various cytostatic drugs often causes side effects and after their prolonged use resistance to these drugs appears." | ( Góralczyk, A; Wróblewska-Łuczka, P; Łuszczki, JJ, 2023) |
| "Malignant melanoma is one of the most aggressive and lethal skin cancer." | ( Ding, C; Ge, X; Jiang, J; Li, S; Li, Y; Qiao, Y; Wang, D; Wang, M; Wang, Y; Zheng, X, 2023) |
| "Malignant melanoma is challenging to treat, and metastatic cases need chemotherapy strategies." | ( Cserepes, M; Kigyós, A; Ladányi, A; Surguta, SE; Tóvári, J; Vári-Mező, D, 2023) |
| "Malignant melanoma is a dangerous skin cancer, accounting for the majority of skin cancer-related deaths." | ( Wilanowski, T; Wnuk, J, 2023) |
| Drug | Indicated | Relationship Strength | Studies | Trials |
|---|
| dinitrochlorobenzene | 0 | medium | 79 | 5 |
| alpha-hydroxyglutarate | 0 | low | 1 | 0 |
| protocatechuic acid | 0 | low | 2 | 0 |
| 3-hydroxyanthranilic acid | 0 | low | 1 | 0 |
| acetoacetic acid | 0 | low | 3 | 0 |
| phosphoserine | 0 | low | 5 | 0 |
| gamma-aminobutyric acid | 0 | low | 6 | 0 |
| 4-hydroxyphenylacetic acid | 0 | low | 2 | 0 |
| aminolevulinic acid | 0 | medium | 40 | 3 |
| 5-hydroxytryptophan | 0 | low | 3 | 0 |
| acetic acid | 0 | low | 8 | 0 |
| acetone | 0 | low | 8 | 0 |
| adenine | 0 | medium | 20 | 1 |
| adipic acid | 0 | low | 4 | 0 |
| allantoin | 0 | low | 2 | 0 |
| ammonium hydroxide | 0 | low | 3 | 0 |
| anthranilic acid | 0 | low | 1 | 0 |
| quinacrine | 0 | low | 6 | 0 |
| beta-alanine | 0 | low | 1 | 0 |
| benzene | 0 | medium | 4 | 1 |
| benzoic acid | 0 | low | 3 | 0 |
| benzyl alcohol | 0 | low | 1 | 0 |
| bromide | 0 | low | 2 | 0 |
| 1-butanol | 0 | low | 6 | 0 |
| butyric acid | 0 | low | 16 | 0 |
| cadaverine | 0 | low | 8 | 0 |
| carbamates | 0 | medium | 74 | 9 |
| carbamyl phosphate | 0 | low | 1 | 0 |
| ureidosuccinic acid | 0 | low | 1 | 0 |
| carbon monoxide | 0 | medium | 4 | 1 |
| aminooxyacetic acid | 0 | low | 1 | 0 |
| carnitine | 0 | low | 4 | 0 |
| catechol | 0 | low | 2 | 0 |
| methane | 0 | low | 25 | 0 |
| choline | 0 | low | 8 | 0 |
| citric acid, anhydrous | 0 | low | 13 | 0 |
| chlorine | 0 | low | 32 | 0 |
| hydrochloric acid | 0 | low | 1 | 0 |
| coumarin | 0 | medium | 7 | 2 |
| cuminaldehyde | 0 | low | 1 | 0 |
| salicylic acid | 0 | medium | 324 | 1 |
| digallic acid | 0 | low | 1 | 0 |
| phloroglucinol | 0 | low | 2 | 0 |
| gallic acid | 0 | low | 10 | 0 |
| octanoic acid | 0 | low | 2 | 0 |
| hydrogen sulfide | 0 | low | 6 | 0 |
| 4-aminophenol | 0 | low | 3 | 0 |
| dihydrolipoic acid | 0 | low | 1 | 0 |
| trimethylenediamine | 0 | low | 1 | 0 |
| 3-hydroxybutyric acid | 0 | low | 4 | 0 |
| guaiacol | 0 | low | 1 | 0 |
| n(1)-acetylspermidine | 0 | low | 2 | 0 |
| malic acid | 0 | low | 1 | 0 |
| phosphonoacetic acid | 0 | medium | 14 | 1 |
| 3,4-dihydroxyphenylacetic acid | 0 | low | 5 | 0 |
| aminocaproic acid | 0 | low | 4 | 0 |
| creatine | 0 | low | 3 | 0 |
| cytosine | 0 | low | 26 | 0 |
| lactic acid | 0 | low | 72 | 0 |
| 5,6-dihydroorotate | 0 | low | 1 | 0 |
| diacetyl | 0 | low | 1 | 0 |
| dihydroxyacetone | 0 | low | 3 | 0 |
| dimethyl sulfoxide | 0 | low | 36 | 0 |
| ethanolamine | 0 | low | 1 | 0 |
| formaldehyde | 0 | medium | 119 | 2 |
| formamide | 0 | low | 1 | 0 |
| glycine | 0 | low | 28 | 0 |
| glycerol | 0 | low | 9 | 0 |
| glycolic acid | 0 | low | 1 | 0 |
| glyoxylic acid | 0 | low | 1 | 0 |
| glycocyamine | 0 | low | 1 | 0 |
| hydrogen cyanide | 0 | low | 1 | 0 |
| hydrogen carbonate | 0 | low | 5 | 0 |
| dalteparin | 0 | medium | 8 | 1 |
| histamine | 0 | medium | 52 | 7 |
| homogentisic acid | 0 | low | 1 | 0 |
| hydrogen | 0 | low | 4 | 0 |
| hydroquinone | 0 | low | 8 | 0 |
| hydroxylamine | 0 | low | 1 | 0 |
| imidazole | 0 | low | 8 | 0 |
| indole | 0 | low | 3 | 0 |
| indoleacetic acid | 0 | low | 3 | 0 |
| iodine | 0 | medium | 20 | 1 |
| dihydroxyphenylalanine | 0 | medium | 261 | 1 |
| kynurenine | 0 | medium | 19 | 1 |
| lipoamide | 0 | low | 1 | 0 |
| thioctic acid | 0 | low | 3 | 0 |
| pyruvaldehyde | 0 | low | 2 | 0 |
| methanol | 0 | low | 10 | 0 |
| phytic acid | 0 | medium | 7 | 1 |
| inositol | 0 | low | 3 | 0 |
| melatonin | 0 | medium | 62 | 4 |
| croton oil | 0 | low | 3 | 0 |
| n-acetylserotonin | 0 | low | 4 | 0 |
| n'-acetylspermine | 0 | low | 1 | 0 |
| nickel | 0 | medium | 9 | 1 |
| niacinamide | 0 | medium | 122 | 26 |
| niacin | 0 | low | 4 | 0 |
| nitrates | 0 | medium | 13 | 3 |
| nitroxyl | 0 | medium | 2 | 1 |
| nitrites | 0 | medium | 13 | 3 |
| nitrous oxide | 0 | low | 2 | 0 |
| 1-octanol | 0 | low | 1 | 0 |
| hydroxide ion | 0 | low | 1 | 0 |
| orotic acid | 0 | low | 3 | 0 |
| oxaloacetic acid | 0 | low | 1 | 0 |
| oxalic acid | 0 | low | 2 | 0 |
| oxamic acid | 0 | low | 2 | 0 |
| 4-aminobenzoic acid | 0 | low | 6 | 0 |
| triphosphoric acid | 0 | low | 2 | 0 |
| palmitic acid | 0 | low | 4 | 0 |
| phenol | 0 | low | 6 | 0 |
| phenylpyruvic acid | 0 | low | 1 | 0 |
| phenylacetic acid | 0 | low | 3 | 0 |
| phosphoenolpyruvate | 0 | low | 3 | 0 |
| phosphorylcholine | 0 | medium | 8 | 1 |
| phosphorylethanolamine | 0 | low | 1 | 0 |
| phthalic acid | 0 | low | 1 | 0 |
| porphobilinogen | 0 | low | 2 | 0 |
| diphosphoric acid | 0 | low | 1 | 0 |
| propylene glycol | 0 | low | 1 | 0 |
| 1-propanol | 0 | low | 1 | 0 |
| propionic acid | 0 | low | 2 | 0 |
| pteridines | 0 | medium | 12 | 2 |
| purine | 0 | low | 2 | 0 |
| putrescine | 0 | low | 20 | 0 |
| pyrazole | 0 | low | 2 | 0 |
| pyridoxal | 0 | low | 3 | 0 |
| pyridoxal phosphate | 0 | low | 5 | 0 |
| pyridoxine | 0 | low | 3 | 0 |
| pyrogallol | 0 | low | 7 | 0 |
| pyruvic acid | 0 | low | 12 | 0 |
| thiosulfates | 0 | low | 1 | 0 |
| sarcosine | 0 | low | 1 | 0 |
| selenic acid | 0 | low | 1 | 0 |
| sulfites | 0 | low | 3 | 0 |
| spermidine | 0 | low | 26 | 0 |
| spermine | 0 | medium | 39 | 1 |
| succinic acid | 0 | medium | 6 | 1 |
| taurine | 0 | medium | 14 | 4 |
| thymine | 0 | low | 9 | 0 |
| toluene | 0 | medium | 6 | 1 |
| tryptamine | 0 | low | 1 | 0 |
| uracil | 0 | low | 11 | 0 |
| uric acid | 0 | medium | 5 | 1 |
| urea | 0 | medium | 41 | 5 |
| vanillin | 0 | low | 2 | 0 |
| xanthine | 0 | low | 2 | 0 |
| catechin | 0 | low | 1 | 0 |
| 8-hydroxy-2-(di-n-propylamino)tetralin | 0 | low | 1 | 0 |
| alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid | 0 | low | 1 | 0 |
| normetanephrine | 0 | low | 2 | 0 |
| vanilmandelic acid | 0 | low | 4 | 0 |
| menthol | 0 | low | 3 | 0 |
| perillic acid | 0 | low | 1 | 0 |
| 1,10-phenanthroline | 0 | low | 6 | 0 |
| 1,2-dioctanoylglycerol | 0 | low | 1 | 0 |
| s,s'-1,4-phenylene-bis(1,2-ethanediyl)bis-isothiourea | 0 | low | 1 | 0 |
| 1-(1-naphthyl)piperazine | 0 | low | 1 | 0 |
| pk 11195 | 0 | low | 1 | 0 |
| 1-anilino-8-naphthalenesulfonate | 0 | low | 15 | 0 |
| 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine | 0 | low | 3 | 0 |
| n-(3-(aminomethyl)benzyl)acetamidine | 0 | low | 2 | 0 |
| 2,2'-dipyridyl | 0 | low | 2 | 0 |
| 2,4-dinitrophenol | 0 | low | 4 | 0 |
| 2-aminofluorene | 0 | low | 1 | 0 |
| mercaptoethanol | 0 | low | 4 | 0 |
| 2-aminoethoxydiphenyl borate | 0 | low | 1 | 0 |
| 3,4-methylenedioxyamphetamine | 0 | low | 1 | 0 |
| amitrole | 0 | low | 1 | 0 |
| 3-aminobenzamide | 0 | medium | 9 | 1 |
| 3-methoxytyrosine | 0 | low | 1 | 0 |
| 3-methylcholanthrene | 0 | low | 37 | 0 |
| 3-nitropropionic acid | 0 | low | 1 | 0 |
| ro 5-4864 | 0 | low | 2 | 0 |
| 4-(2-aminoethyl)benzenesulfonylfluoride | 0 | low | 2 | 0 |
| homovanillic acid | 0 | low | 7 | 0 |
| 5,5-dimethyl-1-pyrroline-1-oxide | 0 | low | 1 | 0 |
| phenytoin | 0 | medium | 7 | 1 |
| hydroxyindoleacetic acid | 0 | medium | 5 | 2 |
| 5-methoxytryptamine | 0 | low | 4 | 0 |
| 6-chloromelatonin | 0 | low | 3 | 0 |
| 6-hydroxymelatonin | 0 | low | 4 | 0 |
| etofylline | 0 | low | 1 | 0 |
| oxyquinoline | 0 | medium | 5 | 1 |
| aa 861 | 0 | low | 1 | 0 |
| 2,2'-azobis(2-amidinopropane) | 0 | low | 2 | 0 |
| acetaminophen | 0 | medium | 14 | 3 |
| acetazolamide | 0 | low | 4 | 0 |
| acetochlor | 0 | low | 1 | 0 |
| beta-aminoethyl isothiourea | 0 | low | 2 | 0 |
| tyrphostin ag 1024 | 0 | low | 1 | 0 |
| albendazole | 0 | medium | 6 | 1 |
| alendronate | 0 | low | 2 | 0 |
| alpha-cyano-4-hydroxycinnamate | 0 | low | 4 | 0 |
| altretamine | 0 | low | 3 | 0 |
| am 251 | 0 | low | 2 | 0 |
| amantadine | 0 | low | 2 | 0 |
| ametantrone | 0 | low | 2 | 0 |
| amfenac | 0 | low | 1 | 0 |
| diatrizoic acid | 0 | low | 6 | 0 |
| amifostine anhydrous | 0 | medium | 12 | 4 |
| aminoglutethimide | 0 | medium | 3 | 1 |
| pimagedine | 0 | low | 2 | 0 |
| p-aminohippuric acid | 0 | low | 1 | 0 |
| theophylline | 0 | low | 39 | 0 |
| amiodarone | 0 | low | 1 | 0 |
| amitriptyline | 0 | low | 2 | 0 |
| amlexanox | 0 | low | 2 | 0 |
| amlodipine | 0 | low | 2 | 0 |
| amobarbital | 0 | low | 1 | 0 |
| amodiaquine | 0 | low | 1 | 0 |
| amsacrine | 0 | medium | 21 | 4 |
| anastrozole | 0 | low | 1 | 0 |
| anthralin | 0 | low | 1 | 0 |
| antipyrine | 0 | low | 3 | 0 |
| 2-amino-4-phosphonobutyric acid | 0 | low | 1 | 0 |
| aspirin | 0 | medium | 49 | 3 |
| atenolol | 0 | low | 2 | 0 |
| atrazine | 0 | low | 2 | 0 |
| aurintricarboxylic acid | 0 | low | 1 | 0 |
| azathioprine | 0 | low | 18 | 0 |
| azelaic acid | 0 | low | 29 | 0 |
| azobenzene | 0 | low | 1 | 0 |
| aztreonam | 0 | low | 1 | 0 |
| bay-k-8644 | 0 | low | 1 | 0 |
| bendroflumethiazide | 0 | low | 1 | 0 |
| benserazide | 0 | low | 4 | 0 |
| benzamide | 0 | low | 3 | 0 |
| benzbromarone | 0 | low | 1 | 0 |
| benzo(a)pyrene | 0 | low | 1 | 0 |
| benzyl isothiocyanate | 0 | low | 4 | 0 |
| bepridil | 0 | low | 1 | 0 |
| berberine | 0 | low | 12 | 0 |
| diminazene | 0 | low | 1 | 0 |
| 5-methoxypsoralen | 0 | low | 2 | 0 |
| beta-naphthoflavone | 0 | low | 1 | 0 |
| propiolactone | 0 | low | 1 | 0 |
| bay h 4502 | 0 | low | 1 | 0 |
| bisbenzimidazole | 0 | low | 6 | 0 |
| bisoprolol | 0 | low | 4 | 0 |
| ym 58483 | 0 | low | 1 | 0 |
| bupivacaine | 0 | medium | 9 | 1 |
| busulfan | 0 | medium | 29 | 15 |
| caffeine | 0 | medium | 30 | 1 |
| verapamil | 0 | low | 20 | 0 |
| calmidazolium | 0 | low | 1 | 0 |
| camphor, (+-)-isomer | 0 | low | 1 | 0 |
| candesartan | 0 | low | 3 | 0 |
| cannabinol | 0 | low | 1 | 0 |
| carbamazepine | 0 | medium | 2 | 1 |
| carbazilquinone | 0 | low | 1 | 0 |
| carmofur | 0 | low | 2 | 0 |
| carmustine | 0 | medium | 185 | 66 |
| carprofen | 0 | low | 1 | 0 |
| carvedilol | 0 | low | 3 | 0 |
| carbonyl cyanide m-chlorophenyl hydrazone | 0 | low | 2 | 0 |
| celecoxib | 0 | medium | 26 | 5 |
| cetirizine | 0 | low | 1 | 0 |
| cetyltrimethylammonium ion | 0 | low | 1 | 0 |
| cetylpyridinium | 0 | low | 1 | 0 |
| cgp 37157 | 0 | low | 2 | 0 |
| chelerythrine | 0 | low | 5 | 0 |
| chlorambucil | 0 | medium | 36 | 3 |
| chloroquine | 0 | medium | 61 | 4 |
| chlorpromazine | 0 | medium | 27 | 2 |
| chlorpropamide | 0 | low | 1 | 0 |
| chlorpyrifos | 0 | low | 1 | 0 |
| ciglitazone | 0 | low | 7 | 0 |
| cilostazol | 0 | low | 1 | 0 |
| cimetidine | 0 | medium | 38 | 6 |
| ciprofloxacin | 0 | low | 4 | 0 |
| cisapride | 0 | low | 1 | 0 |
| citalopram | 0 | medium | 2 | 1 |
| 5,7-dimethoxycoumarin | 0 | low | 5 | 0 |
| clidinium | 0 | low | 1 | 0 |
| clioquinol | 0 | low | 1 | 0 |
| clobenpropit | 0 | low | 1 | 0 |
| clofazimine | 0 | low | 1 | 0 |
| clofibrate | 0 | low | 1 | 0 |
| clofibric acid | 0 | low | 1 | 0 |
| clomipramine | 0 | low | 1 | 0 |
| clonazepam | 0 | low | 2 | 0 |
| clonidine | 0 | low | 2 | 0 |
| clotrimazole | 0 | low | 6 | 0 |
| cloxyquin | 0 | low | 1 | 0 |
| 4-cresol | 0 | low | 1 | 0 |
| cyclocreatine | 0 | low | 1 | 0 |
| cycloleucine | 0 | low | 1 | 0 |
| cystamine | 0 | low | 6 | 0 |
| dantrolene | 0 | low | 2 | 0 |
| dapi | 0 | low | 6 | 0 |
| dapsone | 0 | medium | 3 | 1 |
| debrisoquin | 0 | low | 1 | 0 |
| 2,3-dimethoxy-5-methyl-6-decyl-1,4-benzoquinone | 0 | low | 2 | 0 |
| deferoxamine | 0 | low | 11 | 0 |
| dequalinium | 0 | low | 1 | 0 |
| desipramine | 0 | low | 2 | 0 |
| eflornithine | 0 | medium | 33 | 1 |
| diazepam | 0 | low | 8 | 0 |
| diclofenac | 0 | low | 7 | 0 |
| dichlorodiphenyl dichloroethylene | 0 | low | 1 | 0 |
| ddt | 0 | low | 2 | 0 |
| 3,4-dihydroxybenzohydroxamic acid | 0 | low | 1 | 0 |
| diethylcarbamazine | 0 | low | 1 | 0 |
| pentetic acid | 0 | medium | 44 | 4 |
| dihydrocytochalasin b | 0 | low | 1 | 0 |
| 3,3'-diindolylmethane | 0 | low | 3 | 0 |
| dimaprit | 0 | low | 5 | 0 |
| diphenhydramine | 0 | medium | 4 | 1 |
| diphenyleneiodonium | 0 | low | 2 | 0 |
| dipyridamole | 0 | low | 7 | 0 |
| stallimycin | 0 | low | 1 | 0 |
| disulfiram | 0 | low | 12 | 0 |
| valproic acid | 0 | medium | 23 | 2 |
| racemetirosine | 0 | low | 3 | 0 |
| droperidol | 0 | medium | 1 | 1 |
| dsp 4 | 0 | low | 1 | 0 |
| ebselen | 0 | low | 1 | 0 |
| 9-(2-hydroxy-3-nonyl)adenine | 0 | low | 2 | 0 |
| ellipticine | 0 | low | 3 | 0 |
| embelin | 0 | low | 1 | 0 |
| emodin | 0 | low | 6 | 0 |
| enoxacin | 0 | low | 1 | 0 |
| erythrosine | 0 | low | 85 | 0 |
| etanidazole | 0 | low | 6 | 0 |
| ethacrynic acid | 0 | low | 4 | 0 |
| ethenzamide | 0 | low | 1 | 0 |
| ether | 0 | low | 1 | 0 |
| etidronate | 0 | low | 1 | 0 |
| famotidine | 0 | medium | 11 | 3 |
| carbonyl cyanide p-trifluoromethoxyphenylhydrazone | 0 | low | 1 | 0 |
| felodipine | 0 | low | 1 | 0 |
| fenbendazole | 0 | low | 2 | 0 |
| fenofibrate | 0 | low | 3 | 0 |
| berotek | 0 | low | 1 | 0 |
| fentanyl | 0 | low | 2 | 0 |
| fluconazole | 0 | medium | 1 | 1 |
| flucytosine | 0 | low | 10 | 0 |
| fluphenazine | 0 | low | 3 | 0 |
| flumazenil | 0 | low | 2 | 0 |
| flunitrazepam | 0 | low | 2 | 0 |
| fluorouracil | 0 | medium | 203 | 11 |
| fluoxetine | 0 | low | 3 | 0 |
| flutamide | 0 | low | 2 | 0 |
| furosemide | 0 | low | 2 | 0 |
| gabapentin | 0 | low | 3 | 0 |
| gemfibrozil | 0 | low | 3 | 0 |
| gentamicin | 0 | low | 6 | 0 |
| glutaral | 0 | low | 5 | 0 |
| glyburide | 0 | low | 2 | 0 |
| glyphosate | 0 | low | 2 | 0 |
| gö6983 | 0 | low | 1 | 0 |
| go 6976 | 0 | low | 5 | 0 |
| gossypol | 0 | low | 10 | 0 |
| guaifenesin | 0 | low | 3 | 0 |
| guanethidine | 0 | low | 1 | 0 |
| guanidine | 0 | low | 3 | 0 |
| n-(2-(methylamino)ethyl)-5-isoquinolinesulfonamide | 0 | low | 1 | 0 |
| 1-(5-isoquinolinesulfonyl)-2-methylpiperazine | 0 | low | 7 | 0 |
| ha 1004 | 0 | low | 1 | 0 |
| ha14-1 | 0 | low | 1 | 0 |
| haloperidol | 0 | low | 10 | 0 |
| haloprogin | 0 | low | 1 | 0 |
| halothane | 0 | low | 3 | 0 |
| miltefosine | 0 | low | 2 | 0 |
| hexestrol | 0 | low | 1 | 0 |
| hexylresorcinol | 0 | low | 1 | 0 |
| beta-thujaplicin | 0 | low | 3 | 0 |
| hexamethylene bisacetamide | 0 | low | 5 | 0 |
| ethidium | 0 | low | 14 | 0 |
| hydralazine | 0 | low | 4 | 0 |
| hydrochlorothiazide | 0 | low | 16 | 0 |
| p-hydroxyamphetamine | 0 | low | 1 | 0 |
| hydroxychloroquine | 0 | medium | 12 | 5 |
| hydroxyurea | 0 | medium | 73 | 12 |
| hydroxyzine | 0 | low | 1 | 0 |
| hypericin | 0 | low | 9 | 0 |
| ibuprofen | 0 | medium | 4 | 1 |
| lidocaine | 0 | low | 10 | 0 |
| ifosfamide | 0 | medium | 14 | 1 |
| indapamide | 0 | low | 1 | 0 |
| indole-3-carbinol | 0 | low | 7 | 0 |
| indomethacin | 0 | medium | 45 | 8 |
| iodoacetamide | 0 | low | 4 | 0 |
| iodoquinol | 0 | low | 1 | 0 |
| iofetamine | 0 | medium | 32 | 1 |
| iohexol | 0 | low | 5 | 0 |
| iomeprol | 0 | low | 2 | 0 |
| iopromide | 0 | low | 2 | 0 |
| iothalamic acid | 0 | low | 1 | 0 |
| ioversol | 0 | low | 1 | 0 |
| ioxaglate | 0 | low | 1 | 0 |
| 1-methyl-3-isobutylxanthine | 0 | low | 22 | 0 |
| isocarboxazid | 0 | low | 1 | 0 |
| isoconazole | 0 | low | 1 | 0 |
| isoflurane | 0 | low | 2 | 0 |
| isoniazid | 0 | low | 8 | 0 |
| 2-propanol | 0 | medium | 382 | 1 |
| isoproterenol | 0 | low | 6 | 0 |
| juglone | 0 | low | 4 | 0 |
| staurosporine aglycone | 0 | low | 2 | 0 |
| ketamine | 0 | low | 2 | 0 |
| ketanserin | 0 | low | 1 | 0 |
| ketoconazole | 0 | low | 3 | 0 |
| ketoprofen | 0 | low | 1 | 0 |
| ketorolac | 0 | low | 1 | 0 |
| khellin | 0 | low | 27 | 0 |
| kinetin | 0 | low | 3 | 0 |
| kojic acid | 0 | low | 22 | 0 |
| kynurenic acid | 0 | low | 4 | 0 |
| mimosine | 0 | low | 3 | 0 |
| labetalol | 0 | low | 1 | 0 |
| lamotrigine | 0 | low | 1 | 0 |
| lansoprazole | 0 | low | 3 | 0 |
| lapachol | 0 | low | 2 | 0 |
| beta-lapachone | 0 | low | 4 | 0 |
| lavendustin a | 0 | low | 1 | 0 |
| leflunomide | 0 | low | 3 | 0 |
| letrozole | 0 | low | 1 | 0 |
| lomefloxacin | 0 | low | 1 | 0 |
| lomustine | 0 | medium | 114 | 30 |
| loperamide | 0 | low | 1 | 0 |
| loratadine | 0 | low | 1 | 0 |
| lorazepam | 0 | low | 1 | 0 |
| losartan | 0 | low | 5 | 0 |
| ly 303511 | 0 | low | 1 | 0 |
| 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one | 0 | low | 38 | 0 |
| 6-anilino-5,8-quinolinedione | 0 | low | 1 | 0 |
| maprotiline | 0 | low | 1 | 0 |
| mebendazole | 0 | low | 7 | 0 |
| mechlorethamine | 0 | medium | 55 | 1 |
| meclofenamic acid | 0 | low | 1 | 0 |
| sarkolysin | 0 | low | 1 | 0 |
| vitamin k 3 | 0 | low | 4 | 0 |
| meperidine | 0 | low | 1 | 0 |
| mesalamine | 0 | low | 1 | 0 |
| metformin | 0 | medium | 43 | 2 |
| methadone | 0 | low | 1 | 0 |
| methiothepin | 0 | low | 1 | 0 |
| methocarbamol | 0 | low | 1 | 0 |
| methoxyamine | 0 | low | 1 | 0 |
| methoxsalen | 0 | low | 16 | 0 |
| nocodazole | 0 | low | 7 | 0 |
| methyl methanesulfonate | 0 | low | 4 | 0 |
| methylphenidate | 0 | low | 4 | 0 |
| metoclopramide | 0 | medium | 3 | 2 |
| metoprolol | 0 | low | 3 | 0 |
| metronidazole | 0 | low | 8 | 0 |
| metyrapone | 0 | low | 1 | 0 |
| mianserin | 0 | low | 2 | 0 |
| miconazole | 0 | low | 2 | 0 |
| midazolam | 0 | medium | 2 | 1 |
| mirtazapine | 0 | low | 2 | 0 |
| mitotane | 0 | low | 2 | 0 |
| mitoxantrone | 0 | medium | 35 | 1 |
| modafinil | 0 | low | 1 | 0 |
| molsidomine | 0 | low | 2 | 0 |
| monodansylcadaverine | 0 | low | 3 | 0 |
| entinostat | 0 | medium | 7 | 3 |
| n(1),n(11)-diethylnorspermine | 0 | medium | 14 | 1 |
| n(1), n(12)-diethylspermine | 0 | low | 2 | 0 |
| deet | 0 | low | 2 | 0 |
| n-(8-aminooctyl)-5-iodonaphthalene-1-sulfonamide | 0 | low | 1 | 0 |
| n-(6-aminohexyl)-1-naphthalenesulfonamide | 0 | low | 1 | 0 |
| ethylmaleimide | 0 | low | 3 | 0 |
| clorgyline | 0 | low | 1 | 0 |
| deoxyepinephrine | 0 | low | 1 | 0 |
| nalidixic acid | 0 | low | 1 | 0 |
| activins | 0 | low | 6 | 0 |
| naphazoline | 0 | low | 1 | 0 |
| neostigmine | 0 | low | 2 | 0 |
| nevirapine | 0 | low | 1 | 0 |
| niclosamide | 0 | low | 4 | 0 |
| nifedipine | 0 | low | 4 | 0 |
| nimesulide | 0 | low | 2 | 0 |
| nimodipine | 0 | low | 1 | 0 |
| nitidine | 0 | low | 1 | 0 |
| nitroglycerin | 0 | medium | 1 | 1 |
| masoprocol | 0 | low | 1 | 0 |
| nortriptyline | 0 | low | 2 | 0 |
| n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide | 0 | low | 6 | 0 |
| o(6)-benzylguanine | 0 | medium | 8 | 1 |
| octopamine | 0 | low | 1 | 0 |
| ofloxacin | 0 | medium | 4 | 1 |
| olomoucine | 0 | low | 2 | 0 |
| omeprazole | 0 | medium | 3 | 1 |
| ondansetron | 0 | medium | 8 | 4 |
| 1,2-cyclohexanediamine | 0 | low | 1 | 0 |
| oxidopamine | 0 | low | 1 | 0 |
| oxybenzone | 0 | low | 1 | 0 |
| oxybutynin | 0 | low | 2 | 0 |
| oxyphenbutazone | 0 | low | 1 | 0 |
| aminosalicylic acid | 0 | low | 1 | 0 |
| quinone | 0 | low | 2 | 0 |
| fenclonine | 0 | low | 1 | 0 |
| p-fluorophenylalanine | 0 | low | 2 | 0 |
| pamidronate | 0 | low | 4 | 0 |
| pantoprazole | 0 | low | 1 | 0 |
| papaverine | 0 | low | 4 | 0 |
| pargyline | 0 | low | 1 | 0 |
| patulin | 0 | low | 1 | 0 |
| pca 4248 | 0 | low | 1 | 0 |
| pd 153035 | 0 | low | 2 | 0 |
| pd 169316 | 0 | low | 1 | 0 |
| pd 98059 | 0 | low | 31 | 0 |
| pentamidine | 0 | low | 4 | 0 |
| pentobarbital | 0 | low | 2 | 0 |
| pentoxifylline | 0 | medium | 16 | 2 |
| perhexiline | 0 | low | 1 | 0 |
| perphenazine | 0 | low | 2 | 0 |
| phenacetin | 0 | low | 3 | 0 |
| phenobarbital | 0 | low | 2 | 0 |
| 4-phenylbutyric acid | 0 | low | 1 | 0 |
| oxophenylarsine | 0 | low | 1 | 0 |
| phloretin | 0 | low | 3 | 0 |
| o-phthalaldehyde | 0 | low | 1 | 0 |
| pifithrin | 0 | low | 4 | 0 |
| pioglitazone | 0 | medium | 4 | 1 |
| piperazine | 0 | low | 1 | 0 |
| potassium chloride | 0 | low | 8 | 0 |
| potassium iodide | 0 | low | 4 | 0 |
| 4-aminobenzoic acid | 0 | low | 3 | 0 |
| ag 1879 | 0 | low | 3 | 0 |
| prazosin | 0 | low | 2 | 0 |
| prilocaine | 0 | low | 1 | 0 |
| proadifen | 0 | low | 1 | 0 |
| probenecid | 0 | low | 2 | 0 |
| procainamide | 0 | low | 2 | 0 |
| procaine | 0 | low | 5 | 0 |
| procarbazine | 0 | medium | 38 | 8 |
| prochlorperazine | 0 | low | 3 | 0 |
| propafenone | 0 | low | 1 | 0 |
| propidium | 0 | low | 12 | 0 |
| propofol | 0 | medium | 3 | 2 |
| propranolol | 0 | medium | 18 | 1 |
| propyl gallate | 0 | low | 1 | 0 |
| propyliodone | 0 | low | 1 | 0 |
| protoporphyrin ix | 0 | low | 14 | 0 |
| pyrilamine | 0 | low | 1 | 0 |
| pyrimethamine | 0 | medium | 8 | 1 |
| 1,2,5,8-tetrahydroxy anthraquinone | 0 | low | 1 | 0 |
| quipazine | 0 | low | 1 | 0 |
| 6-nitroquipazine | 0 | low | 1 | 0 |
| resorcinol | 0 | low | 3 | 0 |
| riluzole | 0 | medium | 15 | 3 |
| ro 31-8220 | 0 | low | 3 | 0 |
| 4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone | 0 | low | 1 | 0 |
| rofecoxib | 0 | medium | 5 | 2 |
| rolipram | 0 | low | 3 | 0 |
| aurin | 0 | low | 1 | 0 |
| saccharin | 0 | low | 1 | 0 |
| salicylamide | 0 | low | 1 | 0 |
| sanguinarine | 0 | low | 2 | 0 |
| sb 202190 | 0 | low | 6 | 0 |
| suberoyl bis-hydroxamic acid | 0 | low | 3 | 0 |
| carbamylhydrazine | 0 | low | 1 | 0 |
| semustine | 0 | medium | 44 | 12 |
| sevoflurane | 0 | low | 1 | 0 |
| linsidomine | 0 | low | 2 | 0 |
| sodium fluoride | 0 | medium | 6 | 1 |
| sodium iodide | 0 | low | 1 | 0 |
| sotalol | 0 | low | 1 | 0 |
| spiperone | 0 | low | 1 | 0 |
| stearic acid | 0 | low | 1 | 0 |
| imatinib | 0 | low | 1 | 0 |
| streptonigrin | 0 | medium | 9 | 2 |
| vorinostat | 0 | medium | 22 | 3 |
| succinylcholine | 0 | low | 1 | 0 |
| sulfamethazine | 0 | low | 3 | 0 |
| sulfaquinoxaline | 0 | low | 1 | 0 |
| sulfasalazine | 0 | low | 1 | 0 |
| sulforaphane | 0 | medium | 10 | 1 |
| suramin | 0 | medium | 7 | 1 |
| tazarotene | 0 | low | 3 | 0 |
| tegafur | 0 | low | 3 | 0 |
| temazepam | 0 | low | 1 | 0 |
| temozolomide | 0 | medium | 317 | 96 |
| terbutaline | 0 | low | 1 | 0 |
| terfenadine | 0 | low | 3 | 0 |
| tetracaine | 0 | low | 3 | 0 |
| tetraethylammonium | 0 | low | 3 | 0 |
| thalidomide | 0 | medium | 42 | 23 |
| thioridazine | 0 | low | 1 | 0 |
| thiotepa | 0 | medium | 72 | 1 |
| ticlopidine | 0 | low | 4 | 0 |
| tilorone | 0 | low | 3 | 0 |
| tranexamic acid | 0 | medium | 6 | 1 |
| trapidil | 0 | low | 1 | 0 |
| trazodone | 0 | low | 2 | 0 |
| triclosan | 0 | low | 2 | 0 |
| trifluoperazine | 0 | low | 5 | 0 |
| trimetrexate | 0 | low | 2 | 0 |
| trioxsalen | 0 | low | 7 | 0 |
| troglitazone | 0 | low | 3 | 0 |
| tropicamide | 0 | low | 1 | 0 |
| thenoyltrifluoroacetone | 0 | low | 1 | 0 |
| tyramine | 0 | low | 5 | 0 |
| urethane | 0 | medium | 7 | 1 |
| usnic acid | 0 | low | 2 | 0 |
| w 7 | 0 | low | 6 | 0 |
| pirinixic acid | 0 | low | 1 | 0 |
| 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-((phenylamino)carbonyl)-2h-tetrazolium hydroxide | 0 | low | 1 | 0 |
| 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole | 0 | low | 1 | 0 |
| zaleplon | 0 | low | 1 | 0 |
| zardaverine | 0 | low | 1 | 0 |
| zinc chloride | 0 | low | 8 | 0 |
| zolpidem | 0 | low | 2 | 0 |
| mitomycin | 0 | medium | 92 | 8 |
| corticosterone | 0 | low | 5 | 0 |
| prednisolone | 0 | medium | 52 | 1 |
| estriol | 0 | low | 3 | 0 |
| reserpine | 0 | low | 4 | 0 |
| phentolamine | 0 | low | 2 | 0 |
| sorbitol | 0 | low | 2 | 0 |
| thymidine | 0 | medium | 195 | 3 |
| floxuridine | 0 | low | 17 | 0 |
| benzimidazole | 0 | low | 2 | 0 |
| triethylenemelamine | 0 | low | 3 | 0 |
| 2-aminophenol | 0 | low | 1 | 0 |
| bromouracil | 0 | low | 1 | 0 |
| hydroxyproline | 0 | low | 6 | 0 |
| thyroxine | 0 | low | 18 | 0 |
| carbachol | 0 | low | 5 | 0 |
| spironolactone | 0 | low | 1 | 0 |
| prednisolone acetate | 0 | low | 2 | 0 |
| aldosterone | 0 | low | 3 | 0 |
| penicillamine | 0 | medium | 12 | 1 |
| prednisone | 0 | medium | 71 | 1 |
| estrone | 0 | low | 4 | 0 |
| fluprednisolone | 0 | low | 1 | 0 |
| methylprednisolone acetate | 0 | low | 1 | 0 |
| dehydroepiandrosterone | 0 | low | 2 | 0 |
| dichlororibofuranosylbenzimidazole | 0 | low | 2 | 0 |
| 2-acetylaminofluorene | 0 | low | 2 | 0 |
| adrenochrome | 0 | low | 4 | 0 |
| azauridine | 0 | low | 1 | 0 |
| penicillin g | 0 | low | 1 | 0 |
| idoxuridine | 0 | low | 39 | 0 |
| pilocarpine | 0 | low | 1 | 0 |
| pentylenetetrazole | 0 | low | 1 | 0 |
| triiodothyronine | 0 | low | 8 | 0 |
| isoflurophate | 0 | low | 5 | 0 |
| biguanides | 0 | low | 1 | 0 |
| carbon tetrachloride | 0 | low | 1 | 0 |
| cantharidin | 0 | low | 3 | 0 |
| alanine | 0 | medium | 26 | 1 |
| serine | 0 | low | 47 | 0 |
| benz(a)anthracene | 0 | low | 10 | 0 |
| 4-nitroquinoline-1-oxide | 0 | low | 8 | 0 |
| chloramphenicol | 0 | low | 2 | 0 |
| aspartic acid | 0 | medium | 38 | 1 |
| glutamine | 0 | medium | 51 | 1 |
| lysine | 0 | low | 42 | 0 |
| allyl isothiocyanate | 0 | low | 3 | 0 |
| cyanides | 0 | low | 4 | 0 |
| vincristine | 0 | low | 1 | 0 |
| sucrose | 0 | low | 9 | 0 |
| ethinyl estradiol | 0 | low | 6 | 0 |
| 9,10-dimethyl-1,2-benzanthracene | 0 | low | 40 | 0 |
| apomorphine | 0 | low | 1 | 0 |
| methyltestosterone | 0 | low | 2 | 0 |
| adenosine diphosphate | 0 | low | 15 | 0 |
| cephalothin | 0 | low | 1 | 0 |
| uridine | 0 | low | 42 | 0 |
| uridine monophosphate | 0 | low | 3 | 0 |
| uridine diphosphate | 0 | low | 1 | 0 |
| kanamycin a | 0 | low | 1 | 0 |
| bromodeoxyuridine | 0 | medium | 110 | 1 |
| galactose | 0 | low | 25 | 0 |
| carbostyril | 0 | medium | 18 | 3 |
| phenylephrine | 0 | low | 2 | 0 |
| levodopa | 0 | medium | 121 | 1 |
| edetic acid | 0 | medium | 23 | 1 |
| tributyrin | 0 | low | 3 | 0 |
| p-dimethylaminoazobenzene | 0 | low | 1 | 0 |
| phenylethyl alcohol | 0 | low | 12 | 0 |
| tyrosine | 0 | medium | 270 | 5 |
| cysteamine | 0 | low | 23 | 0 |
| phlorhizin | 0 | low | 1 | 0 |
| adenosine monophosphate | 0 | low | 7 | 0 |
| n,n-dimethyltryptamine | 0 | low | 1 | 0 |
| methylene blue | 0 | medium | 34 | 3 |
| leucine | 0 | medium | 49 | 2 |
| ethyl methanesulfonate | 0 | low | 2 | 0 |
| aniline | 0 | low | 3 | 0 |
| 2-aminoisobutyric acid | 0 | low | 3 | 0 |
| dimethylnitrosamine | 0 | low | 3 | 0 |
| androstenedione | 0 | low | 1 | 0 |
| carbaryl | 0 | low | 1 | 0 |
| cytidine monophosphate | 0 | low | 3 | 0 |
| uridine triphosphate | 0 | low | 3 | 0 |
| lactose | 0 | low | 6 | 0 |
| methionine | 0 | medium | 48 | 2 |
| 1,2-dipalmitoylphosphatidylcholine | 0 | low | 4 | 0 |
| phenylalanine | 0 | medium | 107 | 8 |
| n-phenylurea | 0 | low | 1 | 0 |
| desoxycorticosterone | 0 | low | 3 | 0 |
| colchicine | 0 | low | 40 | 0 |
| cytidine | 0 | low | 6 | 0 |
| cycloheximide | 0 | low | 80 | 0 |
| ficusin | 0 | low | 10 | 0 |
| egtazic acid | 0 | low | 14 | 0 |
| chloroform | 0 | low | 4 | 0 |
| dimethyl sulfone | 0 | low | 1 | 0 |
| fluocinolone acetonide | 0 | low | 3 | 0 |
| dimethylformamide | 0 | low | 2 | 0 |
| norethindrone | 0 | low | 2 | 0 |
| triaziquone | 0 | low | 7 | 0 |
| tubercidin | 0 | low | 2 | 0 |
| mannitol | 0 | medium | 22 | 11 |
| cytarabine | 0 | medium | 61 | 8 |
| dithionitrobenzoic acid | 0 | low | 2 | 0 |
| ornithine | 0 | low | 18 | 0 |
| dinitrofluorobenzene | 0 | medium | 4 | 1 |
| asparagine | 0 | medium | 20 | 1 |
| histidine | 0 | low | 9 | 0 |
| medroxyprogesterone acetate | 0 | medium | 3 | 1 |
| valine | 0 | medium | 32 | 1 |
| threonine | 0 | low | 13 | 0 |
| dichlorodiphenyldichloroethane | 0 | low | 1 | 0 |
| cordycepin | 0 | low | 4 | 0 |
| tryptophan | 0 | medium | 49 | 5 |
| isoleucine | 0 | low | 3 | 0 |
| arginine | 0 | medium | 61 | 4 |
| ethane | 0 | low | 1 | 0 |
| acetylene | 0 | low | 1 | 0 |
| methyl iodide | 0 | low | 1 | 0 |
| methylamine | 0 | low | 2 | 0 |
| boranes | 0 | medium | 5 | 1 |
| vinyl chloride | 0 | low | 3 | 0 |
| acetonitrile | 0 | low | 1 | 0 |
| methylene chloride | 0 | low | 1 | 0 |
| propyleneimine | 0 | low | 1 | 0 |
| methanesulfonic acid | 0 | low | 1 | 0 |
| trifluoroethanol | 0 | low | 2 | 0 |
| tert-butylhydroperoxide | 0 | low | 3 | 0 |
| perflutren | 0 | low | 3 | 0 |
| triamcinolone acetonide | 0 | medium | 21 | 1 |
| fluoxymesterone | 0 | low | 2 | 0 |
| phencyclidine | 0 | medium | 4 | 1 |
| dicyclopentadiene | 0 | low | 1 | 0 |
| tromethamine | 0 | low | 3 | 0 |
| quinic acid | 0 | low | 4 | 0 |
| 3-mercaptopropionic acid | 0 | low | 2 | 0 |
| linalool | 0 | low | 1 | 0 |
| isoprene | 0 | low | 1 | 0 |
| trichloroethylene | 0 | low | 2 | 0 |
| propionamide | 0 | low | 1 | 0 |
| acrylamide | 0 | low | 1 | 0 |
| acrylic acid | 0 | medium | 1 | 1 |
| dichloroacetic acid | 0 | low | 7 | 0 |
| pantothenic acid | 0 | low | 3 | 0 |
| camphene | 0 | low | 1 | 0 |
| cumene hydroperoxide | 0 | low | 1 | 0 |
| alpha-pinene | 0 | low | 1 | 0 |
| methylmethacrylate | 0 | low | 3 | 0 |
| taurocholic acid | 0 | low | 1 | 0 |
| rhodamine b | 0 | medium | 3 | 1 |
| visnagin | 0 | low | 1 | 0 |
| methylprednisolone | 0 | medium | 28 | 1 |
| lawsone | 0 | low | 1 | 0 |
| rotenone | 0 | low | 6 | 0 |
| phthalic anhydride | 0 | low | 1 | 0 |
| carbazole | 0 | low | 1 | 0 |
| symclosene | 0 | low | 1 | 0 |
| n-vinyl-2-pyrrolidinone | 0 | medium | 8 | 1 |
| picryl chloride | 0 | low | 1 | 0 |
| picric acid | 0 | low | 1 | 0 |
| 1-naphthylphenylamine | 0 | low | 1 | 0 |
| aminacrine | 0 | low | 3 | 0 |
| benzohydrol | 0 | low | 1 | 0 |
| quinoxalines | 0 | low | 19 | 0 |
| 1,2,3,4-tetrahydroisoquinoline | 0 | low | 1 | 0 |
| quinoline | 0 | low | 2 | 0 |
| isatin | 0 | low | 1 | 0 |
| 2-naphthylamine | 0 | low | 1 | 0 |
| 3,3'-diaminobenzidine | 0 | low | 5 | 0 |
| tolonium chloride | 0 | low | 1 | 0 |
| phenidone | 0 | low | 1 | 0 |
| diphenyl | 0 | low | 3 | 0 |
| xanthenes | 0 | low | 10 | 0 |
| phenothiazine | 0 | low | 2 | 0 |
| benzidine | 0 | low | 1 | 0 |
| veratric acid | 0 | low | 1 | 0 |
| acetyleugenol | 0 | low | 1 | 0 |
| propylparaben | 0 | low | 2 | 0 |
| benzoyl peroxide | 0 | low | 2 | 0 |
| benzotriazole | 0 | low | 1 | 0 |
| benzothiophene | 0 | low | 1 | 0 |
| benzothiazole | 0 | low | 2 | 0 |
| 1,2-diaminobenzene | 0 | low | 1 | 0 |
| 1,3-dichloro-2-propanol | 0 | low | 1 | 0 |
| alpha-chlorohydrin | 0 | low | 1 | 0 |
| 4-butyrolactone | 0 | low | 5 | 0 |
| phosphoribosyl pyrophosphate | 0 | low | 1 | 0 |
| p-tert-butyl catechol | 0 | low | 4 | 0 |
| butylphen | 0 | low | 3 | 0 |
| pyrrolidonecarboxylic acid | 0 | low | 5 | 0 |
| trehalose | 0 | low | 4 | 0 |
| sym-trinitrobenzene | 0 | low | 2 | 0 |
| carvone | 0 | low | 2 | 0 |
| 4-cymene | 0 | low | 1 | 0 |
| 4-aminoacetophenone | 0 | low | 1 | 0 |
| 2-diethylaminoethanol | 0 | low | 1 | 0 |
| ethylbenzene | 0 | medium | 1 | 1 |
| quinuclidines | 0 | medium | 5 | 1 |
| boric acid | 0 | low | 2 | 0 |
| 2-ethylhexyl acrylate | 0 | low | 1 | 0 |
| monobenzone | 0 | low | 6 | 0 |
| phenylisothiocyanate | 0 | low | 1 | 0 |
| 4-phenylenediamine | 0 | low | 6 | 0 |
| acrolein | 0 | low | 5 | 0 |
| acrylonitrile | 0 | low | 13 | 0 |
| glyoxal | 0 | low | 2 | 0 |
| dimethyldioctadecylammonium | 0 | low | 2 | 0 |
| 2-methylpentane | 0 | low | 1 | 0 |
| maleic anhydride | 0 | low | 2 | 0 |
| melamine | 0 | low | 1 | 0 |
| cyclohexanol | 0 | low | 1 | 0 |
| diethylamine | 0 | low | 1 | 0 |
| pyrroles | 0 | medium | 88 | 11 |
| thiophenes | 0 | medium | 27 | 1 |
| 2,5-hexanedione | 0 | low | 2 | 0 |
| isopropyl myristate | 0 | low | 1 | 0 |
| piperidine | 0 | low | 1 | 0 |
| morpholine | 0 | low | 1 | 0 |
| tetraethylenepentamine | 0 | low | 1 | 0 |
| lauryl acetate | 0 | low | 1 | 0 |
| ergotamine | 0 | low | 1 | 0 |
| phenformin | 0 | low | 10 | 0 |
| linalyl acetate | 0 | low | 1 | 0 |
| diethylhexyl phthalate | 0 | low | 2 | 0 |
| homosalate | 0 | low | 1 | 0 |
| chloranil | 0 | low | 1 | 0 |
| framycetin | 0 | medium | 7 | 2 |
| isoquinoline | 0 | low | 2 | 0 |
| anthracene | 0 | low | 1 | 0 |
| dibenzoylmethane | 0 | low | 1 | 0 |
| ethyl-p-hydroxybenzoate | 0 | low | 1 | 0 |
| vanillic acid | 0 | low | 1 | 0 |
| sulfan blue | 0 | medium | 30 | 4 |
| pyrazolanthrone | 0 | low | 7 | 0 |
| iodoantipyrine | 0 | low | 2 | 0 |
| 1,4-naphthoquinone | 0 | low | 1 | 0 |
| diatrizoate meglumine | 0 | low | 2 | 0 |
| meglumine | 0 | low | 8 | 0 |
| uridine diphosphate glucose | 0 | low | 1 | 0 |
| fluorodeoxyuridylate | 0 | low | 2 | 0 |
| 2-naphthol | 0 | low | 7 | 0 |
| shikimic acid | 0 | low | 1 | 0 |
| nitrilotriacetic acid | 0 | low | 5 | 0 |
| protocatechualdehyde | 0 | low | 1 | 0 |
| dodecyl sulfate | 0 | low | 1 | 0 |
| ethyl acetate | 0 | low | 2 | 0 |
| yohimbine | 0 | low | 3 | 0 |
| 2-chloroadenosine | 0 | low | 1 | 0 |
| copper phthalocyanine | 0 | low | 1 | 0 |
| nafcillin | 0 | low | 1 | 0 |
| ditiocarb | 0 | low | 12 | 0 |
| 2-vanillin | 0 | low | 1 | 0 |
| 1,2-dihydroxybenzene-3,5-disulfonic acid disodium salt | 0 | low | 2 | 0 |
| 3-hydroxyanisole | 0 | low | 1 | 0 |
| mequinol | 0 | medium | 15 | 1 |
| 1,4-dimethoxybenzene | 0 | low | 1 | 0 |
| catechin | 0 | low | 44 | 0 |
| coronene | 0 | low | 1 | 0 |
| perylene | 0 | low | 13 | 0 |
| quinazolines | 0 | medium | 71 | 7 |
| acridines | 0 | low | 22 | 0 |
| indazoles | 0 | medium | 49 | 6 |
| benzofuran | 0 | low | 1 | 0 |
| benzoxazoles | 0 | low | 2 | 0 |
| adamantane | 0 | low | 6 | 0 |
| cyclopentane | 0 | medium | 14 | 1 |
| isoxazoles | 0 | low | 13 | 0 |
| oxazoles | 0 | medium | 13 | 1 |
| thiazoles | 0 | medium | 94 | 3 |
| pyrimidine | 0 | low | 6 | 0 |
| pyrazines | 0 | medium | 52 | 8 |
| nitroblue tetrazolium | 0 | low | 3 | 0 |
| calcium gluconate | 0 | low | 1 | 0 |
| hydrazine | 0 | medium | 37 | 3 |
| perfluorodecalin | 0 | low | 1 | 0 |
| perfluorooctane | 0 | low | 1 | 0 |
| evans blue | 0 | low | 1 | 0 |
| 5-fluorouridine | 0 | low | 3 | 0 |
| azacitidine | 0 | medium | 112 | 7 |
| diazomethane | 0 | low | 2 | 0 |
| bromochlorodifluoromethane | 0 | low | 1 | 0 |
| perfluorobutane | 0 | low | 4 | 0 |
| perflexane | 0 | low | 1 | 0 |
| fluocinonide | 0 | low | 3 | 0 |
| trifluoroethene | 0 | low | 1 | 0 |
| aminoimidazole carboxamide | 0 | medium | 16 | 1 |
| methysergide | 0 | low | 1 | 0 |
| kynuramine | 0 | low | 3 | 0 |
| citrulline | 0 | medium | 3 | 1 |
| betamethasone | 0 | low | 7 | 0 |
| cyanamide | 0 | low | 1 | 0 |
| ethylene sulfide | 0 | low | 1 | 0 |
| perflubron | 0 | low | 3 | 0 |
| fluorometholone | 0 | low | 1 | 0 |
| cyproterone acetate | 0 | low | 1 | 0 |
| nandrolone | 0 | low | 1 | 0 |
| thiazolidine-4-carboxylic acid | 0 | low | 2 | 0 |
| 2-aminopurine | 0 | low | 1 | 0 |
| 4-methylcatechol | 0 | low | 2 | 0 |
| 4-fluorobenzoic acid | 0 | low | 1 | 0 |
| hydantoins | 0 | medium | 2 | 1 |
| fluorobenzenes | 0 | low | 1 | 0 |
| limestone | 0 | low | 3 | 0 |
| nuciferine | 0 | low | 1 | 0 |
| fusarium | 0 | low | 1 | 0 |
| berbamine | 0 | low | 1 | 0 |
| indirubin | 0 | low | 5 | 0 |
| plumbagin | 0 | low | 5 | 0 |
| cepharanthine | 0 | low | 3 | 0 |
| aloe emodin | 0 | low | 3 | 0 |
| menadiol | 0 | low | 1 | 0 |
| imperatorin | 0 | low | 1 | 0 |
| emetine | 0 | low | 4 | 0 |
| osthol | 0 | low | 1 | 0 |
| 9-phenanthrol | 0 | low | 1 | 0 |
| reticulin | 0 | medium | 10 | 1 |
| flavanone | 0 | low | 1 | 0 |
| kainic acid | 0 | low | 1 | 0 |
| topanol 354 | 0 | low | 1 | 0 |
| thymoquinone | 0 | low | 3 | 0 |
| phenylpropanolamine | 0 | low | 1 | 0 |
| beclamide | 0 | low | 1 | 0 |
| 4-hydroxyphenylethanol | 0 | low | 1 | 0 |
| phloretic acid | 0 | low | 1 | 0 |
| caprolactone | 0 | low | 1 | 0 |
| hexahydrofarnesylacetone | 0 | low | 1 | 0 |
| azetidine | 0 | low | 1 | 0 |
| alpha-aminopyridine | 0 | low | 20 | 0 |
| thiazolidines | 0 | low | 10 | 0 |
| iberin | 0 | low | 1 | 0 |
| suberic acid | 0 | low | 1 | 0 |
| hexadecanedioic acid | 0 | low | 1 | 0 |
| mustard gas | 0 | low | 2 | 0 |
| cyanogen bromide | 0 | low | 6 | 0 |
| oleanolic acid | 0 | medium | 26 | 1 |
| abietic acid | 0 | low | 2 | 0 |
| hematoxylin | 0 | medium | 45 | 1 |
| podophyllotoxin | 0 | medium | 22 | 3 |
| triphenylmethane | 0 | low | 1 | 0 |
| hesperidin | 0 | low | 2 | 0 |
| medroxyprogesterone | 0 | low | 6 | 0 |
| dihydrotestosterone | 0 | low | 7 | 0 |
| luminol | 0 | low | 1 | 0 |
| physcione | 0 | low | 1 | 0 |
| copper gluconate | 0 | low | 2 | 0 |
| azomycin | 0 | low | 27 | 0 |
| uridine diphosphate n-acetylglucosamine | 0 | low | 3 | 0 |
| herniarin | 0 | low | 1 | 0 |
| furothiazole | 0 | low | 1 | 0 |
| tropolone | 0 | low | 3 | 0 |
| perillyl alcohol | 0 | low | 1 | 0 |
| methamphetamine | 0 | low | 1 | 0 |
| pentamethonium | 0 | low | 1 | 0 |
| maleimide | 0 | low | 1 | 0 |
| malondialdehyde | 0 | medium | 13 | 3 |
| myristic acid | 0 | low | 1 | 0 |
| triethylenephosphoramide | 0 | low | 1 | 0 |
| trinitrobenzenesulfonic acid | 0 | low | 1 | 0 |
| eosine yellowish-(ys) | 0 | medium | 49 | 1 |
| violacein | 0 | low | 4 | 0 |
| lucanthone hydrochloride | 0 | low | 1 | 0 |
| gentian violet | 0 | low | 3 | 0 |
| paeonol | 0 | low | 2 | 0 |
| hematoporphyrin | 0 | low | 42 | 0 |
| neutral red | 0 | low | 6 | 0 |
| aniline mustard | 0 | low | 2 | 0 |
| lithium carbonate | 0 | low | 1 | 0 |
| 4-methyl-1-(1-methylethyl)-3-cyclohexen-1-ol | 0 | low | 1 | 0 |
| glycerylphosphorylcholine | 0 | low | 2 | 0 |
| 3-hydroxyflavone | 0 | low | 16 | 0 |
| diphenylamine | 0 | medium | 15 | 1 |
| allyl sulfide | 0 | low | 1 | 0 |
| megestrol acetate | 0 | medium | 9 | 3 |
| alpha-naphthoflavone | 0 | low | 1 | 0 |
| toyocamycin | 0 | low | 1 | 0 |
| 5-nitroquinoline | 0 | low | 1 | 0 |
| galactitol | 0 | medium | 2 | 2 |
| acetylcysteine | 0 | medium | 46 | 2 |
| dimethyl disulfide | 0 | low | 1 | 0 |
| c.i. 42510 | 0 | medium | 95 | 7 |
| 2-pyrrolecarboxylic acid | 0 | low | 1 | 0 |
| dehydroepiandrosterone sulfate | 0 | low | 1 | 0 |
| homoserine | 0 | low | 1 | 0 |
| 2-piperidone | 0 | medium | 6 | 1 |
| methylnitrosourea | 0 | medium | 25 | 4 |
| dodecanedioic acid | 0 | low | 4 | 0 |
| ethylnitrosourea | 0 | low | 9 | 0 |
| 2,3-dimethylmaleic anhydride | 0 | low | 1 | 0 |
| levonorgestrel | 0 | medium | 3 | 1 |
| porfiromycin | 0 | low | 2 | 0 |
| vinblastine | 0 | low | 1 | 0 |
| 3-hydroxy-1-benzopyran-2-one | 0 | low | 1 | 0 |
| deoxycytidine | 0 | medium | 47 | 14 |
| deoxyuridine | 0 | low | 10 | 0 |
| 2,6-dichloroindophenol | 0 | low | 1 | 0 |
| rhodamine 6g | 0 | low | 1 | 0 |
| ethambutol | 0 | low | 1 | 0 |
| 4-(4-nitrobenzyl)pyridine | 0 | low | 1 | 0 |
| decabromobiphenyl ether | 0 | low | 2 | 0 |
| lauryl gallate | 0 | low | 1 | 0 |
| ethylenediamine-n,n'-bis(2-hydroxyphenylacetic acid) | 0 | low | 1 | 0 |
| calcium peroxide | 0 | medium | 1 | 1 |
| durapatite | 0 | medium | 18 | 1 |
| sodium hydroxide | 0 | low | 3 | 0 |
| manganese dioxide | 0 | medium | 3 | 1 |
| molybdenum trioxide | 0 | low | 1 | 0 |
| zinc oxide | 0 | medium | 9 | 1 |
| thorium dioxide | 0 | low | 3 | 0 |
| cupric sulfide | 0 | low | 2 | 0 |
| arsenic trioxide | 0 | medium | 12 | 3 |
| beta-pinene | 0 | low | 2 | 0 |
| ammonium hydroxide | 0 | low | 1 | 0 |
| sorbitan monostearate | 0 | low | 1 | 0 |
| ferrous oxide | 0 | low | 1 | 0 |
| vancomycin | 0 | low | 2 | 0 |
| glycyrrhizic acid | 0 | low | 6 | 0 |
| d-alpha tocopherol | 0 | medium | 43 | 3 |
| tocopherols | 0 | low | 8 | 0 |
| pseudouridine | 0 | low | 1 | 0 |
| picolinamide | 0 | low | 1 | 0 |
| isonicotinamide | 0 | low | 1 | 0 |
| selenomethionine | 0 | low | 5 | 0 |
| selenocystine | 0 | low | 1 | 0 |
| meturedepa | 0 | low | 1 | 0 |
| digoxigenin | 0 | low | 2 | 0 |
| stearylamine | 0 | low | 2 | 0 |
| paraquat | 0 | low | 5 | 0 |
| pristane | 0 | low | 1 | 0 |
| 2'-deoxyadenosine triphosphate | 0 | low | 1 | 0 |
| 2-tert-butylhydroquinone | 0 | low | 1 | 0 |
| 5-hydroxyindole | 0 | low | 1 | 0 |
| dronabinol | 0 | low | 3 | 0 |
| methionine sulfoximine | 0 | low | 11 | 0 |
| amiloride | 0 | low | 2 | 0 |
| diallyl trisulfide | 0 | low | 6 | 0 |
| pimozide | 0 | low | 7 | 0 |
| n-isopropylacrylamide | 0 | low | 1 | 0 |
| benzylguanidine | 0 | low | 1 | 0 |
| phenethyl isothiocyanate | 0 | low | 5 | 0 |
| fluorescein | 0 | low | 8 | 0 |
| methylprednisolone hemisuccinate | 0 | low | 1 | 0 |
| thioflavin t | 0 | low | 1 | 0 |
| flupenthixol | 0 | low | 1 | 0 |
| fucose | 0 | low | 20 | 0 |
| sulfur hexafluoride | 0 | low | 9 | 0 |
| uridine diphosphate glucuronic acid | 0 | low | 1 | 0 |
| thiocholchicine | 0 | low | 1 | 0 |
| doxifluridine | 0 | low | 4 | 0 |
| didodecyldimethylammonium | 0 | low | 1 | 0 |
| 2,2-bis(bromomethyl)-1,3-propanediol | 0 | low | 1 | 0 |
| fluorescein-5-isothiocyanate | 0 | low | 18 | 0 |
| sabinene | 0 | low | 24 | 0 |
| mannose | 0 | low | 27 | 0 |
| trimethylcolchicinic acid methyl ether | 0 | low | 1 | 0 |
| dithiothreitol | 0 | low | 6 | 0 |
| megestrol | 0 | medium | 6 | 2 |
| azo rubin s | 0 | low | 1 | 0 |
| ecdysone | 0 | low | 2 | 0 |
| tranylcypromine | 0 | low | 2 | 0 |
| streptomycin | 0 | low | 2 | 0 |
| carbonates | 0 | low | 1 | 0 |
| l 451167 | 0 | low | 1 | 0 |
| mitomycin a | 0 | low | 2 | 0 |
| dideoxyadenosine | 0 | low | 1 | 0 |
| cladribine | 0 | low | 4 | 0 |
| 4-hydroxypyrimidine | 0 | low | 1 | 0 |
| buthionine sulfoximine | 0 | low | 31 | 0 |
| octylmethoxycinnamate | 0 | low | 3 | 0 |
| vidarabine | 0 | medium | 18 | 8 |
| iodinated glycerol | 0 | low | 1 | 0 |
| dimethindene | 0 | low | 1 | 0 |
| limonene | 0 | low | 6 | 0 |
| acetoxyacetylaminofluorene | 0 | low | 2 | 0 |
| octocrylene | 0 | low | 1 | 0 |
| n-methylaspartate | 0 | low | 1 | 0 |
| 3-deazaadenosine | 0 | low | 1 | 0 |
| levodopa methyl ester | 0 | low | 4 | 0 |
| trimethaphan | 0 | medium | 1 | 1 |
| 1-(4-chlorophenyl)-3,3-dimethyltriazene | 0 | low | 1 | 0 |
| 1-(4-carboxyphenyl)-3,3-dimethyltriazene | 0 | medium | 5 | 3 |
| 1-phenyl-3,3-dimethyltriazene | 0 | low | 2 | 0 |
| 3,3'-diselenodipropionic acid | 0 | low | 1 | 0 |
| iridium | 0 | low | 9 | 0 |
| lanthanum | 0 | low | 3 | 0 |
| lutetium | 0 | low | 7 | 0 |
| manganese | 0 | medium | 28 | 1 |
| mercury | 0 | medium | 8 | 1 |
| molybdenum | 0 | medium | 6 | 1 |
| neodymium | 0 | low | 13 | 0 |
| neon | 0 | medium | 4 | 1 |
| osmium | 0 | low | 3 | 0 |
| palladium | 0 | medium | 59 | 7 |
| platinum | 0 | low | 21 | 0 |
| plutonium | 0 | low | 3 | 0 |
| rhenium | 0 | medium | 22 | 1 |
| rhodium | 0 | low | 31 | 0 |
| ruthenium | 0 | low | 63 | 0 |
| samarium | 0 | low | 2 | 0 |
| scandium | 0 | low | 1 | 0 |
| silver | 0 | medium | 37 | 1 |
| tantalum | 0 | low | 7 | 0 |
| technetium | 0 | medium | 154 | 10 |
| terbium | 0 | low | 3 | 0 |
| thorium | 0 | low | 2 | 0 |
| titanium | 0 | medium | 16 | 1 |
| tungsten | 0 | low | 1 | 0 |
| americium | 0 | low | 3 | 0 |
| argon | 0 | medium | 19 | 2 |
| cadmium | 0 | low | 9 | 0 |
| cerium | 0 | low | 6 | 0 |
| chromium | 0 | low | 16 | 0 |
| europium | 0 | low | 1 | 0 |
| gadolinium | 0 | low | 38 | 0 |
| gold | 0 | medium | 114 | 2 |
| helium | 0 | medium | 45 | 10 |
| vanadium | 0 | low | 1 | 0 |
| xenon | 0 | low | 7 | 0 |
| ytterbium | 0 | low | 3 | 0 |
| yttrium | 0 | low | 5 | 0 |
| zirconium | 0 | low | 3 | 0 |
| californium | 0 | medium | 8 | 1 |
| cupric chloride | 0 | low | 2 | 0 |
| zalcitabine | 0 | low | 1 | 0 |
| magnesium sulfate | 0 | medium | 3 | 2 |
| mercuric chloride | 0 | low | 4 | 0 |
| acetylglucosamine | 0 | low | 13 | 0 |
| galactosamine | 0 | medium | 3 | 1 |
| hypochlorous acid | 0 | low | 2 | 0 |
| camptothecin | 0 | medium | 60 | 7 |
| ferric chloride | 0 | low | 3 | 0 |
| nickel chloride | 0 | low | 1 | 0 |
| ferrous sulfate | 0 | low | 1 | 0 |
| sodium pyrophosphate | 0 | low | 2 | 0 |
| phosphine | 0 | low | 1 | 0 |
| isopentenyladenosine | 0 | low | 1 | 0 |
| bromine | 0 | medium | 4 | 1 |
| barium sulfate | 0 | low | 13 | 0 |
| zinc sulfate | 0 | medium | 5 | 1 |
| tricalcium phosphate | 0 | medium | 6 | 1 |
| chromates | 0 | low | 1 | 0 |
| copper sulfate | 0 | low | 3 | 0 |
| metoprine | 0 | low | 2 | 0 |
| silver nitrate | 0 | medium | 16 | 1 |
| sodium thiosulfate | 0 | low | 1 | 0 |
| calcium sulfate | 0 | low | 1 | 0 |
| zinc phosphate | 0 | low | 1 | 0 |
| deuterium | 0 | low | 5 | 0 |
| fluorine | 0 | low | 6 | 0 |
| chlorine | 0 | medium | 13 | 1 |
| nickel sulfate | 0 | low | 1 | 0 |
| thallium chloride | 0 | low | 2 | 0 |
| glycerol 1-stearate | 0 | low | 1 | 0 |
| galactose | 0 | low | 7 | 0 |
| poloxalene | 0 | low | 3 | 0 |
| hexadimethrine bromide | 0 | low | 1 | 0 |
| vasotocin | 0 | low | 1 | 0 |
| sizofiran | 0 | low | 1 | 0 |
| ozone | 0 | low | 43 | 0 |
| hydroiodic acid | 0 | low | 3 | 0 |
| aluminum sulfate | 0 | medium | 5 | 3 |
| radon | 0 | low | 10 | 0 |
| sodium selenite | 0 | low | 6 | 0 |
| cadmium chloride | 0 | low | 1 | 0 |
| 4-chloro-7-nitrobenzofurazan | 0 | low | 2 | 0 |
| ancitabine | 0 | medium | 2 | 1 |
| barium chloride | 0 | low | 1 | 0 |
| chlormerodrin | 0 | low | 6 | 0 |
| trolamine salicylate | 0 | low | 28 | 0 |
| chloropyramine | 0 | low | 1 | 0 |
| rhamnose | 0 | low | 1 | 0 |
| clodronic acid | 0 | low | 4 | 0 |
| ammonium chloride | 0 | medium | 16 | 1 |
| isobutyl xanthate | 0 | low | 1 | 0 |
| glucoheptonate | 0 | low | 1 | 0 |
| titanium dioxide | 0 | medium | 9 | 1 |
| misonidazole | 0 | low | 20 | 0 |
| mopidamol | 0 | low | 5 | 0 |
| 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidinyl)-1-nitrosourea | 0 | low | 3 | 0 |
| menthone | 0 | low | 1 | 0 |
| tiletamine hydrochloride | 0 | low | 3 | 0 |
| selegiline | 0 | medium | 4 | 1 |
| levamisole | 0 | medium | 52 | 14 |
| ab 163 | 0 | low | 1 | 0 |
| 1-methyladenosine | 0 | low | 1 | 0 |
| cromolyn sodium | 0 | low | 3 | 0 |
| pentamethylmelamine | 0 | low | 1 | 0 |
| n'-nitrosonornicotine | 0 | low | 1 | 0 |
| tetradecanoylphorbol acetate | 0 | medium | 154 | 1 |
| sodium bisulfide | 0 | low | 1 | 0 |
| ornidazole | 0 | low | 1 | 0 |
| fluorides | 0 | medium | 9 | 1 |
| iomethin | 0 | low | 4 | 0 |
| hypnorm | 0 | low | 1 | 0 |
| danazol | 0 | low | 1 | 0 |
| chromium | 0 | low | 3 | 0 |
| mecysteine | 0 | low | 1 | 0 |
| oryzalin | 0 | low | 1 | 0 |
| 1-deoxynojirimycin | 0 | low | 7 | 0 |
| taurolidine | 0 | medium | 4 | 1 |
| iodine | 0 | low | 6 | 0 |
| daunorubicin | 0 | medium | 45 | 4 |
| padimate-o | 0 | low | 1 | 0 |
| razoxane | 0 | medium | 8 | 1 |
| fludarabine phosphate | 0 | medium | 1 | 1 |
| phosphotyrosine | 0 | low | 22 | 0 |
| indium phosphide | 0 | low | 1 | 0 |
| phenyl acetate | 0 | medium | 26 | 1 |
| cetylpyridinium chloride anhydrous | 0 | low | 7 | 0 |
| myrcene | 0 | low | 1 | 0 |
| methylformamide | 0 | medium | 3 | 1 |
| triamcinolone | 0 | low | 4 | 0 |
| azetepa | 0 | low | 1 | 0 |
| chloroprene | 0 | low | 1 | 0 |
| tetrachloroethylene | 0 | low | 1 | 0 |
| fludrocortisone | 0 | low | 2 | 0 |
| ursodeoxycholic acid | 0 | low | 4 | 0 |
| pyrene | 0 | low | 2 | 0 |
| isothiuronium | 0 | low | 2 | 0 |
| benzonidazole | 0 | low | 1 | 0 |
| 4-methoxyamphetamine | 0 | low | 10 | 0 |
| prospidium | 0 | medium | 7 | 2 |
| 8-bromo cyclic adenosine monophosphate | 0 | low | 5 | 0 |
| transferrin | 0 | medium | 49 | 1 |
| rose bengal b disodium salt | 0 | low | 2 | 0 |
| tridemorph | 0 | low | 12 | 0 |
| alkenes | 0 | low | 4 | 0 |
| glutamic acid | 0 | low | 50 | 0 |
| glucaric acid | 0 | low | 1 | 0 |
| alovudine | 0 | medium | 6 | 3 |
| sodium azide | 0 | low | 4 | 0 |
| azides | 0 | low | 12 | 0 |
| adenosine diphosphate ribose | 0 | low | 5 | 0 |
| halofenate | 0 | low | 1 | 0 |
| amoxicillin | 0 | low | 2 | 0 |
| timolol | 0 | low | 2 | 0 |
| ensulizole | 0 | low | 1 | 0 |
| gallium citrate | 0 | low | 4 | 0 |
| prednimustine | 0 | low | 1 | 0 |
| vidarabine phosphate | 0 | medium | 1 | 1 |
| zidovudine | 0 | low | 6 | 0 |
| acetylgalactosamine | 0 | low | 6 | 0 |
| flubendazole | 0 | low | 4 | 0 |
| paclitaxel | 0 | medium | 256 | 68 |
| etoposide | 0 | medium | 78 | 6 |
| substance p | 0 | low | 5 | 0 |
| promegestone | 0 | low | 1 | 0 |
| phenyl-2-aminoethyl sulfide | 0 | low | 1 | 0 |
| diflubenzuron | 0 | low | 4 | 0 |
| enilconazole | 0 | low | 1 | 0 |
| ribavirin | 0 | low | 7 | 0 |
| lentinan | 0 | low | 1 | 0 |
| phorbol 12,13-dibutyrate | 0 | low | 10 | 0 |
| fluorescamine | 0 | low | 1 | 0 |
| carbidopa | 0 | low | 1 | 0 |
| n-(2-hydroxypropyl)methacrylamide | 0 | low | 3 | 0 |
| triazinate | 0 | low | 1 | 0 |
| methyldopa | 0 | low | 3 | 0 |
| bezafibrate | 0 | low | 2 | 0 |
| spirogermanium | 0 | low | 2 | 0 |
| diltiazem | 0 | low | 2 | 0 |
| nimustine | 0 | medium | 58 | 5 |
| 1-methyl-4-phenylpyridinium | 0 | low | 2 | 0 |
| lonidamine | 0 | low | 16 | 0 |
| vx | 0 | low | 1 | 0 |
| ng-nitroarginine methyl ester | 0 | low | 4 | 0 |
| 1,3,4,6-tetrachloro-3 alpha,6 alpha-diphenylglycoluril | 0 | low | 2 | 0 |
| permethrin | 0 | low | 1 | 0 |
| quisqualic acid | 0 | low | 2 | 0 |
| 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid | 0 | low | 1 | 0 |
| 1-carboxyglutamic acid | 0 | low | 2 | 0 |
| pyriminil | 0 | low | 1 | 0 |
| vindesine | 0 | medium | 76 | 16 |
| 3,3',5,5'-tetramethylbenzidine | 0 | low | 1 | 0 |
| 7,8-dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | 0 | low | 1 | 0 |
| 5'-palmitoyl cytarabine | 0 | low | 2 | 0 |
| epirubicin | 0 | medium | 17 | 3 |
| desflurane | 0 | low | 1 | 0 |
| diaziquone | 0 | medium | 3 | 1 |
| elliptinium acetate | 0 | low | 1 | 0 |
| enkephalin, methionine | 0 | low | 6 | 0 |
| idarubicin | 0 | medium | 6 | 2 |
| nafazatrom | 0 | low | 4 | 0 |
| propiconazole | 0 | low | 141 | 0 |
| paroxetine | 0 | medium | 4 | 3 |
| captopril | 0 | low | 1 | 0 |
| staurosporine | 0 | low | 3 | 0 |
| 4-(n-methyl-n-nitrosamino)-1-(3-pyridyl)-1-butanone | 0 | low | 1 | 0 |
| azimexon | 0 | low | 2 | 0 |
| moxalactam | 0 | low | 1 | 0 |
| fazarabine | 0 | low | 1 | 0 |
| colforsin | 0 | low | 38 | 0 |
| iso-sulfan blue | 0 | medium | 55 | 4 |
| amonafide | 0 | low | 4 | 0 |
| pimonidazole | 0 | low | 12 | 0 |
| avobenzone | 0 | low | 1 | 0 |
| octenidine | 0 | low | 2 | 0 |
| bisantrene | 0 | medium | 9 | 1 |
| fomesafen | 0 | low | 2 | 0 |
| fenoxycarb | 0 | low | 1 | 0 |
| miglustat | 0 | low | 3 | 0 |
| swainsonine | 0 | low | 11 | 0 |
| lovastatin | 0 | medium | 11 | 1 |
| rimcazole | 0 | low | 1 | 0 |
| piritrexim | 0 | medium | 2 | 2 |
| castanospermine | 0 | low | 4 | 0 |
| simvastatin | 0 | low | 15 | 0 |
| pravastatin | 0 | low | 2 | 0 |
| ilmofosine | 0 | medium | 1 | 1 |
| mifepristone | 0 | low | 4 | 0 |
| itraconazole | 0 | medium | 5 | 1 |
| 1-(2-chloroethyl)-3-(2-(dimethylaminosulfonyl)ethyl)-1-nitrosourea | 0 | medium | 5 | 3 |
| flavone acetic acid | 0 | medium | 12 | 4 |
| iopentol | 0 | low | 1 | 0 |
| antineoplaston a10 | 0 | low | 1 | 0 |
| fluorodopa f 18 | 0 | low | 4 | 0 |
| salmeterol xinafoate | 0 | medium | 1 | 1 |
| ranolazine | 0 | low | 2 | 0 |
| brequinar | 0 | medium | 3 | 1 |
| fura-2 | 0 | low | 5 | 0 |
| imiquimod | 0 | medium | 139 | 12 |
| esmolol | 0 | low | 1 | 0 |
| piroxantrone | 0 | medium | 1 | 1 |
| adapalene | 0 | low | 13 | 0 |
| aromasil | 0 | low | 1 | 0 |
| sulofenur | 0 | low | 1 | 0 |
| sparfloxacin | 0 | low | 1 | 0 |
| zileuton | 0 | low | 1 | 0 |
| clopidogrel | 0 | low | 4 | 0 |
| cidofovir anhydrous | 0 | low | 3 | 0 |
| mibefradil | 0 | low | 2 | 0 |
| topotecan | 0 | medium | 12 | 4 |
| n(1),n(14)-bis(ethyl)homospermine | 0 | low | 1 | 0 |
| gemcitabine | 0 | medium | 33 | 14 |
| temoporfin | 0 | low | 1 | 0 |
| remifentanil | 0 | medium | 1 | 1 |
| atorvastatin | 0 | low | 6 | 0 |
| duloxetine hydrochloride | 0 | low | 1 | 0 |
| irinotecan | 0 | medium | 18 | 2 |
| valsartan | 0 | low | 2 | 0 |
| ibandronic acid | 0 | low | 1 | 0 |
| 3-iodobenzylguanidine | 0 | low | 8 | 0 |
| bisnafide | 0 | low | 1 | 0 |
| capecitabine | 0 | low | 5 | 0 |
| adenosine | 0 | medium | 66 | 2 |
| myrtenal | 0 | low | 1 | 0 |
| 2,5-bis(1-aziridinyl)-3,6-bis(2-methoxyethoxy)-4-benzoquinone | 0 | low | 4 | 0 |
| octyl gallate | 0 | low | 1 | 0 |
| terbium chloride | 0 | low | 1 | 0 |
| gadolinium chloride | 0 | low | 1 | 0 |
| gallium nitrate | 0 | low | 1 | 0 |
| vanadates | 0 | low | 5 | 0 |
| dimethylhydrazines | 0 | low | 1 | 0 |
| acridine orange | 0 | low | 7 | 0 |
| benzylaminopurine | 0 | low | 1 | 0 |
| isothiocyanic acid | 0 | low | 3 | 0 |
| barium fluoride | 0 | low | 1 | 0 |
| carbogen | 0 | medium | 3 | 1 |
| caloreen | 0 | low | 2 | 0 |
| styromal | 0 | low | 1 | 0 |
| octyl glucoside | 0 | low | 1 | 0 |
| halofuginone | 0 | low | 2 | 0 |
| venlafaxine hydrochloride | 0 | low | 1 | 0 |
| dt 5061 | 0 | low | 1 | 0 |
| trazodone hydrochloride | 0 | medium | 3 | 1 |
| efavirenz | 0 | low | 2 | 0 |
| nelfinavir | 0 | low | 3 | 0 |
| u 37883a | 0 | low | 1 | 0 |
| glucose, (beta-d)-isomer | 0 | medium | 20 | 3 |
| mevastatin | 0 | low | 2 | 0 |
| ursolic acid | 0 | low | 10 | 0 |
| iodonitrotetrazolium | 0 | low | 1 | 0 |
| thiazolyl blue | 0 | low | 27 | 0 |
| thymidine 5'-triphosphate | 0 | low | 3 | 0 |
| 18-hydroxydeoxycorticosterone | 0 | low | 1 | 0 |
| betulinic acid | 0 | low | 27 | 0 |
| platanic acid | 0 | low | 1 | 0 |
| baicalin | 0 | low | 1 | 0 |
| plerixafor | 0 | low | 3 | 0 |
| oseltamivir | 0 | low | 1 | 0 |
| 5-methylcytosine | 0 | low | 23 | 0 |
| guanidine thiocyanate | 0 | low | 2 | 0 |
| diacetylfluorescein | 0 | low | 1 | 0 |
| ibacitabine | 0 | low | 1 | 0 |
| diphenylcyclopropenone | 0 | medium | 25 | 1 |
| methylthymidine | 0 | low | 1 | 0 |
| epigallocatechin gallate | 0 | low | 26 | 0 |
| deoxyuridine triphosphate | 0 | low | 1 | 0 |
| fluorexon | 0 | low | 2 | 0 |
| cholesteryl succinate | 0 | low | 5 | 0 |
| gallocatechol | 0 | low | 1 | 0 |
| xanthotoxol | 0 | low | 1 | 0 |
| 2'-deoxycytidine 5'-triphosphate | 0 | low | 1 | 0 |
| 25-hydroxycholesterol | 0 | low | 1 | 0 |
| 10,10'-dimethyl-9,9'-biacridinium | 0 | low | 1 | 0 |
| chlorin | 0 | low | 4 | 0 |
| phosphoramidic acid | 0 | low | 1 | 0 |
| squaric acid dibutyl ester | 0 | low | 1 | 0 |
| 1,2-dipalmitoyl-3-phosphatidylethanolamine | 0 | low | 1 | 0 |
| aica ribonucleotide | 0 | low | 4 | 0 |
| thomsen-friedenreich antigen | 0 | low | 3 | 0 |
| salvin | 0 | low | 1 | 0 |
| distearoyl phosphatidylglycerol | 0 | low | 1 | 0 |
| 1,2-distearoyllecithin | 0 | low | 1 | 0 |
| 2',5'-dideoxyadenosine | 0 | low | 1 | 0 |
| 5-bromo-4-chloro-3-indolyl beta-galactoside | 0 | low | 1 | 0 |
| metaperiodate | 0 | low | 5 | 0 |
| lissamine rhodamine b | 0 | low | 5 | 0 |
| neocuproine | 0 | low | 2 | 0 |
| 1,2,3,4,6-pentakis-O-galloyl-beta-D-glucose | 0 | low | 2 | 0 |
| tris(2,2'-bipyridine)ruthenium(II) | 0 | low | 1 | 0 |
| 2-oxothiazolidine-4-carboxylic acid | 0 | low | 4 | 0 |
| o-(6)-methylguanine | 0 | medium | 8 | 1 |
| surfactin peptide | 0 | low | 2 | 0 |
| pyrrolidine dithiocarbamate | 0 | low | 3 | 0 |
| glutathione disulfide | 0 | low | 6 | 0 |
| 4-nitrobenzylthioinosine | 0 | low | 1 | 0 |
| triptonide | 0 | low | 1 | 0 |
| iopamidol | 0 | low | 7 | 0 |
| proxicromil | 0 | low | 1 | 0 |
| cephalosporin c | 0 | low | 4 | 0 |
| aloxistatin | 0 | low | 3 | 0 |
| trofosfamide | 0 | medium | 6 | 1 |
| rutecarpine | 0 | low | 1 | 0 |
| tretoquinol | 0 | medium | 1 | 1 |
| sertaconazole | 0 | low | 1 | 0 |
| flomoxef | 0 | low | 1 | 0 |
| web 2086 | 0 | low | 4 | 0 |
| arpromidine | 0 | low | 1 | 0 |
| methoxy-morpholinyl-doxorubicin | 0 | low | 1 | 0 |
| goralatide | 0 | low | 1 | 0 |
| intoplicine | 0 | low | 1 | 0 |
| telmisartan | 0 | low | 1 | 0 |
| n-phenylglycine | 0 | low | 1 | 0 |
| omega-aminocaprylic acid | 0 | low | 1 | 0 |
| zinc iodide | 0 | low | 1 | 0 |
| iridium radioisotopes | 0 | medium | 13 | 1 |
| xenon radioisotopes | 0 | low | 2 | 0 |
| 2-methoxyestradiol | 0 | low | 9 | 0 |
| perylenediimide | 0 | low | 1 | 0 |
| naphthalimides | 0 | low | 5 | 0 |
| benzeneboronic acid | 0 | low | 2 | 0 |
| 3-methyl-n,n-diethyl-p-phenylenediamine | 0 | low | 1 | 0 |
| 1,7-phenanthroline | 0 | low | 11 | 0 |
| benzofurazan | 0 | low | 1 | 0 |
| 1h-imidazo(4,5-b)pyridine | 0 | low | 1 | 0 |
| triazoles | 0 | medium | 41 | 1 |
| atranorin | 0 | low | 1 | 0 |
| pinocembrin | 0 | low | 1 | 0 |
| tangeretin | 0 | low | 1 | 0 |
| isopimpinellin | 0 | low | 1 | 0 |
| 2,4,6-trihydroxybenzaldehyde | 0 | low | 1 | 0 |
| isocoumarins | 0 | low | 2 | 0 |
| delphinidin | 0 | low | 31 | 0 |
| 2,3-trimethylene-4-quinazolone | 0 | low | 1 | 0 |
| azure b | 0 | low | 3 | 0 |
| sesamol | 0 | low | 4 | 0 |
| fluorodeoxyglucose f18 | 0 | medium | 547 | 40 |
| sertraline | 0 | low | 3 | 0 |
| lonazolac | 0 | low | 1 | 0 |
| zoledronic acid | 0 | low | 14 | 0 |
| schizandrol b | 0 | low | 1 | 0 |
| elmustine | 0 | low | 2 | 0 |
| artemisinin | 0 | low | 1 | 0 |
| n-leucyldoxorubicin | 0 | low | 1 | 0 |
| forphenicinol | 0 | low | 1 | 0 |
| piloty's acid | 0 | low | 1 | 0 |
| ubiquinone-o | 0 | low | 1 | 0 |
| naphthyl phenyl ketone | 0 | low | 1 | 0 |
| 2-hydroxy-4-methoxybenzaldehyde | 0 | low | 1 | 0 |
| 1-hydroxy-2(1h)-pyridinone | 0 | low | 1 | 0 |
| diphenyltin | 0 | low | 1 | 0 |
| 5-hydroxymethylcytosine | 0 | low | 15 | 0 |
| hydroxyaniline mustard | 0 | low | 2 | 0 |
| bicinchoninic acid | 0 | low | 1 | 0 |
| n-methylscopolamine | 0 | low | 1 | 0 |
| anaxirone | 0 | low | 1 | 0 |
| fosquidone | 0 | medium | 1 | 1 |
| masoprocol | 0 | low | 6 | 0 |
| tocophersolan | 0 | low | 1 | 0 |
| bay i 7433 | 0 | low | 2 | 0 |
| 4-fluorobenzamide | 0 | low | 1 | 0 |
| voriconazole | 0 | low | 6 | 0 |
| inproquone | 0 | low | 2 | 0 |
| carazolol | 0 | low | 1 | 0 |
| ranimustine | 0 | low | 5 | 0 |
| mitozolomide | 0 | medium | 8 | 1 |
| dw a 2114r | 0 | low | 1 | 0 |
| datelliptium chloride | 0 | low | 1 | 0 |
| quindoxin | 0 | low | 1 | 0 |
| prednisolone phosphate | 0 | low | 1 | 0 |
| ubenimex | 0 | medium | 7 | 2 |
| 7-hydroxystaurosporine | 0 | medium | 3 | 2 |
| epicatechin | 0 | low | 1 | 0 |
| hesperetin | 0 | low | 2 | 0 |
| illimaquinone | 0 | low | 1 | 0 |
| 4-o-methyl-12-o-tetradecanoylphorbol 13-acetate | 0 | low | 2 | 0 |
| phorbol-12,13-diacetate | 0 | low | 1 | 0 |
| magnolol | 0 | low | 2 | 0 |
| honokiol | 0 | low | 9 | 0 |
| sesamin | 0 | low | 2 | 0 |
| columbamine | 0 | low | 1 | 0 |
| jatrorrhizine | 0 | low | 1 | 0 |
| betulin | 0 | low | 3 | 0 |
| hernandezine | 0 | low | 1 | 0 |
| n-(2-(hydroxyethoxy)methyl)-5-methyluracil | 0 | low | 1 | 0 |
| narciclasine | 0 | low | 2 | 0 |
| lycorine | 0 | low | 4 | 0 |
| 5-iminodaunorubicin | 0 | low | 1 | 0 |
| 9-aminocamptothecin | 0 | low | 1 | 0 |
| teleocidin b-4 | 0 | low | 2 | 0 |
| leupeptin | 0 | low | 3 | 0 |
| picropodophyllin | 0 | low | 9 | 0 |
| methylbenzoprim | 0 | low | 1 | 0 |
| 3-deazaaristeromycin | 0 | low | 1 | 0 |
| pentazirinocyclodiphosphathiazene | 0 | low | 1 | 0 |
| 3-aminophenoxazone | 0 | low | 1 | 0 |
| alpha-lapachone | 0 | low | 1 | 0 |
| nsc 361456 | 0 | medium | 1 | 1 |
| cyclopentenyl cytosine | 0 | low | 2 | 0 |
| 3-deazaneplanocin | 0 | low | 2 | 0 |
| tingenin b | 0 | low | 2 | 0 |
| nodakenin | 0 | low | 1 | 0 |
| fascaplysine | 0 | low | 1 | 0 |
| jacaranone | 0 | low | 1 | 0 |
| o(6)-methyl-2'-deoxyguanosine | 0 | low | 1 | 0 |
| calpeptin | 0 | low | 3 | 0 |
| gliclazide | 0 | low | 1 | 0 |
| dauricine | 0 | low | 1 | 0 |
| brusatol | 0 | low | 2 | 0 |
| chrysomycin a | 0 | low | 1 | 0 |
| betulinic acid methyl ester | 0 | low | 1 | 0 |
| tryptanthrine | 0 | low | 2 | 0 |
| sakuranetin | 0 | low | 2 | 0 |
| 4beta-Hydroxywithanolide E | 0 | low | 1 | 0 |
| maslinic acid | 0 | low | 2 | 0 |
| tetracyanoquinodimethane | 0 | low | 1 | 0 |
| ceric oxide | 0 | low | 5 | 0 |
| triphenylmethylphosphonium | 0 | low | 1 | 0 |
| phenylenediamine mustard | 0 | low | 3 | 0 |
| azoprocarbazine | 0 | low | 1 | 0 |
| 1-(2-chloroethyl)-1-nitrosourea | 0 | low | 2 | 0 |
| c.i. direct red 80 | 0 | low | 1 | 0 |
| adipostatin a | 0 | low | 2 | 0 |
| 6-carboxyfluorescein | 0 | low | 4 | 0 |
| 5-(3-methyl-1-triazeno)imidazole-4-carboxamide | 0 | low | 3 | 0 |
| bendamustine hydrochloride | 0 | medium | 2 | 2 |
| sofosbuvir | 0 | low | 1 | 0 |
| rosiglitazone | 0 | low | 5 | 0 |
| ortho-(1-naphthoyl)benzoic acid | 0 | low | 1 | 0 |
| imidazo(1,2-a)pyridine | 0 | low | 2 | 0 |
| phenyl vinyl sulfone | 0 | low | 1 | 0 |
| 2,6-diformyl-p-cresol | 0 | low | 1 | 0 |
| cryptolepine | 0 | low | 1 | 0 |
| bexarotene | 0 | low | 2 | 0 |
| s20098 | 0 | low | 1 | 0 |
| 3,4-dihydroxyphenylethanol | 0 | low | 3 | 0 |
| 4-phenylbutylamine | 0 | low | 1 | 0 |
| 1-(2-fluoroethyl)-3-cyclohexyl-1-nitrosourea | 0 | low | 1 | 0 |
| biocytin | 0 | low | 1 | 0 |
| 5-(biotinamido)pentylamine | 0 | low | 1 | 0 |
| 7-deoxyadriamycin aglycone | 0 | medium | 1 | 1 |
| clarithromycin | 0 | low | 1 | 0 |
| 4-aminoquinazoline | 0 | low | 1 | 0 |
| 6,6'-dithiodinicotinic acid | 0 | low | 1 | 0 |
| nordimaprit | 0 | low | 5 | 0 |
| 3,4-dihydroxymandelic acid | 0 | low | 1 | 0 |
| epidepride | 0 | low | 1 | 0 |
| 4-methylumbelliferyl heptanoate | 0 | low | 1 | 0 |
| coenzyme a | 0 | low | 5 | 0 |
| manganese sulfide | 0 | low | 1 | 0 |
| 5-thio-d-glucose | 0 | low | 2 | 0 |
| tretazicar | 0 | low | 1 | 0 |
| nicotine | 0 | low | 2 | 0 |
| nsc-172755 | 0 | low | 1 | 0 |
| fibrinogen | 0 | medium | 60 | 2 |
| friedelin | 0 | low | 1 | 0 |
| 7-ketocholesterol | 0 | low | 1 | 0 |
| 6-phosphogluconic acid | 0 | low | 1 | 0 |
| cadmium telluride | 0 | low | 3 | 0 |
| homocysteine | 0 | low | 7 | 0 |
| 3,4-dihydroxybenzylamine | 0 | low | 8 | 0 |
| 8-((4-chlorophenyl)thio)cyclic-3',5'-amp | 0 | low | 1 | 0 |
| 9-hydroxyellipticine | 0 | low | 1 | 0 |
| hydroxyflutamide | 0 | low | 1 | 0 |
| methionyl-leucyl-phenylalanine | 0 | medium | 1 | 1 |
| coronatine | 0 | low | 1 | 0 |
| 1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine | 0 | low | 1 | 0 |
| 4-hydroxylomustine | 0 | low | 1 | 0 |
| methylumbelliferyl-beta-d-xyloside | 0 | low | 1 | 0 |
| fluoromisonidazole | 0 | low | 1 | 0 |
| levobupivacaine | 0 | low | 2 | 0 |
| melanotan-ii | 0 | low | 5 | 0 |
| lopinavir | 0 | low | 1 | 0 |
| gamma-tocopherol | 0 | medium | 2 | 2 |
| firefly luciferin | 0 | low | 1 | 0 |
| alanyltyrosine | 0 | low | 1 | 0 |
| norcantharidin | 0 | low | 2 | 0 |
| glycidyl nitrate | 0 | low | 4 | 0 |
| titanium nitride (tin) | 0 | low | 1 | 0 |
| 1-(4-carboxamidophenyl)-3,3-dimethyltriazene | 0 | low | 1 | 0 |
| pyrimidine dimers | 0 | medium | 46 | 1 |
| coumarin 7 | 0 | low | 1 | 0 |
| glucuronic acid | 0 | low | 1 | 0 |
| 2,2',4,4'-tetrabromodiphenyl ether | 0 | low | 1 | 0 |
| nsc 30705 | 0 | low | 1 | 0 |
| 2,3-naphthalenedicarboxaldehyde | 0 | low | 1 | 0 |
| 2-phenyl-5,5-dimethyltetrahydro-1,4-oxazine | 0 | low | 1 | 0 |
| 3,4-dehydroproline | 0 | low | 4 | 0 |
| 2-(4-bromo-2,5-dimethoxyphenyl)ethylamine | 0 | low | 1 | 0 |
| 4-acryloylmorpholine | 0 | low | 1 | 0 |
| diosgenin | 0 | low | 5 | 0 |
| 5,6-dihydro-5-azacytidine | 0 | medium | 2 | 1 |
| 4-hydroxycyclophosphamide | 0 | low | 1 | 0 |
| hydroperoxyisophosphamide | 0 | low | 1 | 0 |
| dianhydro-3,4-diacetylgalactitol | 0 | low | 2 | 0 |
| pyrimidin-2-one beta-ribofuranoside | 0 | low | 1 | 0 |
| foxes | 0 | low | 1 | 0 |
| alpha-glutamyltryptophan | 0 | low | 1 | 0 |
| gamma-l-glutaminyl-4-hydroxybenzene | 0 | low | 5 | 0 |
| 1-(2-nitro-1-imidazolyl)-3-aziridino-2-propanol | 0 | low | 4 | 0 |
| combretastatin | 0 | low | 3 | 0 |
| fangchinoline | 0 | low | 3 | 0 |
| loliolide | 0 | low | 1 | 0 |
| arctiin | 0 | low | 1 | 0 |
| lavendamycin | 0 | low | 1 | 0 |
| saframycin a | 0 | low | 1 | 0 |
| 7-amino-4-trifluoromethylcoumarin | 0 | low | 1 | 0 |
| n-hydroxysuccinimide suberic acid ester | 0 | low | 1 | 0 |
| rapanone | 0 | low | 1 | 0 |
| n-succinimidyl 3-(2-pyridyldithio)propionate | 0 | low | 3 | 0 |
| bimolane | 0 | low | 1 | 0 |
| 5-chloro-2'-deoxycytidine | 0 | low | 1 | 0 |
| cyclic dtpa anhydride | 0 | low | 1 | 0 |
| corydaline | 0 | low | 1 | 0 |
| friedelinol | 0 | low | 1 | 0 |
| tingenone | 0 | low | 1 | 0 |
| sesamolin | 0 | low | 1 | 0 |
| carbobenzoxyproline | 0 | low | 1 | 0 |
| 2-methoxyestriol | 0 | low | 1 | 0 |
| n-methyladenosine | 0 | low | 10 | 0 |
| neokestose | 0 | low | 1 | 0 |
| 1,2-distearoylphosphatidylethanolamine | 0 | low | 2 | 0 |
| cobalt | 0 | low | 19 | 0 |
| p-methoxy-n-methylphenethylamine | 0 | low | 1 | 0 |
| fulvestrant | 0 | low | 4 | 0 |
| mafosfamide | 0 | low | 4 | 0 |
| hydrogen sulfite | 0 | low | 2 | 0 |
| 1,2-bis(2-aminophenoxy)ethane-n,n,n',n'-tetraacetic acid | 0 | low | 2 | 0 |
| yttrium radioisotopes | 0 | medium | 29 | 3 |
| carbidopa, levodopa drug combination | 0 | low | 1 | 0 |
| fotemustine | 0 | medium | 141 | 45 |
| arginyl-glycyl-aspartic acid | 0 | medium | 88 | 1 |
| wr 1065 | 0 | low | 2 | 0 |
| vitamin b 6 | 0 | low | 2 | 0 |
| 1,4-dihydropyridine | 0 | low | 1 | 0 |
| cremophor el | 0 | low | 1 | 0 |
| s-nitrosoglutathione | 0 | low | 1 | 0 |
| bosentan anhydrous | 0 | medium | 6 | 2 |
| hydroxymethyltrioxsalen | 0 | low | 1 | 0 |
| 1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1h-imidazole | 0 | low | 1 | 0 |
| fluo-3 | 0 | low | 1 | 0 |
| paxilline | 0 | low | 26 | 0 |
| beauvericin | 0 | low | 1 | 0 |
| artesunic acid | 0 | low | 3 | 0 |
| cyanates | 0 | low | 2 | 0 |
| indo-1 | 0 | low | 1 | 0 |
| fura-2-am | 0 | low | 1 | 0 |
| fluorocitrate | 0 | low | 1 | 0 |
| 4'-(9-acridinylamino)methanesulfonanilide | 0 | low | 2 | 0 |
| arginyl-glycyl-aspartyl-serine | 0 | low | 5 | 0 |
| fusarochromanone | 0 | low | 1 | 0 |
| saikosaponin d | 0 | low | 3 | 0 |
| 6-hydroxydopa | 0 | low | 3 | 0 |
| n-(2'-(dimethylamino)ethyl)acridine-4-carboxamide | 0 | low | 3 | 0 |
| perindopril | 0 | low | 2 | 0 |
| tryptoline | 0 | low | 1 | 0 |
| procyanidin | 0 | low | 13 | 0 |
| epicatechin gallate | 0 | low | 4 | 0 |
| asulacrine | 0 | low | 1 | 0 |
| deguelin | 0 | low | 1 | 0 |
| fingolimod hydrochloride | 0 | low | 12 | 0 |
| triptolide | 0 | low | 10 | 0 |
| 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide | 0 | medium | 8 | 2 |
| cafestol | 0 | low | 1 | 0 |
| proanthocyanidin | 0 | low | 2 | 0 |
| diazan | 0 | low | 1 | 0 |
| parthenolide | 0 | low | 9 | 0 |
| tesmilifene | 0 | low | 4 | 0 |
| schizandrin b | 0 | low | 1 | 0 |
| carboxyamido-triazole | 0 | low | 2 | 0 |
| ecteinascidin 743 | 0 | low | 3 | 0 |
| 1-hexadecyl-2-acetyl-glycero-3-phosphocholine | 0 | low | 12 | 0 |
| deoxyglucose | 0 | medium | 44 | 2 |
| tadalafil | 0 | low | 3 | 0 |
| ribonolactone | 0 | low | 1 | 0 |
| anecortave acetate | 0 | low | 1 | 0 |
| 5,6-dihydroxyindole | 0 | low | 10 | 0 |
| 3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione | 0 | medium | 3 | 2 |
| 1-phenyl-2-decanoylamino-3-morpholino-1-propanol | 0 | low | 2 | 0 |
| 5-hydroxydopamine | 0 | low | 1 | 0 |
| homoorientin | 0 | medium | 1 | 1 |
| kahweol | 0 | low | 1 | 0 |
| valerates | 0 | low | 1 | 0 |
| selenomethylselenocysteine | 0 | low | 2 | 0 |
| aluminum phthalocyanine | 0 | low | 3 | 0 |
| thromboxanes | 0 | low | 3 | 0 |
| glutathione monoisopropyl ester | 0 | low | 1 | 0 |
| tanshinone | 0 | low | 5 | 0 |
| 1,2-dimyristoylphosphatidylethanolamine | 0 | low | 1 | 0 |
| 3,4-dimethoxydalbergione | 0 | low | 1 | 0 |
| geraniin | 0 | low | 1 | 0 |
| gastrodin | 0 | low | 1 | 0 |
| ponasterone a | 0 | low | 1 | 0 |
| fr 41565 | 0 | low | 3 | 0 |
| 3'-o-(4-benzoyl)benzoyladenosine 5'-triphosphate | 0 | low | 1 | 0 |
| 3beta-(n-(n',n'-dimethylaminoethane)carbamoyl)cholesterol | 0 | low | 3 | 0 |
| 2-aminobicyclo(2,2,1)heptane-2-carboxylic acid | 0 | low | 3 | 0 |
| 4-bromo-a-23187 | 0 | low | 1 | 0 |
| cp 65,526 | 0 | low | 1 | 0 |
| glycyl-arginyl-glycyl-aspartyl-seryl-proline | 0 | low | 1 | 0 |
| 4-s-cysteaminylphenol | 0 | low | 11 | 0 |
| 2-iodomelatonin | 0 | low | 2 | 0 |
| cubebin | 0 | low | 1 | 0 |
| marimastat | 0 | medium | 4 | 1 |
| asiatic acid | 0 | low | 1 | 0 |
| ruthenium tetraoxide | 0 | low | 2 | 0 |
| cynaropicrin | 0 | low | 1 | 0 |
| 1'-acetoxychavicol acetate | 0 | low | 1 | 0 |
| nitrobenzylthioinosine 5'-monophosphate | 0 | low | 1 | 0 |
| ak 2123 | 0 | low | 1 | 0 |
| silicon phthalocyanine pc4 | 0 | low | 2 | 0 |
| sr 48692 | 0 | low | 1 | 0 |
| dioscin | 0 | low | 3 | 0 |
| 4-(4-(4-chlorophenyl)-4-hydroxy-1-piperidinyl)-1-(4-fluorophenyl)-1-butanol | 0 | low | 1 | 0 |
| cucurbitacins | 0 | low | 2 | 0 |
| ginsenoside rh2 | 0 | low | 3 | 0 |
| sr 33557 | 0 | low | 1 | 0 |
| elacridar | 0 | low | 1 | 0 |
| caprylates | 0 | low | 5 | 0 |
| 1,3,4-thiadiazole | 0 | low | 1 | 0 |
| dopachrome | 0 | low | 10 | 0 |
| 5,6-dihydroxy-2-indolylcarboxylic acid | 0 | low | 8 | 0 |
| daphnetoxin | 0 | low | 1 | 0 |
| muramylnac-ala-isogln-lys-tripeptide | 0 | medium | 5 | 1 |
| n'-(2-chloroethyl)-n-(2-(methylsulfonyl)ethyl)-n'-nitrosourea | 0 | medium | 10 | 5 |
| 1-(2-nitro-1-imidazoly)-3-(2,3-dimethylaziridino)-2-propanol | 0 | low | 2 | 0 |
| dt 5461 | 0 | low | 1 | 0 |
| parecoxib | 0 | low | 1 | 0 |
| angustmycin a | 0 | low | 1 | 0 |
| 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid | 0 | low | 13 | 0 |
| gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate | 0 | low | 5 | 0 |
| 1-(4-methoxyphenyl)pyridinium | 0 | low | 1 | 0 |
| luzindole | 0 | low | 1 | 0 |
| (3-dimyristyloxypropyl)(dimethyl)(hydroxyethyl)ammonium | 0 | medium | 3 | 1 |
| dansylarginine n-(3-ethyl-1,5-pentanediyl)amide | 0 | low | 1 | 0 |
| benzyl-alpha-n-acetylgalactosamine | 0 | low | 1 | 0 |
| 5-chloromethylfluorescein diacetate | 0 | low | 1 | 0 |
| 6-hydroxy-5-methoxy-2-indolylcarboxylic acid | 0 | low | 12 | 0 |
| val-leu-arg-p-nitroanilide | 0 | low | 1 | 0 |
| ursocholic acid | 0 | low | 1 | 0 |
| n-acetylputrescine | 0 | low | 1 | 0 |
| celastrol | 0 | low | 9 | 0 |
| olivomycin a | 0 | low | 1 | 0 |
| betulonic acid | 0 | low | 3 | 0 |
| dehydroacetic acid | 0 | low | 1 | 0 |
| carbene | 0 | low | 3 | 0 |
| phosphoramide | 0 | low | 1 | 0 |
| peroxynitrous acid | 0 | low | 3 | 0 |
| fullerene c60 | 0 | low | 8 | 0 |
| imatinib mesylate | 0 | medium | 90 | 14 |
| mk 0663 | 0 | medium | 2 | 1 |
| gefitinib | 0 | medium | 17 | 1 |
| n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine | 0 | low | 2 | 0 |
| tyrosyl-glycyl-glycine | 0 | low | 1 | 0 |
| 3-iodo-alpha-methyltyrosine | 0 | low | 4 | 0 |
| galactosyl-(1-3)galactose | 0 | low | 2 | 0 |
| acth (4-10) | 0 | low | 1 | 0 |
| n(6)-carboxymethyllysine | 0 | low | 1 | 0 |
| technetium tc 99m hydroxymethylene diphosphonate | 0 | low | 1 | 0 |
| glycyl-arginyl-glycyl-aspartyl-serine | 0 | low | 4 | 0 |
| cyclic adp-ribose | 0 | low | 1 | 0 |
| antibiotic g 418 | 0 | low | 4 | 0 |
| 4-iodoamphetamine | 0 | low | 2 | 0 |
| glycerophosphoethanolamine | 0 | low | 1 | 0 |
| 1-((3,5-dichloro)-2,6-dihydroxy-4-methoxyphenyl)-1-hexanone | 0 | low | 4 | 0 |
| rmi 12330a | 0 | low | 2 | 0 |
| statine | 0 | low | 1 | 0 |
| naadp | 0 | low | 1 | 0 |
| 9-o-acetyl-n-acetylneuraminic acid | 0 | low | 1 | 0 |
| vadimezan | 0 | low | 6 | 0 |
| 27-hydroxycholesterol | 0 | low | 1 | 0 |
| tyrosyl-isoleucyl-glycyl-seryl-arginine | 0 | low | 3 | 0 |
| e 64 | 0 | low | 1 | 0 |
| fraxinellone | 0 | low | 1 | 0 |
| desloratadine | 0 | low | 1 | 0 |
| glutathionyldopa | 0 | low | 3 | 0 |
| 1,4,7-triazacyclononane-n,n',n''-triacetic acid | 0 | low | 3 | 0 |
| 5-hexyl-2'-deoxyuridine | 0 | low | 1 | 0 |
| n-acetyl-4-s-cysteaminylphenol | 0 | low | 10 | 0 |
| teloxantrone | 0 | medium | 1 | 1 |
| 1-o-hexadecyl-2-n-methylcarbamol -sn-glycerol-3-phosphocholine | 0 | low | 2 | 0 |
| n-acetyl-demethylmuramyl-alanyl-isoglutamine | 0 | low | 2 | 0 |
| 2-(n-myristoylamino)-1-phenyl-1-propanol | 0 | low | 1 | 0 |
| imidazolium-bis(imidazole)tetrachlororuthenate(iii) | 0 | low | 1 | 0 |
| valyl-glycyl-valyl-alanyl-prolyl-glycine | 0 | low | 2 | 0 |
| glycerophosphoinositol 4,5-bisphosphate | 0 | low | 1 | 0 |
| n-(4-carboxycyclohexylmethyl)maleimide n-hydroxysuccinimide ester | 0 | low | 1 | 0 |
| benzyloxycarbonyl-phenylalanylarginine-4-methylcoumaryl-7-amide | 0 | low | 1 | 0 |
| benzyloxycarbonylphenylalanylphenylalanine diazomethyl ketone | 0 | low | 1 | 0 |
| o(6)-benzyl-2'-deoxyguanosine | 0 | low | 1 | 0 |
| 5-aza-2'-deoxycytidine-5'-monophosphate | 0 | low | 1 | 0 |
| msh (11-13) | 0 | low | 1 | 0 |
| 1-(4-methoxyphenyl)-2-(3,4,5-trimethoxyphenyl)ethene | 0 | low | 4 | 0 |
| n'-(2-chloroethyl)-n-(2-(methylsulfinyl)ethyl)-n'-nitrosourea | 0 | low | 1 | 0 |
| ectoine | 0 | low | 2 | 0 |
| cetylmannoside | 0 | low | 1 | 0 |
| 4-s-cysteinylphenol | 0 | low | 5 | 0 |
| bd 1008 | 0 | low | 1 | 0 |
| 4-amino-3-hydroxyphenylalanine | 0 | medium | 5 | 1 |
| 4-(2-amino-6-chloro-9h-purin-9-yl)-1,3-dioxolane-2-methanol | 0 | low | 1 | 0 |
| methotrexate | 0 | medium | 207 | 11 |
| phe-cyclo(cys-tyr-trp-lys-val-cys)thr-nh2 | 0 | low | 1 | 0 |
| porphycene | 0 | low | 1 | 0 |
| chlorolissoclimide | 0 | low | 1 | 0 |
| ro 32-0432 | 0 | low | 1 | 0 |
| 4-iodo-n-piperidinoethylbenzamide | 0 | low | 1 | 0 |
| 4-nitrophenyl 2-fluoropropionate | 0 | low | 1 | 0 |
| dihydroethidium | 0 | low | 1 | 0 |
| rsu 1172 | 0 | low | 1 | 0 |
| delphinidin | 0 | low | 1 | 0 |
| eudistomin e | 0 | low | 1 | 0 |
| 5h-furo(3,2-g)(1)benzopyran-5-one | 0 | low | 1 | 0 |
| n-(2-(diethylamino)ethyl)-4-iodobenzamide | 0 | medium | 15 | 4 |
| 6-n-aziridinyl-3-hydrox-7-methyl-2,3-dihydro-1h-pyrrolo(1,2-a)benzimidazole-5,8-dione 3-acetate | 0 | low | 1 | 0 |
| bis-benzimidazole | 0 | low | 1 | 0 |
| glycero-3-phosphoinositol 4-phosphate | 0 | low | 1 | 0 |
| 4-succinimidyloxycarbonyl-alpha-methyl-alpha(2-pyridyldithio)toluene | 0 | low | 1 | 0 |
| leucyl-aspartyl-valine | 0 | low | 1 | 0 |
| isoleucyl-lysyl-valyl-alanyl-valine | 0 | low | 1 | 0 |
| ro 43-5054 | 0 | low | 1 | 0 |
| c 1311 | 0 | low | 1 | 0 |
| s-(2-(n,n-diisopropylamino)ethyl)isothiourea | 0 | low | 1 | 0 |
| rx-ra 69 | 0 | low | 1 | 0 |
| ilomastat | 0 | low | 1 | 0 |
| l 733060 | 0 | low | 1 | 0 |
| omega-n-methylarginine | 0 | low | 2 | 0 |
| 5,8-dihydroxy-3-methyl-4-(9h)-naphtho(2,3-c)furanone | 0 | low | 1 | 0 |
| zinquin | 0 | low | 1 | 0 |
| abiraterone | 0 | low | 3 | 0 |
| kw 2189 | 0 | medium | 1 | 1 |
| hexestrol diphosphate | 0 | low | 1 | 0 |
| n-(gamma-maleimidobutyryloxy)succinimide | 0 | low | 1 | 0 |
| imidazolecarboxamide | 0 | low | 1 | 0 |
| 4-hydroxy-equilenin | 0 | low | 1 | 0 |
| triiodothyronine | 0 | low | 1 | 0 |
| podophyllic acid | 0 | low | 1 | 0 |
| xylose | 0 | low | 1 | 0 |
| 21-hydroxy-9beta,10alpha-pregna-5,7-diene-3-ol-20-one | 0 | low | 1 | 0 |
| cd 437 | 0 | low | 5 | 0 |
| quinone methide | 0 | low | 2 | 0 |
| beta-lactams | 0 | low | 1 | 0 |
| 1,3,5-triaza-7-phosphaadamantane | 0 | low | 1 | 0 |
| proline | 0 | low | 20 | 0 |
| cucurbitaceae | 0 | low | 1 | 0 |
| sl-mercaptoethanol | 0 | low | 1 | 0 |
| diamsar chelate | 0 | low | 1 | 0 |
| fusidic acid | 0 | low | 1 | 0 |
| docetaxel | 0 | low | 1 | 0 |
| docetaxel anhydrous | 0 | medium | 58 | 17 |
| 2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a | 0 | low | 1 | 0 |
| perifosine | 0 | medium | 1 | 1 |
| irofulven | 0 | medium | 2 | 1 |
| lonafarnib | 0 | low | 3 | 0 |
| cositecan | 0 | medium | 4 | 2 |
| aclacinomycin | 0 | low | 1 | 0 |
| dichlorotetrakis(dimethyl sulfoxide)ruthenium ii | 0 | low | 1 | 0 |
| 4-boronophenylalanine | 0 | medium | 31 | 3 |
| pyrrole-2,3,5-tricarboxylic acid | 0 | low | 4 | 0 |
| pyrrole-2,3-dicarboxylic acid | 0 | low | 1 | 0 |
| nepafenac | 0 | low | 2 | 0 |
| 6-carboxyfluorescein diacetate | 0 | low | 1 | 0 |
| cox 189 | 0 | low | 1 | 0 |
| cariporide | 0 | low | 1 | 0 |
| ptk 787 | 0 | low | 1 | 0 |
| vatalanib | 0 | medium | 4 | 1 |
| oleanolic acid 3-acetate | 0 | low | 1 | 0 |
| evodiamine | 0 | low | 9 | 0 |
| 3,3,5,5-tetramethyl-1-pyrroline n-oxide | 0 | low | 1 | 0 |
| 3-hydroxyhexanoic acid | 0 | low | 1 | 0 |
| phosphorodithioic acid | 0 | low | 4 | 0 |
| imidazole-4-carboxamide | 0 | low | 1 | 0 |
| mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin | 0 | low | 1 | 0 |
| 1-4-(3-methyltriazeno)benzoic acid | 0 | low | 1 | 0 |
| phorbols | 0 | low | 16 | 0 |
| paclitaxel | 0 | low | 1 | 0 |
| tomentosin | 0 | low | 1 | 0 |
| schizandrin a | 0 | low | 1 | 0 |
| sideritoflavone | 0 | low | 1 | 0 |
| naproxen | 0 | low | 1 | 0 |
| canertinib dihydrochloride | 0 | medium | 2 | 2 |
| canertinib | 0 | low | 2 | 0 |
| birb 796 | 0 | low | 1 | 0 |
| hydroxyl radical | 0 | low | 7 | 0 |
| naphthalenediimide | 0 | low | 2 | 0 |
| methyl 5-aminolevulinate | 0 | low | 3 | 0 |
| dichlorobis(1-(2-hydroxyethyl)-2-methyl-5-nitroimidazole)platinum (ii) | 0 | low | 1 | 0 |
| bacteriochlorin a | 0 | low | 2 | 0 |
| tipifarnib | 0 | medium | 3 | 2 |
| potassium titanylphosphate | 0 | low | 1 | 0 |
| celastrol methyl ester | 0 | low | 1 | 0 |
| amotosalen | 0 | low | 1 | 0 |
| resiquimod | 0 | medium | 7 | 3 |
| copper silicate | 0 | low | 1 | 0 |
| indium trichloride | 0 | low | 1 | 0 |
| singlet oxygen | 0 | low | 24 | 0 |
| 2-s-cysteinyldopa | 0 | low | 3 | 0 |
| ukrain | 0 | low | 6 | 0 |
| aloesin | 0 | low | 1 | 0 |
| cryptotanshinone | 0 | low | 4 | 0 |
| fenton's reagent | 0 | low | 2 | 0 |
| 4,4'-(2,2-bis((4-(aminoiminomethyl)-2-bromophenoxy)methyl)-1,3-propanediyl)bis(oxy))bis(3-bromobenzenecarboximidamide | 0 | low | 1 | 0 |
| cyc 202 | 0 | low | 7 | 0 |
| 6-hydroxytryptamine | 0 | low | 1 | 0 |
| vanillactic acid | 0 | low | 1 | 0 |
| 5-hydroxy-6-methoxy-2-indolylcarboxylic acid | 0 | low | 6 | 0 |
| 2-phenyl-4-oxohydroquinoline | 0 | low | 1 | 0 |
| 5-hydroxydopa | 0 | low | 1 | 0 |
| prostaglandins b | 0 | low | 2 | 0 |
| 4'-hydroxydiazepam | 0 | low | 1 | 0 |
| pyropheophorbide a | 0 | low | 2 | 0 |
| ampelopsin | 0 | low | 2 | 0 |
| methylselenic acid | 0 | low | 2 | 0 |
| cochlioquinone a | 0 | low | 1 | 0 |
| ag 3-5 | 0 | low | 1 | 0 |
| 7-deoxyadriamycinol aglycone | 0 | medium | 1 | 1 |
| dopamine quinone | 0 | low | 1 | 0 |
| pannarin | 0 | low | 1 | 0 |
| beta-cyclodextrin-benzaldehyde | 0 | low | 2 | 0 |
| cgp 6809 | 0 | low | 1 | 0 |
| a2-binding peptide | 0 | medium | 1 | 1 |
| tin(iv) chlorin e6 | 0 | low | 1 | 0 |
| n-(2-amino-3-(4-isothiocyanatophenyl)propyl)cyclohexane-1,2-diamine-n,n',n',n'',n''-pentaacetic acid | 0 | low | 2 | 0 |
| 4-trifluoromethylsalicylic acid | 0 | low | 1 | 0 |
| tetraphenylphosphonium | 0 | low | 1 | 0 |
| 5-hydroxy-6-methoxyindole | 0 | low | 1 | 0 |
| histidinol | 0 | low | 1 | 0 |
| avasimibe | 0 | low | 1 | 0 |
| technetium tc 99m pentetate | 0 | medium | 13 | 4 |
| metaperiodate | 0 | low | 2 | 0 |
| anacardic acid | 0 | low | 1 | 0 |
| fusigen | 0 | low | 1 | 0 |
| boswellic acid | 0 | low | 2 | 0 |
| magnolin | 0 | low | 1 | 0 |
| aminopterin | 0 | medium | 10 | 2 |
| trichochrome c | 0 | low | 1 | 0 |
| 6-aminodopamine | 0 | low | 1 | 0 |
| bathocuproine disulfonate | 0 | low | 1 | 0 |
| n-acetyl-n-formyl-5-methoxykynurenamine | 0 | low | 2 | 0 |
| biotin | 0 | low | 23 | 0 |
| isoputreanine | 0 | low | 1 | 0 |
| angiotensin ii | 0 | medium | 8 | 1 |
| carboline-3-carboxylic acid | 0 | low | 1 | 0 |
| 1-nitrohydroxyphenyl-n-benzoylalanine | 0 | low | 1 | 0 |
| atropine | 0 | low | 5 | 0 |
| trimix | 0 | medium | 1 | 1 |
| lignin | 0 | low | 2 | 0 |
| ropivacaine | 0 | low | 3 | 0 |
| dendrophenol | 0 | low | 1 | 0 |
| sb 203580 | 0 | low | 13 | 0 |
| sb 216763 | 0 | low | 1 | 0 |
| enzastaurin | 0 | low | 3 | 0 |
| sk&f 99085 | 0 | medium | 2 | 1 |
| inuviscolide | 0 | low | 1 | 0 |
| erlotinib | 0 | low | 1 | 0 |
| erlotinib hydrochloride | 0 | medium | 12 | 2 |
| cilengitide | 0 | medium | 9 | 1 |
| corynoline | 0 | low | 1 | 0 |
| organophosphonates | 0 | medium | 11 | 1 |
| ambamustine | 0 | low | 3 | 0 |
| nickel monoxide | 0 | low | 1 | 0 |
| arnicolide d | 0 | low | 1 | 0 |
| schaftoside | 0 | low | 1 | 0 |
| scutellarin | 0 | low | 2 | 0 |
| alpha-fluoromethylhistidine | 0 | low | 1 | 0 |
| 5'-deoxy-5'-iodouridine | 0 | low | 1 | 0 |
| chrysosplenol c | 0 | low | 1 | 0 |
| deflazacort | 0 | low | 1 | 0 |
| glutaconaldehyde | 0 | low | 1 | 0 |
| hoe 166 | 0 | low | 1 | 0 |
| n-(3-cyano-4-methyl-1h-indol-7-yl)-3-cyanobenzene-sulfonamide | 0 | low | 1 | 0 |
| gossypolone | 0 | low | 2 | 0 |
| chlorite | 0 | low | 1 | 0 |
| chelidonine | 0 | low | 2 | 0 |
| desmethylselegiline | 0 | low | 1 | 0 |
| chromomycin a2 | 0 | low | 1 | 0 |
| maropitant | 0 | low | 1 | 0 |
| 4-n-butylresorcinol | 0 | low | 1 | 0 |
| 3-(alpha-l-arabinopyranosyl)-1-methyl-1-nitrosourea | 0 | medium | 3 | 1 |
| ramelteon | 0 | low | 1 | 0 |
| lapatinib | 0 | low | 8 | 0 |
| deferasirox | 0 | low | 2 | 0 |
| taspine | 0 | low | 1 | 0 |
| sorafenib | 0 | medium | 123 | 23 |
| lenalidomide | 0 | medium | 9 | 6 |
| senicapoc | 0 | low | 1 | 0 |
| n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide | 0 | medium | 2 | 1 |
| alanyl-glutamyl-aspartyl-glycine | 0 | low | 1 | 0 |
| phenoxodiol | 0 | low | 2 | 0 |
| demecolcine | 0 | low | 8 | 0 |
| cholic acid | 0 | low | 2 | 0 |
| deoxycholic acid | 0 | low | 7 | 0 |
| delrin | 0 | low | 1 | 0 |
| cortisone | 0 | low | 12 | 0 |
| 2-(4-aminophenyl)benzothiazole | 0 | low | 1 | 0 |
| 3-nitrotyrosine | 0 | low | 6 | 0 |
| blastmycin | 0 | low | 1 | 0 |
| 8-methyl-5-nitroquinoline | 0 | low | 1 | 0 |
| lanosterol | 0 | low | 1 | 0 |
| nogalamycin | 0 | low | 3 | 0 |
| pheophorbide a | 0 | low | 2 | 0 |
| anisomycin | 0 | low | 5 | 0 |
| benzofurans | 0 | medium | 14 | 1 |
| nsc 83265 | 0 | low | 1 | 0 |
| estramustine | 0 | medium | 5 | 1 |
| lupeol | 0 | low | 6 | 0 |
| metribolone | 0 | low | 1 | 0 |
| solanine | 0 | low | 1 | 0 |
| withaferin a | 0 | low | 5 | 0 |
| noscapine | 0 | low | 1 | 0 |
| homoharringtonine | 0 | low | 5 | 0 |
| acivicin | 0 | low | 3 | 0 |
| n-(2-carboxyethyl)pyrrole | 0 | low | 1 | 0 |
| elesclomol | 0 | medium | 13 | 2 |
| diospyrin | 0 | low | 1 | 0 |
| u-104 | 0 | low | 2 | 0 |
| wortmannin | 0 | low | 16 | 0 |
| ibogaine | 0 | low | 1 | 0 |
| menogaril | 0 | low | 2 | 0 |
| 2-oxindole | 0 | low | 1 | 0 |
| 2,2-bis(hydroxymethyl)-1-azabicyclo(2,2,2,)octan-3-one | 0 | low | 1 | 0 |
| mitonafide | 0 | low | 1 | 0 |
| pifithrin mu | 0 | low | 1 | 0 |
| withanolides | 0 | low | 9 | 0 |
| rocaglamide | 0 | low | 1 | 0 |
| illudin m | 0 | low | 2 | 0 |
| illudin s | 0 | low | 1 | 0 |
| anthricin | 0 | low | 1 | 0 |
| acronine | 0 | low | 1 | 0 |
| indole-3-acetonitrile | 0 | low | 1 | 0 |
| graveoline | 0 | low | 1 | 0 |
| 3-(2-Methylpropanoyloxy)-8-(2-methylbutanoyloxy)-9,10-epoxy-p-mentha-1,3,5-triene | 0 | low | 1 | 0 |
| erianin | 0 | low | 3 | 0 |
| trimethoprim, sulfamethoxazole drug combination | 0 | low | 3 | 0 |
| (4-methoxyphenyl)(3,4,5-trimethoxyphenyl)methanone | 0 | low | 1 | 0 |
| o-(chloroacetylcarbamoyl)fumagillol | 0 | low | 4 | 0 |
| 2,5-bis(5-hydroxymethyl-2-thienyl)furan | 0 | low | 1 | 0 |
| pomolic acid | 0 | low | 1 | 0 |
| ochraceolide a | 0 | low | 1 | 0 |
| bortezomib | 0 | medium | 50 | 7 |
| 2-(2-nitro-1h-imidazol-1-yl)-n-(2,2,3,3,3-pentafluoropropyl)acetamide | 0 | low | 1 | 0 |
| n-acetyl-5-methoxy kynurenamine | 0 | low | 1 | 0 |
| calcein am | 0 | low | 3 | 0 |
| ritonavir | 0 | low | 2 | 0 |
| sjg 136 | 0 | medium | 1 | 1 |
| acetogenins | 0 | low | 1 | 0 |
| evodine | 0 | low | 1 | 0 |
| Bardoxolone | 0 | low | 1 | 0 |
| bardoxolone methyl | 0 | medium | 3 | 1 |
| fluorocholine | 0 | low | 1 | 0 |
| n,n-dimethyl-n-(18f)fluoromethyl-2-hydroxyethylammonium | 0 | low | 2 | 0 |
| cimadronate | 0 | low | 2 | 0 |
| dihydropyridines | 0 | low | 3 | 0 |
| gant 61 | 0 | low | 2 | 0 |
| nsc 141537 | 0 | low | 1 | 0 |
| leupeptins | 0 | low | 18 | 0 |
| carboplatin | 0 | medium | 119 | 45 |
| nsc 259,968 | 0 | low | 1 | 0 |
| lithium chloride | 0 | low | 4 | 0 |
| 9-deazaadenosine | 0 | low | 1 | 0 |
| leptomycin b | 0 | low | 1 | 0 |
| s-adenosylhomocysteine | 0 | low | 1 | 0 |
| 5'-methylthioadenosine | 0 | low | 5 | 0 |
| glycogen | 0 | low | 14 | 0 |
| n-acetylneuraminic acid | 0 | medium | 32 | 1 |
| mannose-6-phosphate | 0 | low | 3 | 0 |
| fibrin | 0 | low | 38 | 0 |
| bradykinin | 0 | low | 2 | 0 |
| glucosamine | 0 | low | 38 | 0 |
| elastin | 0 | low | 15 | 0 |
| mevalonic acid | 0 | low | 5 | 0 |
| naringenin | 0 | low | 2 | 0 |
| epiglucan | 0 | low | 6 | 0 |
| n-acetyllactosamine | 0 | low | 1 | 0 |
| diaminopimelic acid | 0 | low | 3 | 0 |
| oxytocin | 0 | low | 1 | 0 |
| laminaran | 0 | low | 1 | 0 |
| dopaquinone | 0 | low | 5 | 0 |
| pantetheine | 0 | low | 1 | 0 |
| theanine | 0 | low | 1 | 0 |
| 7-dehydrocholesterol | 0 | low | 3 | 0 |
| inositol 1,4,5-trisphosphate | 0 | low | 2 | 0 |
| ouabain | 0 | low | 13 | 0 |
| puromycin | 0 | low | 11 | 0 |
| desmosterol | 0 | low | 1 | 0 |
| pentostatin | 0 | medium | 1 | 1 |
| n-glycolylneuraminic acid | 0 | low | 5 | 0 |
| inositol 3-phosphate | 0 | low | 32 | 0 |
| adenosine 5'-o-(3-thiotriphosphate) | 0 | low | 1 | 0 |
| mimosine | 0 | low | 1 | 0 |
| dehydroascorbic acid | 0 | low | 5 | 0 |
| eriodictyol | 0 | low | 1 | 0 |
| arbutin | 0 | low | 17 | 0 |
| fructans | 0 | low | 3 | 0 |
| cellulase | 0 | low | 1 | 0 |
| iduronate | 0 | low | 1 | 0 |
| strychnine | 0 | low | 1 | 0 |
| quinidine | 0 | low | 1 | 0 |
| meropenem | 0 | low | 1 | 0 |
| griseofulvin | 0 | low | 1 | 0 |
| monensin | 0 | low | 12 | 0 |
| digitoxin | 0 | low | 1 | 0 |
| saquinavir | 0 | low | 2 | 0 |
| pentazocine | 0 | low | 1 | 0 |
| pancuronium | 0 | low | 1 | 0 |
| rocuronium | 0 | low | 1 | 0 |
| hyperforin | 0 | low | 2 | 0 |
| miglitol | 0 | low | 1 | 0 |
| phalloidine | 0 | low | 4 | 0 |
| pancratistatin | 0 | low | 1 | 0 |
| ryanodine | 0 | low | 1 | 0 |
| ginsenoside re | 0 | low | 1 | 0 |
| biflorin | 0 | low | 3 | 0 |
| carnosol | 0 | low | 2 | 0 |
| ferruginol | 0 | low | 1 | 0 |
| ingenol | 0 | low | 1 | 0 |
| decursin | 0 | low | 1 | 0 |
| naringin | 0 | low | 1 | 0 |
| pulegone | 0 | low | 1 | 0 |
| nanaomycin a | 0 | low | 1 | 0 |
| gingerol | 0 | low | 3 | 0 |
| cyclopamine | 0 | low | 3 | 0 |
| lignans | 0 | low | 22 | 0 |
| acetylleucyl-leucyl-norleucinal | 0 | low | 1 | 0 |
| bq 123 | 0 | low | 1 | 0 |
| n-formylmethionine leucyl-phenylalanine | 0 | medium | 8 | 2 |
| diprenorphine | 0 | low | 1 | 0 |
| sodium arsenite | 0 | low | 10 | 0 |
| 1-O-Acetyllycorine | 0 | low | 1 | 0 |
| pseudolycorine | 0 | low | 1 | 0 |
| difluprednate | 0 | low | 1 | 0 |
| doxorubicin hydrochloride | 0 | low | 1 | 0 |
| metrizamide | 0 | low | 1 | 0 |
| vinpocetine | 0 | low | 1 | 0 |
| betadex | 0 | low | 18 | 0 |
| acetyl coenzyme a | 0 | low | 3 | 0 |
| e-z cinnamic acid | 0 | low | 7 | 0 |
| ergosterol | 0 | low | 3 | 0 |
| trichostatin a | 0 | low | 24 | 0 |
| tretinoin | 0 | medium | 166 | 6 |
| equilenin | 0 | low | 1 | 0 |
| arachidonic acid | 0 | low | 13 | 0 |
| elinafide | 0 | low | 1 | 0 |
| farnesol | 0 | low | 3 | 0 |
| phosphoramidon | 0 | low | 1 | 0 |
| 3-hydroxy-3-methylglutaryl-coenzyme a | 0 | low | 1 | 0 |
| resveratrol | 0 | low | 49 | 0 |
| retinol | 0 | medium | 53 | 2 |
| cyanoginosin lr | 0 | low | 2 | 0 |
| palmitoleic acid | 0 | low | 1 | 0 |
| oleic acid | 0 | low | 12 | 0 |
| tacrolimus | 0 | low | 18 | 0 |
| farnesyl pyrophosphate | 0 | low | 2 | 0 |
| ferulic acid | 0 | low | 2 | 0 |
| pectins | 0 | low | 4 | 0 |
| geranyl pyrophosphate | 0 | low | 1 | 0 |
| cerivastatin | 0 | low | 1 | 0 |
| cocaine | 0 | low | 2 | 0 |
| eicosapentaenoic acid | 0 | low | 7 | 0 |
| sr 12813 | 0 | low | 1 | 0 |
| thapsigargin | 0 | low | 18 | 0 |
| mycophenolic acid | 0 | medium | 16 | 1 |
| mupirocin | 0 | low | 1 | 0 |
| clindamycin | 0 | low | 1 | 0 |
| keratan sulfate | 0 | low | 11 | 0 |
| lycopene | 0 | low | 6 | 0 |
| zithromax | 0 | low | 3 | 0 |
| cefoxitin | 0 | low | 5 | 0 |
| geranylgeranyl pyrophosphate | 0 | low | 1 | 0 |
| 2-butenal | 0 | low | 1 | 0 |
| gw 3965 | 0 | low | 2 | 0 |
| t0901317 | 0 | low | 2 | 0 |
| epothilone b | 0 | low | 1 | 0 |
| n-(4-methoxybenzyl)-n'-(5-nitro-1,3-thiazol-2-yl)urea | 0 | low | 1 | 0 |
| y 27632 | 0 | low | 4 | 0 |
| cytidine monophosphate n-acetylneuraminic acid | 0 | low | 2 | 0 |
| n(1)-guanyl-1,7-diaminoheptane | 0 | low | 1 | 0 |
| prostaglandin d2 | 0 | low | 19 | 0 |
| diethylstilbestrol | 0 | low | 9 | 0 |
| epothilone a | 0 | medium | 4 | 3 |
| 6-bromoindirubin-3'-oxime | 0 | low | 2 | 0 |
| alitretinoin | 0 | low | 4 | 0 |
| h 89 | 0 | low | 5 | 0 |
| afimoxifene | 0 | low | 5 | 0 |
| imidazolidines | 0 | low | 1 | 0 |
| fluciclovine f-18 | 0 | low | 2 | 0 |
| n-succinimidyl-4-fluorobenzoate | 0 | low | 2 | 0 |
| aclarubicin | 0 | low | 2 | 0 |
| thymopentin | 0 | medium | 4 | 3 |
| decitabine | 0 | medium | 78 | 6 |
| d-glucaro-delta-lactam | 0 | low | 1 | 0 |
| colfosceril palmitate | 0 | low | 1 | 0 |
| phorbol-12,13-didecanoate | 0 | low | 1 | 0 |
| texas red | 0 | low | 1 | 0 |
| iridoids | 0 | low | 2 | 0 |
| troxacitabine | 0 | low | 1 | 0 |
| kt 5720 | 0 | low | 1 | 0 |
| valrubicin | 0 | low | 1 | 0 |
| 3,2'-dihydroxyflavone | 0 | low | 1 | 0 |
| dactinomycin | 0 | medium | 196 | 25 |
| gamma-sitosterol | 0 | low | 1 | 0 |
| tiazofurin | 0 | low | 3 | 0 |
| aphidicolin | 0 | low | 10 | 0 |
| arsphenamine | 0 | low | 1 | 0 |
| azaserine | 0 | medium | 3 | 1 |
| melphalan | 0 | medium | 593 | 74 |
| enkephalin, leucine | 0 | low | 4 | 0 |
| benzyloxycarbonylleucyl-leucyl-leucine aldehyde | 0 | low | 13 | 0 |
| tenofovir | 0 | low | 2 | 0 |
| 5-ethynyl-2'-deoxyuridine | 0 | low | 1 | 0 |
| bromodeoxycytidine | 0 | low | 2 | 0 |
| rubitecan | 0 | medium | 4 | 1 |
| betulonal | 0 | low | 1 | 0 |
| terameprocol | 0 | low | 2 | 0 |
| beta, beta-dimethylacrylshikonin, (+)-isomer | 0 | low | 2 | 0 |
| beta-hydroxyisovalerylshikonin | 0 | low | 1 | 0 |
| shikonin | 0 | low | 9 | 0 |
| elatol | 0 | low | 1 | 0 |
| 8-prenylnaringenin | 0 | low | 1 | 0 |
| riboflavin | 0 | low | 2 | 0 |
| 3-((4-azidophenyl)dithio)propionic n-hydroxysuccinimide | 0 | low | 1 | 0 |
| lisofylline | 0 | medium | 1 | 1 |
| isoxanthohumol | 0 | low | 1 | 0 |
| 5-fluoro-2'-deoxycytidine | 0 | low | 1 | 0 |
| potassium permanganate | 0 | low | 10 | 0 |
| sodium bicarbonate | 0 | low | 2 | 0 |
| sodium cyanate | 0 | low | 1 | 0 |
| zn(ii)-phthalocyanine | 0 | low | 6 | 0 |
| triacetoneamine-n-oxyl | 0 | low | 1 | 0 |
| dipyrone | 0 | low | 1 | 0 |
| 6-hydroxyindole | 0 | low | 1 | 0 |
| bromochloroacetic acid | 0 | medium | 154 | 1 |
| ck-0944666 | 0 | low | 1 | 0 |
| 3-carbamoyl-2,2,5,5-tetramethyl-3-pyrroline-1-yloxyl | 0 | low | 1 | 0 |
| 1,3-bis(3,5-dichlorophenyl)urea | 0 | low | 1 | 0 |
| diphenylbutadiene | 0 | low | 1 | 0 |
| piperyline | 0 | low | 1 | 0 |
| nemorosone | 0 | low | 1 | 0 |
| communic acid | 0 | low | 1 | 0 |
| cinnamaldehyde | 0 | low | 4 | 0 |
| trans-4-coumaric acid | 0 | low | 2 | 0 |
| dimethyl fumarate | 0 | low | 6 | 0 |
| glycosides | 0 | medium | 30 | 2 |
| chalcone | 0 | low | 5 | 0 |
| isomethyleugenol | 0 | low | 81 | 0 |
| piplartine | 0 | low | 5 | 0 |
| citral | 0 | low | 4 | 0 |
| beta-ionone | 0 | low | 1 | 0 |
| retinaldehyde | 0 | low | 3 | 0 |
| piperine | 0 | low | 2 | 0 |
| retinol acetate | 0 | low | 2 | 0 |
| squalene | 0 | low | 2 | 0 |
| stilbenes | 0 | medium | 61 | 2 |
| isoliquiritigenin | 0 | low | 6 | 0 |
| propolin c | 0 | low | 1 | 0 |
| picibanil | 0 | medium | 21 | 3 |
| cardamonin | 0 | low | 1 | 0 |
| flavin-adenine dinucleotide | 0 | low | 1 | 0 |
| cannabidiol | 0 | low | 4 | 0 |
| buprenorphine | 0 | low | 1 | 0 |
| arginine vasopressin | 0 | medium | 1 | 1 |
| pyrophosphate | 0 | medium | 9 | 1 |
| gw9662 | 0 | low | 1 | 0 |
| s 1033 | 0 | medium | 16 | 4 |
| bz-423 | 0 | low | 2 | 0 |
| amygdalin | 0 | low | 1 | 0 |
| tropisetron | 0 | medium | 3 | 1 |
| tram 34 | 0 | low | 4 | 0 |
| leuprolide | 0 | medium | 2 | 1 |
| fludarabine | 0 | medium | 16 | 8 |
| propylthiouracil | 0 | low | 3 | 0 |
| nsc 4347 | 0 | low | 1 | 0 |
| sesquiterpenes | 0 | medium | 54 | 1 |
| mercaptopurine | 0 | medium | 16 | 1 |
| methylthiouracil | 0 | low | 1 | 0 |
| 3,3',4,5'-tetrahydroxystilbene | 0 | low | 5 | 0 |
| 4-bromophenylalanine | 0 | medium | 2 | 2 |
| 1-methyltryptophan | 0 | medium | 6 | 1 |
| thioinosine | 0 | low | 1 | 0 |
| phenylthiourea | 0 | low | 16 | 0 |
| (e)-3-(4-t-butylphenyl)-n-(2,3-dihydrobenzo(b)(1,4)dioxin-6-yl)acrylamide | 0 | low | 1 | 0 |
| benzylthiouracil | 0 | low | 1 | 0 |
| 3,4'-dihydroxyflavone | 0 | low | 1 | 0 |
| caffeic acid | 0 | low | 1 | 0 |
| methyl caffeate | 0 | low | 1 | 0 |
| urocanic acid | 0 | low | 7 | 0 |
| ethyl 2,4-dihydroxybenzoate | 0 | low | 1 | 0 |
| rhododendrol | 0 | low | 2 | 0 |
| flunarizine | 0 | low | 2 | 0 |
| eszopiclone | 0 | low | 1 | 0 |
| tetrahydropalmatine | 0 | low | 1 | 0 |
| curcumin | 0 | low | 71 | 0 |
| cct018159 | 0 | low | 1 | 0 |
| tenovin-1 | 0 | low | 2 | 0 |
| hc 030031 | 0 | low | 1 | 0 |
| rhodanine | 0 | low | 1 | 0 |
| 3-(2-aminoethyl)-5-(4-ethoxybenzylidene)thiazolidine-2,4-dione | 0 | low | 1 | 0 |
| nootkatone | 0 | low | 1 | 0 |
| thiouracil | 0 | low | 22 | 0 |
| 5-(4-ethylbenzylidene)-2-thioxothiazolidin-4-one | 0 | low | 1 | 0 |
| thiohydantoins | 0 | medium | 1 | 1 |
| methimazole | 0 | low | 3 | 0 |
| cinnarizine | 0 | low | 3 | 0 |
| sulindac | 0 | medium | 3 | 1 |
| capsaicin | 0 | low | 12 | 0 |
| enclomiphene | 0 | low | 8 | 0 |
| metiamide | 0 | low | 1 | 0 |
| terbinafine | 0 | low | 1 | 0 |
| 1,4-benzoquinone guanylhydrazone thiosemicarbazone | 0 | low | 1 | 0 |
| tosylarginine methyl ester | 0 | low | 1 | 0 |
| aurapten | 0 | low | 1 | 0 |
| oxazolone | 0 | low | 4 | 0 |
| caryophyllene oxide | 0 | low | 1 | 0 |
| umbelliprenin | 0 | low | 1 | 0 |
| chlorogenic acid | 0 | medium | 5 | 1 |
| fatostatin | 0 | low | 1 | 0 |
| thioguanine anhydrous | 0 | medium | 12 | 1 |
| thiobarbituric acid | 0 | low | 1 | 0 |
| 1,3-dimethylthiourea | 0 | low | 1 | 0 |
| thiosemicarbazide | 0 | low | 1 | 0 |
| thiourea | 0 | medium | 19 | 1 |
| safranine t | 0 | low | 1 | 0 |
| indigo carmine | 0 | low | 1 | 0 |
| D-fructopyranose | 0 | medium | 8 | 3 |
| thiocarbohydrazide | 0 | low | 1 | 0 |
| ferric ferrocyanide | 0 | low | 3 | 0 |
| succimer | 0 | low | 1 | 0 |
| digoxin | 0 | medium | 3 | 1 |
| fumonisin b1 | 0 | low | 2 | 0 |
| 2-phenyl-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide | 0 | low | 1 | 0 |
| tamoxifen citrate | 0 | low | 1 | 0 |
| tamoxifen | 0 | medium | 186 | 65 |
| hydroxypropyl-gamma-cyclodextrin | 0 | low | 1 | 0 |
| sodium taurodeoxycholate | 0 | low | 1 | 0 |
| nadp | 0 | low | 26 | 0 |
| 1,1-diphenyl-2-picrylhydrazyl | 0 | low | 5 | 0 |
| stattic | 0 | low | 1 | 0 |
| srpin340 | 0 | low | 2 | 0 |
| 3-nitrocoumarin | 0 | low | 1 | 0 |
| sc 514 | 0 | low | 1 | 0 |
| p5091 | 0 | low | 1 | 0 |
| krn 7000 | 0 | medium | 14 | 3 |
| sirtinol | 0 | low | 1 | 0 |
| methyl-thiohydantoin-tryptophan | 0 | low | 1 | 0 |
| hlm006474 | 0 | low | 1 | 0 |
| k 858 | 0 | low | 1 | 0 |
| monastrol | 0 | low | 1 | 0 |
| nabam | 0 | low | 1 | 0 |
| valinomycin | 0 | low | 1 | 0 |
| ranitidine | 0 | medium | 9 | 4 |
| toremifene | 0 | medium | 2 | 1 |
| alpha-2'-deoxythioguanosine | 0 | low | 1 | 0 |
| 2'-deoxy-2'-methylenecytidine | 0 | low | 2 | 0 |
| u 0126 | 0 | low | 36 | 0 |
| dieckol | 0 | low | 3 | 0 |
| oxalomalic acid | 0 | low | 1 | 0 |
| lomeguatrib | 0 | medium | 6 | 4 |
| bms 387032 | 0 | low | 1 | 0 |
| lithium | 0 | low | 9 | 0 |
| zineb | 0 | low | 1 | 0 |
| iodothiouracil | 0 | low | 8 | 0 |
| cobaltous chloride | 0 | low | 5 | 0 |
| nitrogen dioxide | 0 | low | 4 | 0 |
| maneb | 0 | low | 2 | 0 |
| dermatan sulfate | 0 | low | 5 | 0 |
| hydroxylysine | 0 | low | 1 | 0 |
| droloxifene | 0 | low | 2 | 0 |
| mannomustine | 0 | low | 2 | 0 |
| orlistat | 0 | low | 6 | 0 |
| carzelesin | 0 | medium | 1 | 1 |
| quinine | 0 | low | 3 | 0 |
| kaurenoic acid | 0 | low | 1 | 0 |
| nsc 290205 | 0 | low | 2 | 0 |
| manool | 0 | low | 1 | 0 |
| 1,2-bis(2-aminophenoxy)ethane n,n,n',n'-tetraacetic acid acetoxymethyl ester | 0 | low | 5 | 0 |
| dihydroteleocidin b | 0 | low | 1 | 0 |
| indium oxine | 0 | medium | 2 | 1 |
| peptidoglycan pentapeptide-mdap3 | 0 | low | 1 | 0 |
| 2,2-dimethyl-5-hydroxy-1-pyrrolidinyloxy | 0 | low | 1 | 0 |
| mdl 72527 | 0 | low | 2 | 0 |
| rtki cpd | 0 | low | 1 | 0 |
| 2'-cyano-2'-deoxyarabinofuranosylcytosine | 0 | low | 1 | 0 |
| e 7010 | 0 | low | 1 | 0 |
| 2-chloro-n(6)-(3-iodobenzyl)adenosine-5'-n-methyluronamide | 0 | low | 5 | 0 |
| cystine | 0 | low | 8 | 0 |
| rx-ra 85 | 0 | low | 1 | 0 |
| rasagiline | 0 | low | 2 | 0 |
| safingol | 0 | low | 2 | 0 |
| dasatinib | 0 | medium | 26 | 4 |
| vuf 8430 | 0 | low | 1 | 0 |
| drimenol | 0 | low | 1 | 0 |
| oxalylglycine | 0 | low | 1 | 0 |
| zd 6474 | 0 | medium | 5 | 1 |
| motexafin lutetium | 0 | low | 1 | 0 |
| dipyrromethene | 0 | low | 2 | 0 |
| cactinomycin | 0 | medium | 2 | 1 |
| olivomycins | 0 | low | 9 | 0 |
| cytellin | 0 | low | 1 | 0 |
| 3-aminotyrosine | 0 | low | 2 | 0 |
| salinomycin | 0 | low | 3 | 0 |
| thymic factor, circulating | 0 | low | 1 | 0 |
| ginsenosides | 0 | low | 18 | 0 |
| 2-(4-(2-carboxyethyl)phenethylamino)-5'-n-ethylcarboxamidoadenosine | 0 | low | 1 | 0 |
| 1,4-benzothiazine | 0 | low | 1 | 0 |
| compound 968 | 0 | low | 1 | 0 |
| ml106 | 0 | low | 1 | 0 |
| phosphothreonine | 0 | low | 3 | 0 |
| ovalbumin | 0 | low | 45 | 0 |
| sodium dodecyl sulfate | 0 | low | 11 | 0 |
| uc-112 | 0 | low | 1 | 0 |
| blister | 0 | low | 2 | 0 |
| butin | 0 | low | 1 | 0 |
| crocin | 0 | low | 2 | 0 |
| mtt formazan | 0 | low | 9 | 0 |
| chloramine-t | 0 | low | 3 | 0 |
| l 663536 | 0 | low | 3 | 0 |
| flavan-3-ol | 0 | low | 1 | 0 |
| ungeremine | 0 | low | 1 | 0 |
| primuline | 0 | low | 1 | 0 |
| 6-hydrazinopyridine-3-carboxylic acid | 0 | low | 3 | 0 |
| ocotillol | 0 | low | 1 | 0 |
| 4-phenyl-2-propionamidotetraline | 0 | low | 1 | 0 |
| alpha-chymotrypsin | 0 | low | 12 | 0 |
| ferrostatin-1 | 0 | low | 2 | 0 |
| tetramethylrhodamine isothiocyanate | 0 | low | 5 | 0 |
| 4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione | 0 | low | 1 | 0 |
| 3-hydroxy-2-methyl-4h-pyran-4-thione | 0 | low | 1 | 0 |
| 17-ketosteroids | 0 | low | 1 | 0 |
| naphthoquinones | 0 | medium | 53 | 3 |
| stx-0119 | 0 | low | 1 | 0 |
| digitoxigenin | 0 | low | 1 | 0 |
| osteoprotegerin | 0 | low | 5 | 0 |
| cathepsin g | 0 | low | 1 | 0 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1h-imidazol-2-yl)benzamide | 0 | low | 4 | 0 |
| rhodamine 123 | 0 | low | 10 | 0 |
| tolcapone | 0 | low | 1 | 0 |
| myelin basic protein | 0 | low | 6 | 0 |
| jnj 7777120 | 0 | low | 1 | 0 |
| merbarone | 0 | medium | 2 | 1 |
| imd 0354 | 0 | low | 1 | 0 |
| ex 527 | 0 | low | 1 | 0 |
| tetrathiomolybdate | 0 | low | 3 | 0 |
| eupatilin | 0 | low | 1 | 0 |
| gallocatechin-3-gallate | 0 | low | 1 | 0 |
| ku 55933 | 0 | low | 1 | 0 |
| sphingosine | 0 | low | 29 | 0 |
| quercetin | 0 | low | 29 | 0 |
| bilirubin | 0 | low | 9 | 0 |
| dinoprostone | 0 | low | 47 | 0 |
| dinoprost | 0 | low | 6 | 0 |
| leukotriene a4 | 0 | low | 1 | 0 |
| arachidonyltrifluoromethane | 0 | low | 1 | 0 |
| vitexin | 0 | low | 1 | 0 |
| apigenin | 0 | low | 17 | 0 |
| luteolin | 0 | medium | 17 | 1 |
| 7,3'-dihydroxy-4'-methoxyisoflavone | 0 | low | 1 | 0 |
| linoleic acid | 0 | low | 9 | 0 |
| calcitriol | 0 | low | 41 | 0 |
| scopoletin | 0 | low | 1 | 0 |
| vitamin k semiquinone radical | 0 | low | 12 | 0 |
| beta carotene | 0 | medium | 17 | 2 |
| 11-cis-retinal | 0 | low | 1 | 0 |
| leukotriene b4 | 0 | low | 4 | 0 |
| leukotriene c4 | 0 | low | 2 | 0 |
| thromboxane a2 | 0 | low | 3 | 0 |
| retinol palmitate | 0 | low | 3 | 0 |
| coniferaldehyde | 0 | low | 1 | 0 |
| herbacetin | 0 | low | 2 | 0 |
| hymecromone | 0 | low | 5 | 0 |
| daphnetin | 0 | low | 2 | 0 |
| 8,11,14-eicosatrienoic acid | 0 | low | 1 | 0 |
| rosin | 0 | low | 1 | 0 |
| chrysoeriol | 0 | low | 1 | 0 |
| alprostadil | 0 | low | 14 | 0 |
| vitamin d 2 | 0 | low | 5 | 0 |
| cholecalciferol | 0 | medium | 16 | 1 |
| rutin | 0 | medium | 3 | 1 |
| kaempferol | 0 | low | 1 | 0 |
| leukotriene d4 | 0 | low | 1 | 0 |
| prostaglandin a2 | 0 | low | 2 | 0 |
| 9-deoxy-delta-9-prostaglandin d2 | 0 | low | 3 | 0 |
| zeaxanthin | 0 | low | 4 | 0 |
| lipoxin a4 | 0 | low | 1 | 0 |
| gamma-linolenic acid | 0 | low | 7 | 0 |
| alpha-linolenic acid | 0 | low | 2 | 0 |
| prostaglandin e3 | 0 | low | 1 | 0 |
| harmine | 0 | low | 3 | 0 |
| genistein | 0 | low | 27 | 0 |
| amphotericin b | 0 | low | 4 | 0 |
| pulmicort | 0 | medium | 8 | 4 |
| pyrvinium | 0 | low | 2 | 0 |
| kava | 0 | low | 1 | 0 |
| paricalcitol | 0 | low | 1 | 0 |
| 2-hexenal, z-isomer | 0 | low | 1 | 0 |
| butein | 0 | low | 2 | 0 |
| astaxanthine | 0 | low | 1 | 0 |
| canthaxanthin | 0 | low | 2 | 0 |
| cryptoxanthins | 0 | low | 1 | 0 |
| fucoxanthin | 0 | low | 1 | 0 |
| lutein | 0 | low | 3 | 0 |
| norbixin | 0 | low | 1 | 0 |
| bruceantin | 0 | low | 1 | 0 |
| cucurbitacin b | 0 | low | 2 | 0 |
| cucurbitacin d | 0 | low | 1 | 0 |
| geranylgeraniol | 0 | low | 1 | 0 |
| genistin | 0 | low | 1 | 0 |
| mezerein | 0 | low | 15 | 0 |
| ophiobolin a | 0 | low | 1 | 0 |
| chartreusin | 0 | low | 2 | 0 |
| harman | 0 | low | 1 | 0 |
| daphnoretin | 0 | low | 1 | 0 |
| esculetin | 0 | low | 3 | 0 |
| pyrethrosin | 0 | low | 1 | 0 |
| humulene | 0 | medium | 5 | 1 |
| oleuropein | 0 | low | 1 | 0 |
| zearalenone | 0 | low | 1 | 0 |
| baicalein | 0 | low | 2 | 0 |
| chrysin | 0 | low | 4 | 0 |
| chrysosplenetin b | 0 | low | 1 | 0 |
| fisetin | 0 | low | 12 | 0 |
| galangin | 0 | low | 1 | 0 |
| gossypin | 0 | low | 1 | 0 |
| hinokiflavone | 0 | low | 1 | 0 |
| hispidulin | 0 | low | 1 | 0 |
| mangiferin | 0 | low | 1 | 0 |
| mangostin | 0 | low | 8 | 0 |
| 3-methylquercetin | 0 | low | 1 | 0 |
| morin | 0 | low | 3 | 0 |
| morusin | 0 | low | 2 | 0 |
| myricetin | 0 | low | 1 | 0 |
| patuletin | 0 | low | 1 | 0 |
| wogonin | 0 | low | 1 | 0 |
| daidzein | 0 | low | 1 | 0 |
| trans-2,3',4,5'-tetrahydroxystilbene | 0 | low | 2 | 0 |
| pterostilbene | 0 | low | 3 | 0 |
| epsilon-viniferin | 0 | low | 1 | 0 |
| caffeic acid phenethyl ester | 0 | low | 8 | 0 |
| rosmarinic acid | 0 | low | 4 | 0 |
| orobol | 0 | low | 1 | 0 |
| wedelolactone | 0 | low | 2 | 0 |
| maytansine | 0 | medium | 4 | 1 |
| rottlerin | 0 | low | 4 | 0 |
| ellagic acid | 0 | low | 3 | 0 |
| sdz psc 833 | 0 | low | 1 | 0 |
| prostaglandin a1 | 0 | low | 5 | 0 |
| coenzyme q10 | 0 | medium | 4 | 1 |
| anandamide | 0 | low | 2 | 0 |
| cerulenin | 0 | low | 4 | 0 |
| l 683590 | 0 | low | 1 | 0 |
| astragalin | 0 | low | 1 | 0 |
| geranylgeranylacetone | 0 | low | 1 | 0 |
| tranilast | 0 | low | 1 | 0 |
| ro 61-8048 | 0 | low | 1 | 0 |
| tocotrienol, delta | 0 | low | 4 | 0 |
| 4,4'-dihydroxystilbene | 0 | low | 1 | 0 |
| etretinate | 0 | low | 7 | 0 |
| isotretinoin | 0 | medium | 20 | 8 |
| fondaparinux | 0 | low | 3 | 0 |
| zinostatin | 0 | low | 3 | 0 |
| 13-hydroxy-9,11-octadecadienoic acid | 0 | low | 1 | 0 |
| 16,16-dimethylprostaglandin e2 | 0 | low | 7 | 0 |
| leukotriene b5 | 0 | low | 1 | 0 |
| thromboxane b2 | 0 | low | 3 | 0 |
| arachidonic acid 5-hydroperoxide | 0 | low | 1 | 0 |
| 4-hydroxy-2-nonenal | 0 | low | 5 | 0 |
| 1-monooleoyl-rac-glycerol | 0 | low | 4 | 0 |
| sphingosine 1-phosphate | 0 | low | 16 | 0 |
| codeine | 0 | medium | 2 | 1 |
| cyclosporine | 0 | low | 2 | 0 |
| mitolactol | 0 | low | 17 | 0 |
| phenylephrine hydrochloride | 0 | medium | 60 | 1 |
| sarcophytol a | 0 | low | 1 | 0 |
| acitretin | 0 | low | 10 | 0 |
| cyproterone | 0 | low | 1 | 0 |
| diminazene aceturate | 0 | low | 1 | 0 |
| granisetron | 0 | medium | 1 | 1 |
| hydrocodone | 0 | low | 1 | 0 |
| hydromorphone | 0 | low | 2 | 0 |
| levetiracetam | 0 | low | 2 | 0 |
| naloxone | 0 | low | 4 | 0 |
| oxycodone | 0 | low | 1 | 0 |
| vitamin k 1 | 0 | low | 1 | 0 |
| sirolimus | 0 | medium | 58 | 8 |
| 4-hydroxystilbene | 0 | low | 1 | 0 |
| gamma-cyclodextrin | 0 | low | 1 | 0 |
| brefeldin a | 0 | low | 11 | 0 |
| alvocidib | 0 | medium | 5 | 1 |
| seocalcitol | 0 | low | 2 | 0 |
| fenretinide | 0 | medium | 14 | 1 |
| 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin | 0 | low | 8 | 0 |
| morphine | 0 | low | 11 | 0 |
| pactamycin | 0 | low | 1 | 0 |
| 4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid | 0 | low | 2 | 0 |
| a 192621 | 0 | low | 4 | 0 |
| anthramycin | 0 | low | 1 | 0 |
| arachidonyl-2-chloroethylamide | 0 | low | 1 | 0 |
| bimatoprost | 0 | low | 1 | 0 |
| istradefylline | 0 | low | 1 | 0 |
| clobetasol | 0 | low | 8 | 0 |
| cloprostenol | 0 | low | 1 | 0 |
| deamino arginine vasopressin | 0 | low | 1 | 0 |
| olvanil | 0 | low | 3 | 0 |
| fluticasone | 0 | medium | 1 | 1 |
| herbimycin | 0 | low | 5 | 0 |
| pd 180970 | 0 | low | 1 | 0 |
| goserelin | 0 | low | 2 | 0 |
| iloprost | 0 | low | 2 | 0 |
| 15-deoxy-delta(12,14)-prostaglandin j2 | 0 | low | 2 | 0 |
| latanoprost | 0 | low | 7 | 0 |
| lysophosphatidic acid | 0 | low | 15 | 0 |
| lysophosphatidylcholines | 0 | low | 7 | 0 |
| mdl 100907 | 0 | low | 2 | 0 |
| cytochalasin b | 0 | low | 19 | 0 |
| n-(4-amino-2-methylquinolin-6-yl)-2-(4-ethylphenoxymethyl)benzamide | 0 | low | 1 | 0 |
| pd 123319 | 0 | low | 1 | 0 |
| kn 93 | 0 | low | 3 | 0 |
| kn 62 | 0 | low | 1 | 0 |
| su 6656 | 0 | low | 2 | 0 |
| casticin | 0 | low | 3 | 0 |
| cannabigerol | 0 | low | 2 | 0 |
| hydroxygenkwanin | 0 | low | 1 | 0 |
| andrographolide | 0 | low | 1 | 0 |
| isoegomaketone | 0 | low | 1 | 0 |
| icaritin | 0 | low | 3 | 0 |
| licochalcone a | 0 | low | 1 | 0 |
| licochalcone b | 0 | low | 1 | 0 |
| methyl-p-coumarate | 0 | low | 1 | 0 |
| cudraflavone c | 0 | low | 1 | 0 |
| podocarpusflavone a | 0 | low | 1 | 0 |
| atractylenolide i | 0 | low | 1 | 0 |
| sophoricoside | 0 | low | 1 | 0 |
| tazettine | 0 | low | 1 | 0 |
| diferuloylputrescine | 0 | low | 1 | 0 |
| 1-(4-(6-bromobenzo(1,3)dioxol-5-yl)-3a,4,5,9b-tetrahydro-3h-cyclopenta(c)quinolin-8-yl)ethanone | 0 | low | 1 | 0 |
| casein kinase ii | 0 | low | 6 | 0 |
| ag-490 | 0 | low | 3 | 0 |
| bosutinib | 0 | low | 2 | 0 |
| cb676475 | 0 | low | 1 | 0 |
| semaxinib | 0 | medium | 7 | 5 |
| orantinib | 0 | low | 1 | 0 |
| su 11248 | 0 | medium | 25 | 3 |
| palbociclib | 0 | medium | 16 | 3 |
| jnj-7706621 | 0 | low | 2 | 0 |
| nifuroxazide | 0 | low | 4 | 0 |
| mitoguazone | 0 | low | 6 | 0 |
| bisantrene | 0 | low | 1 | 0 |
| fosbretabulin | 0 | low | 5 | 0 |
| fosbretabulin | 0 | medium | 5 | 2 |
| guttiferone e | 0 | low | 1 | 0 |
| 4-nerolidylcatechol | 0 | low | 4 | 0 |
| lead | 0 | medium | 9 | 1 |
| tin | 0 | low | 1 | 0 |
| sulindac sulfide | 0 | low | 1 | 0 |
| butylidenephthalide | 0 | low | 1 | 0 |
| 12-hydroxy-5,8,10,14-eicosatetraenoic acid | 0 | low | 8 | 0 |
| bay 11-7082 | 0 | low | 2 | 0 |
| methyl 2,5-dihydroxycinnamate | 0 | low | 1 | 0 |
| 5,5',6,6'-tetrachloro-1,1',3,3'-tetraethylbenzimidazolocarbocyanine | 0 | low | 1 | 0 |
| diamide | 0 | low | 1 | 0 |
| antimony | 0 | medium | 39 | 1 |
| barium | 0 | low | 4 | 0 |
| rubidium | 0 | low | 8 | 0 |
| sinulariolide | 0 | low | 1 | 0 |
| aluminum | 0 | low | 7 | 0 |
| strontium | 0 | medium | 3 | 1 |
| bismuth | 0 | medium | 11 | 2 |
| thallium | 0 | low | 4 | 0 |
| arsenic | 0 | medium | 42 | 3 |
| indium | 0 | medium | 44 | 1 |
| naltrexone | 0 | low | 2 | 0 |
| dextromethorphan | 0 | medium | 1 | 1 |
| gallium | 0 | low | 27 | 0 |
| butorphanol | 0 | low | 1 | 0 |
| lisinopril | 0 | low | 3 | 0 |
| ramipril | 0 | low | 1 | 0 |
| batimastat | 0 | low | 2 | 0 |
| sulfur | 0 | medium | 25 | 2 |
| geldanamycin | 0 | low | 2 | 0 |
| costunolide | 0 | low | 1 | 0 |
| diphenylhexatriene | 0 | low | 3 | 0 |
| jaceosidin | 0 | low | 1 | 0 |
| vallesiachotamine | 0 | low | 1 | 0 |
| 7-hydroxymethotrexate | 0 | low | 2 | 0 |
| 3,3',4,5'-tetramethoxy-trans-stilbene | 0 | low | 1 | 0 |
| 3,4',5-trimethoxystilbene | 0 | low | 1 | 0 |
| dmu-212 | 0 | low | 1 | 0 |
| 1-(4-methoxyphenyl)-2-(3,4,5-trimethoxyphenyl)ethene | 0 | low | 2 | 0 |
| sanglifehrin a | 0 | low | 1 | 0 |
| enalapril | 0 | medium | 1 | 1 |
| cytochalasin a | 0 | low | 1 | 0 |
| cytochalasin e | 0 | low | 1 | 0 |
| ecdysterone | 0 | low | 1 | 0 |
| fumarates | 0 | low | 8 | 0 |
| beryllium | 0 | low | 5 | 0 |
| astatine | 0 | low | 13 | 0 |
| cysteine | 0 | low | 78 | 0 |
| thyronines | 0 | low | 2 | 0 |
| silicon | 0 | low | 3 | 0 |
| indium | 0 | low | 2 | 0 |
| phosphorus | 0 | low | 43 | 0 |
| boron | 0 | medium | 45 | 6 |
| bakuchiol | 0 | low | 1 | 0 |
| s-trans,trans-farnesylthiosalicylic acid | 0 | low | 2 | 0 |
| panaxynol | 0 | low | 1 | 0 |
| zerumbone | 0 | low | 2 | 0 |
| poricoic acid a | 0 | low | 1 | 0 |
| poricoic acid g | 0 | low | 1 | 0 |
| sulindac sulfone | 0 | low | 1 | 0 |
| pinostilbene | 0 | low | 1 | 0 |
| sinularin | 0 | low | 1 | 0 |
| tedanolide | 0 | low | 1 | 0 |
| pepstatin | 0 | low | 2 | 0 |
| phytochlorin | 0 | medium | 15 | 1 |
| cefepime | 0 | low | 2 | 0 |
| morusinol | 0 | low | 1 | 0 |
| benzoporphyrin d | 0 | low | 1 | 0 |
| enkephalin, ala(2)-mephe(4)-gly(5)- | 0 | low | 2 | 0 |
| n-methylnaloxone | 0 | low | 1 | 0 |
| strontium radioisotopes | 0 | low | 11 | 0 |
| 3,3'-dipropyl-2,2'-thiadicarbocyanine | 0 | low | 1 | 0 |
| manganese(iii)tetraphenylporphine sulfonate | 0 | low | 1 | 0 |
| n-acetyl-beta-glucosaminyl-n-acetylmuramyl-alanylisoglutamine | 0 | low | 1 | 0 |
| n-acetylmuramyl-alanyl-isoglutamine-alanyl-cholesterol | 0 | low | 1 | 0 |
| cgp 52608 | 0 | low | 1 | 0 |
| 3,3'-diheptyloxycarbocyanine | 0 | low | 1 | 0 |
| baohuoside i | 0 | low | 6 | 0 |
| hydnocarpin | 0 | low | 1 | 0 |
| aliskiren | 0 | low | 1 | 0 |
| vx680 | 0 | low | 1 | 0 |
| n-acetylsphingosine | 0 | low | 5 | 0 |
| lysophosphatidic acid | 0 | low | 1 | 0 |
| triolein | 0 | low | 2 | 0 |
| bafilomycin a | 0 | low | 3 | 0 |
| n-caproylsphingosine | 0 | low | 4 | 0 |
| 3,3'-dihexyl-2,2'-oxacarbocyanine | 0 | low | 1 | 0 |
| 3,3'-dioctadecylindocarbocyanine | 0 | low | 2 | 0 |
| carbocyanines | 0 | low | 11 | 0 |
| 25-hydroxyvitamin d 2 | 0 | low | 1 | 0 |
| 7-fluoro-2-phenyl-4-quinolone | 0 | low | 1 | 0 |
| semapimod | 0 | medium | 1 | 1 |
| icariside i | 0 | low | 1 | 0 |
| cinidon-ethyl | 0 | low | 1 | 0 |
| gepirone | 0 | low | 1 | 0 |
| 1,2-dielaidoylphosphatidylethanolamine | 0 | low | 2 | 0 |
| gw-5074 | 0 | low | 1 | 0 |
| 6-(bromomethylene)tetrahydro-3-(1-naphthaleneyl)-2h-pyran-2-one | 0 | low | 1 | 0 |
| n-feruloylserotonin | 0 | low | 1 | 0 |
| indicaxanthin | 0 | low | 1 | 0 |
| ammonium sulfate | 0 | low | 4 | 0 |
| monorden | 0 | low | 1 | 0 |
| mastoparan | 0 | low | 1 | 0 |
| tetrodotoxin | 0 | low | 1 | 0 |
| deoxyelephantopin | 0 | low | 1 | 0 |
| muconomycin a | 0 | low | 1 | 0 |
| germanium | 0 | low | 1 | 0 |
| selenium | 0 | medium | 35 | 1 |
| selenocysteine | 0 | low | 3 | 0 |
| tellurium | 0 | low | 5 | 0 |
| radium | 0 | low | 26 | 0 |
| thorium x | 0 | low | 1 | 0 |
| oxalates | 0 | low | 5 | 0 |
| boron-10 atom | 0 | low | 2 | 0 |
| palonosetron | 0 | medium | 1 | 1 |
| (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid | 0 | low | 2 | 0 |
| selenocyanic acid | 0 | low | 1 | 0 |
| n-desmethyltamoxifen | 0 | low | 1 | 0 |
| 2-((4-pyridyl)methyl)amino-n-(3-(trifluoromethyl)phenyl)benzamide | 0 | low | 1 | 0 |
| dizocilpine maleate | 0 | low | 2 | 0 |
| antimycin a | 0 | low | 3 | 0 |
| gamma-cadinene | 0 | low | 1 | 0 |
| dolichols | 0 | low | 1 | 0 |
| bongkrekic acid | 0 | low | 2 | 0 |
| 24,25-dihydroxyvitamin d 3 | 0 | low | 1 | 0 |
| vitamin a2 | 0 | low | 1 | 0 |
| nifurpirinol | 0 | low | 1 | 0 |
| arteflene | 0 | low | 1 | 0 |
| bafilomycin a1 | 0 | low | 6 | 0 |
| rehmannic acid | 0 | low | 1 | 0 |
| sarcophine | 0 | low | 1 | 0 |
| 1-oleoyl-2-acetylglycerol | 0 | low | 5 | 0 |
| ro 13-6298 | 0 | low | 1 | 0 |
| 15-hydroperoxy-5,8,11,13-eicosatetraenoic acid | 0 | low | 1 | 0 |
| rhizoxin | 0 | medium | 3 | 2 |
| 1,2-dioleoyloxy-3-(trimethylammonium)propane | 0 | low | 6 | 0 |
| dioleoyl phosphatidylethanolamine | 0 | low | 3 | 0 |
| concanamycin a | 0 | low | 2 | 0 |
| plastochromanol 8 | 0 | low | 1 | 0 |
| 1,2-dilinolenoyl-3-(4-aminobutyryl)propane-1,2,3-triol | 0 | low | 1 | 0 |
| neo-gambogic acid | 0 | low | 4 | 0 |
| 24,24-difluoro-1,25-dihydroxyvitamin d3 | 0 | low | 1 | 0 |
| cyanine dye 2 | 0 | low | 1 | 0 |
| 5-(3,3-dimethyl-1-triazeno)-1-methylimidazole-4-carboxamide | 0 | medium | 4 | 1 |
| ganglioside gm3 lactone | 0 | low | 4 | 0 |
| 5'-oleoyl cytarabine | 0 | medium | 2 | 1 |
| n-(4-methoxyphenyl)retinamide | 0 | low | 1 | 0 |
| pregna-4,17-diene-3,16-dione | 0 | low | 1 | 0 |
| bacteriochlorophylls | 0 | low | 2 | 0 |
| lankacidins | 0 | low | 1 | 0 |
| diatoxanthin | 0 | low | 1 | 0 |
| everolimus | 0 | medium | 23 | 6 |
| emerin | 0 | low | 1 | 0 |
| laq824 | 0 | low | 1 | 0 |
| ixabepilone | 0 | medium | 2 | 2 |
| arvanil | 0 | low | 3 | 0 |
| 1-oleoyl-2-palmitoylphosphatidylcholine | 0 | low | 1 | 0 |
| vanicoside a | 0 | low | 1 | 0 |
| cdw17 antigen | 0 | low | 3 | 0 |
| ganglioside, gd1b | 0 | low | 3 | 0 |
| trisialoganglioside gt1 | 0 | low | 2 | 0 |
| ganglioside, gd2 | 0 | medium | 71 | 5 |
| asialo gm1 ganglioside | 0 | low | 14 | 0 |
| zy 17617b | 0 | low | 1 | 0 |
| axitinib | 0 | medium | 8 | 4 |
| pai 039 | 0 | low | 1 | 0 |
| su 4312 | 0 | low | 1 | 0 |
| i(3)so3-galactosylceramide | 0 | low | 5 | 0 |
| salacinol | 0 | low | 1 | 0 |
| oxepins | 0 | low | 1 | 0 |
| alpha-cyperone | 0 | low | 1 | 0 |
| technetium tc 99m pyrophosphate | 0 | low | 1 | 0 |
| brazilein | 0 | low | 1 | 0 |
| valyl-alanyl-prolyl-glycine | 0 | low | 1 | 0 |
| belotecan | 0 | low | 1 | 0 |
| beta-escin | 0 | low | 1 | 0 |
| panduratin a | 0 | low | 2 | 0 |
| tanespimycin | 0 | medium | 20 | 4 |
| beta-escin | 0 | medium | 49 | 13 |
| melibiose | 0 | low | 1 | 0 |
| s-nitroso-n-acetylpenicillamine | 0 | low | 3 | 0 |
| nitrofurantoin | 0 | low | 1 | 0 |
| lactacystin | 0 | low | 4 | 0 |
| 4-methyl-5-amino-1-formylisoquinoline thiosemicarbazone | 0 | low | 1 | 0 |
| ispinesib | 0 | medium | 1 | 1 |
| peplomycin | 0 | medium | 18 | 1 |
| dioxotechnetium | 0 | low | 1 | 0 |
| gadolinium dtpa | 0 | medium | 56 | 3 |
| acetyl isogambogic acid | 0 | low | 1 | 0 |
| adenosine-3',5'-cyclic phosphorothioate | 0 | low | 1 | 0 |
| sq-23377 | 0 | low | 4 | 0 |
| fk 866 | 0 | low | 2 | 0 |
| fumagillin | 0 | low | 2 | 0 |
| detorubicin | 0 | medium | 5 | 1 |
| ta 077 | 0 | low | 1 | 0 |
| artesunate | 0 | low | 1 | 0 |
| romurtide | 0 | low | 1 | 0 |
| edatrexate | 0 | medium | 2 | 2 |
| perfosfamide | 0 | low | 2 | 0 |
| rmp 7 | 0 | low | 1 | 0 |
| bay 12-9566 | 0 | medium | 1 | 1 |
| beta-elemene | 0 | low | 2 | 0 |
| pki 166 | 0 | low | 1 | 0 |
| pd 184352 | 0 | low | 12 | 0 |
| docosahexaenoyl-paclitaxel | 0 | medium | 3 | 3 |
| oxi 4503 | 0 | medium | 1 | 1 |
| abt-510 | 0 | medium | 1 | 1 |
| talabostat | 0 | medium | 2 | 1 |
| hti-286 | 0 | low | 1 | 0 |
| pep005 | 0 | low | 8 | 0 |
| on 01910 | 0 | low | 2 | 0 |
| panobinostat | 0 | medium | 10 | 2 |
| isoborneol | 0 | low | 2 | 0 |
| bromopyruvate | 0 | low | 6 | 0 |
| leucyl-leucine-methyl ester | 0 | low | 1 | 0 |
| staurosporine | 0 | medium | 22 | 3 |
| bufalin | 0 | low | 1 | 0 |
| 1,25-dihydroxyergocalciferol | 0 | low | 1 | 0 |
| shu 508 | 0 | medium | 4 | 1 |
| hypericum | 0 | low | 3 | 0 |
| phosphocreatine | 0 | low | 5 | 0 |
| guaiane | 0 | low | 1 | 0 |
| bacteriochlorin | 0 | low | 4 | 0 |
| taxane | 0 | low | 4 | 0 |
| mannich bases | 0 | low | 1 | 0 |
| formazans | 0 | low | 12 | 0 |
| s 1743 | 0 | low | 5 | 0 |
| cgp 48664 | 0 | medium | 3 | 1 |
| st 1481 | 0 | low | 2 | 0 |
| s-allylcysteine | 0 | low | 1 | 0 |
| clasto-lactacystin beta-lactone | 0 | low | 1 | 0 |
| 2-methoxyestradiol-3,17-o,o-bis(sulfamate) | 0 | low | 1 | 0 |
| givinostat | 0 | low | 4 | 0 |
| polyporenic acid c | 0 | low | 1 | 0 |
| ginsenoside f1 | 0 | low | 1 | 0 |
| dolastatin 10 | 0 | medium | 2 | 1 |
| tris(dibenzylideneacetone)dipalladium | 0 | low | 2 | 0 |
| ggti 298 | 0 | low | 1 | 0 |
| plitidepsin | 0 | medium | 3 | 2 |
| cemadotin | 0 | medium | 1 | 1 |
| n-butanoylmannosamine | 0 | low | 1 | 0 |
| bms345541 | 0 | low | 6 | 0 |
| pachastrissamine | 0 | low | 2 | 0 |
| 6-methylsulfinylhexyl isothiocyanate | 0 | low | 1 | 0 |
| n-octyl-beta-valienamine | 0 | low | 1 | 0 |
| 6-(7-nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol | 0 | low | 4 | 0 |
| ncx 4040 | 0 | low | 1 | 0 |
| lenvatinib | 0 | medium | 7 | 4 |
| kb r7943 | 0 | low | 1 | 0 |
| nsc 716970 | 0 | low | 1 | 0 |
| pd 0325901 | 0 | medium | 15 | 1 |
| midostaurin | 0 | medium | 2 | 1 |
| 18f-fluoroethyl-l-tyrosine | 0 | low | 1 | 0 |
| avibactam | 0 | low | 1 | 0 |
| qh-ii-66 | 0 | low | 1 | 0 |
| pd 150606 | 0 | low | 2 | 0 |
| px-866 | 0 | low | 2 | 0 |
| cyclic(arg-gly-asp-d-phe-val) | 0 | low | 1 | 0 |
| ginsenoside m1 | 0 | low | 1 | 0 |
| gambogic acid | 0 | low | 6 | 0 |
| cabazitaxel | 0 | low | 2 | 0 |
| elisidepsin | 0 | low | 1 | 0 |
| valencene | 0 | low | 1 | 0 |
| dx 52-1 | 0 | low | 1 | 0 |
| adarotene | 0 | low | 1 | 0 |
| mocetinostat | 0 | medium | 10 | 1 |
| lipid a | 0 | medium | 19 | 7 |
| 4-methylene-2-octyl-5-oxofuran-3-carboxylic acid | 0 | low | 1 | 0 |
| dehydroxymethylepoxyquinomicin | 0 | low | 2 | 0 |
| treosulfan | 0 | medium | 21 | 14 |
| sb 3ct compound | 0 | low | 1 | 0 |
| pi103 | 0 | low | 4 | 0 |
| 3,5-bis(2-fluorobenzylidene)piperidin-4-one | 0 | low | 1 | 0 |
| pleuromutilin | 0 | low | 1 | 0 |
| sr 59230a | 0 | low | 1 | 0 |
| hx 630 | 0 | low | 1 | 0 |
| tasidotin | 0 | medium | 1 | 1 |
| zd 6126 | 0 | low | 1 | 0 |
| mart-1 antigen | 0 | medium | 745 | 83 |
| shu 9119 | 0 | low | 1 | 0 |
| p 829 | 0 | low | 1 | 0 |
| g(m2) ganglioside | 0 | medium | 38 | 10 |
| bay36-7620 | 0 | low | 1 | 0 |
| hki 272 | 0 | low | 2 | 0 |
| adh-1 pepide | 0 | medium | 3 | 2 |
| secoisolariciresinol diglucoside | 0 | low | 1 | 0 |
| ginsenoside rg3 | 0 | low | 5 | 0 |
| dolastatin 15 | 0 | medium | 1 | 1 |
| motexafin gadolinium | 0 | low | 2 | 0 |
| sorbitan monooleate | 0 | low | 1 | 0 |
| tofacitinib | 0 | low | 5 | 0 |
| tocotrienols | 0 | low | 2 | 0 |
| rucaparib | 0 | medium | 1 | 1 |
| cediranib | 0 | medium | 3 | 1 |
| 6h-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine-6-acetamide, 4-(4-chlorophenyl)-n-(4-hydroxyphenyl)-2,3,9-trimethyl-, (6s)- | 0 | low | 1 | 0 |
| eht 1864 | 0 | low | 1 | 0 |
| cc 1065 | 0 | low | 3 | 0 |
| pasireotide | 0 | medium | 1 | 1 |
| zeolites | 0 | low | 3 | 0 |
| l-779,450 | 0 | low | 3 | 0 |
| cp 31398 | 0 | low | 2 | 0 |
| tetramethylrhodamine | 0 | low | 1 | 0 |
| u 18666a | 0 | low | 1 | 0 |
| chir 99021 | 0 | low | 2 | 0 |
| g(m1) ganglioside | 0 | low | 26 | 0 |
| ganu | 0 | low | 1 | 0 |
| capsazocaine | 0 | low | 1 | 0 |
| aluminum oxide | 0 | medium | 5 | 1 |
| n-caffeoyltyramine | 0 | low | 1 | 0 |
| amarbellisine | 0 | low | 1 | 0 |
| vanicoside b | 0 | low | 1 | 0 |
| 2-bromo-2'-deoxyadenosine | 0 | low | 1 | 0 |
| pelorol | 0 | low | 1 | 0 |
| metapristone | 0 | low | 1 | 0 |
| masitinib | 0 | low | 4 | 0 |
| bx795 | 0 | low | 1 | 0 |
| hispolon | 0 | low | 5 | 0 |
| ly-2157299 | 0 | low | 1 | 0 |
| 4-hydroxy-n-desmethyltamoxifen | 0 | low | 3 | 0 |
| fiscalin b | 0 | low | 1 | 0 |
| givinostat hydrochloride | 0 | low | 1 | 0 |
| diethylamino hydroxybenzoyl hexyl benzoate | 0 | low | 1 | 0 |
| pazopanib | 0 | medium | 7 | 3 |
| sepantronium | 0 | medium | 6 | 3 |
| azd 6244 | 0 | medium | 70 | 14 |
| dimethylarginine | 0 | low | 1 | 0 |
| bibw 2992 | 0 | low | 4 | 0 |
| m 40403 | 0 | low | 4 | 0 |
| vitamin u | 0 | low | 1 | 0 |
| artenimol | 0 | low | 2 | 0 |
| jte 013 | 0 | low | 1 | 0 |
| 5-fluorouridine 5'-triphosphate | 0 | low | 1 | 0 |
| pik 75 | 0 | low | 1 | 0 |
| edoxaban | 0 | low | 1 | 0 |
| binimetinib | 0 | medium | 76 | 13 |
| sotrastaurin | 0 | medium | 5 | 1 |
| aee 788 | 0 | low | 1 | 0 |
| saracatinib | 0 | medium | 4 | 1 |
| alpha-synuclein | 0 | low | 13 | 0 |
| sd-208 | 0 | low | 1 | 0 |
| demethylzeylasteral | 0 | low | 1 | 0 |
| 7-aminoactinomycin d | 0 | low | 1 | 0 |
| 2-acetylfuranonaphthoquinone | 0 | low | 3 | 0 |
| ngr peptide | 0 | low | 2 | 0 |
| tak 385 | 0 | low | 1 | 0 |
| machilin a | 0 | low | 1 | 0 |
| crenolanib | 0 | low | 3 | 0 |
| azd3965 | 0 | low | 1 | 0 |
| le 135 | 0 | low | 1 | 0 |
| homatropine methylbromide | 0 | low | 1 | 0 |
| cis-3,4',5-trimethoxy-3'-aminostilbene | 0 | low | 1 | 0 |
| volasertib | 0 | low | 2 | 0 |
| glaucocalyxin a | 0 | low | 1 | 0 |
| licochalcone d | 0 | low | 1 | 0 |
| oxadiazoles | 0 | low | 11 | 0 |
| curacin d | 0 | low | 1 | 0 |
| 3-o-methylfunicone | 0 | low | 1 | 0 |
| dichlorolissoclimide | 0 | low | 1 | 0 |
| vinflunine | 0 | medium | 1 | 1 |
| digalactosyldiacylglycerol | 0 | low | 1 | 0 |
| ucn 1028 c | 0 | low | 5 | 0 |
| heptelidic acid | 0 | low | 1 | 0 |
| ribose | 0 | medium | 4 | 1 |
| acebutolol | 0 | low | 1 | 0 |
| 8-oxo-2'-deoxyadenosine | 0 | low | 1 | 0 |
| prosapogenin a | 0 | low | 1 | 0 |
| ac-his-dphe-arg-trp-nh2 | 0 | low | 1 | 0 |
| regorafenib | 0 | low | 4 | 0 |
| 4-(1-phenylethyl)resorcinol | 0 | low | 2 | 0 |
| calpain inhibitor iii | 0 | low | 1 | 0 |
| wp1066 | 0 | low | 3 | 0 |
| erastin | 0 | low | 6 | 0 |
| degrasyn | 0 | low | 1 | 0 |
| abt-737 | 0 | low | 23 | 0 |
| euphorbia factor l1 | 0 | low | 1 | 0 |
| amd 070 | 0 | medium | 2 | 1 |
| cardanol | 0 | low | 1 | 0 |
| pd 114,721 | 0 | low | 2 | 0 |
| buprenorphine, naloxone drug combination | 0 | low | 1 | 0 |
| mp470 | 0 | low | 1 | 0 |
| zk-219477 | 0 | medium | 1 | 1 |
| nystatin a1 | 0 | low | 3 | 0 |
| pirarubicin | 0 | medium | 3 | 1 |
| nu 7441 | 0 | low | 2 | 0 |
| marizomib | 0 | medium | 2 | 1 |
| er-086526 | 0 | medium | 3 | 1 |
| bi 2536 | 0 | medium | 2 | 1 |
| 3-o-acetyl-beta-boswellic acid | 0 | low | 1 | 0 |
| inno-406 | 0 | low | 1 | 0 |
| technetium tc 99m disofenin | 0 | low | 1 | 0 |
| nutlin-3a | 0 | low | 17 | 0 |
| danusertib | 0 | low | 2 | 0 |
| zampanolide | 0 | low | 1 | 0 |
| laurinterol | 0 | low | 1 | 0 |
| 10-isobutyryloxy-8,9-epoxythymol isobutyrate | 0 | low | 1 | 0 |
| arq 197 | 0 | low | 1 | 0 |
| ginsenoside rk1 | 0 | low | 1 | 0 |
| lbw242 | 0 | low | 1 | 0 |
| pf 00299804 | 0 | low | 1 | 0 |
| artemisone | 0 | low | 1 | 0 |
| oleandrin | 0 | low | 2 | 0 |
| monomethyl auristatin e | 0 | low | 8 | 0 |
| carfilzomib | 0 | medium | 3 | 1 |
| apremilast | 0 | low | 1 | 0 |
| tpi-287 | 0 | medium | 1 | 1 |
| wz 811 | 0 | low | 1 | 0 |
| marinomycin a | 0 | low | 1 | 0 |
| sitagliptin phosphate | 0 | low | 1 | 0 |
| veratridine | 0 | low | 1 | 0 |
| gw 2580 | 0 | low | 1 | 0 |
| glanatec | 0 | low | 1 | 0 |
| crizotinib | 0 | low | 5 | 0 |
| protoapigenone | 0 | low | 1 | 0 |
| zstk474 | 0 | low | 1 | 0 |
| 2,4,3',5'-tetrahydroxystilbene | 0 | low | 2 | 0 |
| chir-265 | 0 | medium | 4 | 1 |
| az-628 | 0 | low | 1 | 0 |
| trametinib | 0 | medium | 415 | 73 |
| bay 60-6583 | 0 | low | 1 | 0 |
| physalin b | 0 | low | 1 | 0 |
| deoxyarbutin | 0 | low | 1 | 0 |
| losartan potassium | 0 | medium | 19 | 3 |
| dc 88-a | 0 | low | 1 | 0 |
| 3-hydroxyphloretin | 0 | low | 1 | 0 |
| silvestrol | 0 | low | 2 | 0 |
| imidazolone | 0 | low | 1 | 0 |
| alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->4)-[alpha-L-Fucp-(1->3)]-D-GlcpNAc | 0 | low | 5 | 0 |
| 2-(n-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)-2-deoxyglucose | 0 | low | 1 | 0 |
| dihydrolycorine | 0 | low | 1 | 0 |
| ilicic acid | 0 | low | 1 | 0 |
| empagliflozin | 0 | medium | 2 | 1 |
| palmitoylcarnitine | 0 | low | 1 | 0 |
| technetium tc 99m exametazime | 0 | medium | 6 | 1 |
| at 13387 | 0 | low | 2 | 0 |
| calcimycin | 0 | low | 10 | 0 |
| dextrothyroxine | 0 | low | 3 | 0 |
| veliparib | 0 | medium | 5 | 2 |
| anthecotulide | 0 | low | 1 | 0 |
| sepharose | 0 | low | 17 | 0 |
| indocyanine green | 0 | medium | 145 | 11 |
| cinobufagin | 0 | low | 1 | 0 |
| dactolisib | 0 | low | 8 | 0 |
| pituitrin | 0 | low | 2 | 0 |
| podophyllin | 0 | low | 5 | 0 |
| bsc2118 | 0 | low | 1 | 0 |
| n-monoacetylcystine | 0 | low | 1 | 0 |
| 6-o-angeloylprenolin | 0 | low | 1 | 0 |
| bufotalin | 0 | low | 1 | 0 |
| oleanonic acid | 0 | low | 1 | 0 |
| rutundic acid | 0 | low | 1 | 0 |
| clove | 0 | low | 3 | 0 |
| 1,4-dihydroquinoline | 0 | low | 1 | 0 |
| acid phosphatase | 0 | low | 53 | 0 |
| esorubicin | 0 | medium | 5 | 2 |
| mefloquine | 0 | low | 1 | 0 |
| ants | 0 | low | 1 | 0 |
| bleomycetin | 0 | medium | 4 | 1 |
| tetrahydrouridine | 0 | low | 2 | 0 |
| quinocarcin | 0 | low | 1 | 0 |
| ci 959 | 0 | low | 1 | 0 |
| bengazole a | 0 | low | 1 | 0 |
| FR900359 | 0 | low | 4 | 0 |
| cysteinyldopa | 0 | medium | 121 | 3 |
| butaprost | 0 | low | 1 | 0 |
| atractylenolide ii | 0 | low | 1 | 0 |
| mdl 73811 | 0 | low | 1 | 0 |
| jaw | 0 | low | 2 | 0 |
| carbon-11 methionine | 0 | low | 1 | 0 |
| friedelane | 0 | low | 1 | 0 |
| augustic acid | 0 | low | 1 | 0 |
| cyanidin-3-o-beta-glucopyranoside | 0 | low | 1 | 0 |
| nad | 0 | low | 29 | 0 |
| dianhydrogalactitol | 0 | low | 6 | 0 |
| rrx-001 | 0 | low | 1 | 0 |
| mdv 3100 | 0 | low | 2 | 0 |
| tin mesoporphyrin | 0 | low | 1 | 0 |
| n-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide | 0 | low | 1 | 0 |
| toceranib phosphate | 0 | low | 1 | 0 |
| unbs 5162 | 0 | low | 1 | 0 |
| cytochrome c-t | 0 | low | 70 | 0 |
| diphlorethohydroxycarmalol | 0 | low | 2 | 0 |
| subamolide a | 0 | low | 1 | 0 |
| laxaphycin b | 0 | low | 1 | 0 |
| laxaphycin a | 0 | low | 1 | 0 |
| feruloyldopamine | 0 | low | 1 | 0 |
| calcitonin | 0 | low | 1 | 0 |
| cosyntropin | 0 | low | 1 | 0 |
| melitten | 0 | low | 9 | 0 |
| cholecystokinin | 0 | low | 3 | 0 |
| atrial natriuretic factor | 0 | low | 2 | 0 |
| magainin 2 peptide, xenopus | 0 | low | 1 | 0 |
| thymalfasin | 0 | medium | 8 | 3 |
| tn14003 | 0 | low | 1 | 0 |
| (dtpa-phe(1))-octreotide | 0 | low | 2 | 0 |
| cks 17 | 0 | low | 1 | 0 |
| hes1 protein, human | 0 | low | 5 | 0 |
| glycoprotein e2, hepatitis c virus | 0 | low | 1 | 0 |
| peptide i | 0 | low | 1 | 0 |
| msh, 4-nle-alpha- | 0 | low | 1 | 0 |
| galanin (1-16) | 0 | low | 1 | 0 |
| gastrins | 0 | low | 3 | 0 |
| glucagon | 0 | low | 3 | 0 |
| beta-endorphin | 0 | low | 7 | 0 |
| sauvagine | 0 | low | 1 | 0 |
| viscotoxin | 0 | low | 1 | 0 |
| thymosin beta(4) | 0 | low | 6 | 0 |
| thymopoietin iii | 0 | low | 1 | 0 |
| neuropeptide y | 0 | low | 3 | 0 |
| echistatin | 0 | low | 4 | 0 |
| eristostatin | 0 | low | 4 | 0 |
| lactoferricin b | 0 | low | 5 | 0 |
| angiotensinogen | 0 | low | 1 | 0 |
| cucurbit(8)uril | 0 | low | 1 | 0 |
| alpha-msh | 0 | low | 3 | 0 |
| irl 1620 | 0 | low | 1 | 0 |
| tannins | 0 | low | 5 | 0 |
| oligonucleotides | 0 | medium | 43 | 4 |
| transportan | 0 | low | 3 | 0 |
| glucagon-like peptide 1 | 0 | low | 1 | 0 |
| r18 peptide | 0 | low | 1 | 0 |
| msh, 4-nle-7-phe-alpha- | 0 | low | 16 | 0 |
| c-peptide | 0 | low | 2 | 0 |
| natriuretic peptide, c-type | 0 | low | 1 | 0 |
| ctce-9908 | 0 | low | 2 | 0 |
| melanotan-1 | 0 | low | 1 | 0 |
| an 207 | 0 | low | 1 | 0 |
| e 7107 | 0 | low | 1 | 0 |
| cellulose | 0 | medium | 9 | 1 |
| endothelin-1 | 0 | medium | 30 | 1 |
| phosphatidylcholines | 0 | low | 17 | 0 |
| 4-aminobenzoyl-glycyl-prolyl-leucyl-alanine hydroxamic acid | 0 | low | 1 | 0 |
| gdc-0973 | 0 | medium | 116 | 24 |
| mk-8776 | 0 | medium | 1 | 1 |
| buparlisib | 0 | low | 3 | 0 |
| azd 1480 | 0 | low | 2 | 0 |
| chlorophyll a | 0 | low | 8 | 0 |
| phenylmercuric acetate | 0 | low | 1 | 0 |
| 4-aminophenylmercuriacetate | 0 | low | 1 | 0 |
| pha 848125 | 0 | low | 2 | 0 |
| ro5126766 | 0 | low | 1 | 0 |
| pevonedistat | 0 | medium | 6 | 1 |
| way 252623 | 0 | low | 1 | 0 |
| ku 0063794 | 0 | low | 1 | 0 |
| adenosine kinase | 0 | low | 1 | 0 |
| hoe 33342 | 0 | low | 7 | 0 |
| sodium salicylate | 0 | low | 2 | 0 |
| sphingosine kinase | 0 | low | 12 | 0 |
| ubiquinone | 0 | medium | 11 | 1 |
| palmerolide a | 0 | low | 2 | 0 |
| alpha-amanitin | 0 | low | 1 | 0 |
| calpain | 0 | low | 19 | 0 |
| lucifer yellow | 0 | low | 1 | 0 |
| 4-borono-2-fluorophenylalanine | 0 | low | 2 | 0 |
| sapogenins | 0 | low | 2 | 0 |
| n,n'-bis(2-hydroxy-5-(ethylene-beta-carboxy)benzyl)ethylenediamine n,n'-diacetic acid | 0 | low | 1 | 0 |
| antamanide | 0 | low | 1 | 0 |
| isoangustone a | 0 | low | 1 | 0 |
| ozocerite | 0 | low | 1 | 0 |
| pseudoginsenoside f11 | 0 | low | 1 | 0 |
| triazacyclononane | 0 | low | 1 | 0 |
| chitosan | 0 | low | 49 | 0 |
| technetium tc 99m sestamibi | 0 | medium | 18 | 1 |
| 2,6-bis(4-aminophenyl)-4-(4-(dimethylamino)phenyl)thiopyrylium | 0 | low | 1 | 0 |
| enzacamene | 0 | low | 1 | 0 |
| 15-deoxyprostaglandin j2 | 0 | low | 2 | 0 |
| mycosporine-2-glycine | 0 | low | 1 | 0 |
| 1-palmitoyl-2-(5-oxovaleroyl)-sn-glycero-3-phosphorylcholine | 0 | low | 1 | 0 |
| 1-phospho-5-s-methylthioribulose | 0 | low | 1 | 0 |
| bucladesine | 0 | low | 27 | 0 |
| sodium hypochlorite | 0 | low | 4 | 0 |
| sodium bisulfite | 0 | low | 1 | 0 |
| sodium lactate | 0 | low | 1 | 0 |
| sodium nitrite | 0 | low | 1 | 0 |
| stearates | 0 | low | 1 | 0 |
| merocyanine dye | 0 | low | 5 | 0 |
| sodium pertechnetate tc 99m | 0 | medium | 12 | 2 |
| sodium ethylxanthate | 0 | low | 8 | 0 |
| cortisol succinate, sodium salt | 0 | low | 1 | 0 |
| chiniofon | 0 | medium | 9 | 1 |
| nsc 100880 | 0 | low | 1 | 0 |
| arginine | 0 | medium | 5 | 1 |
| echinomycin | 0 | low | 1 | 0 |
| gadofosveset trisodium | 0 | low | 1 | 0 |
| n-(2-diethylaminoethyl)-6-iodoquinoxaline-2-carboxamide | 0 | low | 4 | 0 |
| olaparib | 0 | medium | 9 | 1 |
| thiostrepton | 0 | low | 4 | 0 |
| n-trans-feruloyloctopamine | 0 | low | 1 | 0 |
| plx 4720 | 0 | medium | 79 | 1 |
| lcl161 | 0 | low | 2 | 0 |
| galmic | 0 | low | 1 | 0 |
| s-adenosylmethionine | 0 | low | 7 | 0 |
| cpi 613 | 0 | low | 1 | 0 |
| mln 8237 | 0 | low | 4 | 0 |
| tenovin-6 | 0 | low | 2 | 0 |
| snx 2112 | 0 | low | 1 | 0 |
| lde225 | 0 | low | 3 | 0 |
| gdc 0449 | 0 | low | 2 | 0 |
| eapb0203 | 0 | low | 3 | 0 |
| cep-9722 | 0 | low | 1 | 0 |
| bms 777607 | 0 | low | 1 | 0 |
| sgi 1776 | 0 | low | 1 | 0 |
| picrotoxin | 0 | low | 1 | 0 |
| pci 32765 | 0 | medium | 4 | 1 |
| florbetapir f 18 | 0 | low | 1 | 0 |
| ponatinib | 0 | low | 2 | 0 |
| candidin | 0 | low | 1 | 0 |
| asta z 7557 | 0 | low | 1 | 0 |
| arabinogalactan | 0 | low | 1 | 0 |
| 10-methoxy-9-nitrocamptothecin | 0 | low | 1 | 0 |
| mk-1775 | 0 | low | 1 | 0 |
| oxymatrine | 0 | low | 2 | 0 |
| sch772984 | 0 | low | 8 | 0 |
| dolichol monophosphate | 0 | low | 1 | 0 |
| at13148 | 0 | low | 1 | 0 |
| N-[4-[3-[[[7-(hydroxyamino)-7-oxoheptyl]amino]-oxomethyl]-5-isoxazolyl]phenyl]carbamic acid tert-butyl ester | 0 | low | 1 | 0 |
| niraparib | 0 | medium | 3 | 1 |
| tak 733 | 0 | medium | 6 | 1 |
| mk 2206 | 0 | low | 10 | 0 |
| navitoclax | 0 | medium | 4 | 1 |
| pervanadate | 0 | low | 1 | 0 |
| 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene | 0 | low | 3 | 0 |
| quetiapine fumarate | 0 | low | 1 | 0 |
| cardiovascular agents | 0 | low | 1 | 0 |
| chi 1043 | 0 | low | 1 | 0 |
| trelstar | 0 | medium | 3 | 2 |
| neurotensin | 0 | low | 2 | 0 |
| deslorelin | 0 | low | 1 | 0 |
| fibrinopeptide a | 0 | low | 1 | 0 |
| ah 111585 | 0 | low | 1 | 0 |
| cabozantinib | 0 | medium | 3 | 1 |
| incb-018424 | 0 | low | 3 | 0 |
| entrectinib | 0 | medium | 1 | 1 |
| mannans | 0 | medium | 10 | 2 |
| pexidartinib | 0 | low | 2 | 0 |
| TAK-580 | 0 | low | 1 | 0 |
| gsk 2126458 | 0 | low | 2 | 0 |
| ixazomib | 0 | low | 2 | 0 |
| gallinamide a | 0 | low | 1 | 0 |
| pf 3758309 | 0 | low | 1 | 0 |
| eapb0503 | 0 | low | 3 | 0 |
| (5-(2,4-bis((3s)-3-methylmorpholin-4-yl)pyrido(2,3-d)pyrimidin-7-yl)-2-methoxyphenyl)methanol | 0 | low | 5 | 0 |
| pf 8380 | 0 | low | 1 | 0 |
| plx4032 | 0 | medium | 1,089 | 82 |
| gsk 1363089 | 0 | low | 1 | 0 |
| triiodothyronine, reverse | 0 | low | 1 | 0 |
| ganglioside, gd1a | 0 | low | 1 | 0 |
| gw 1000 | 0 | low | 1 | 0 |
| glycolipids | 0 | medium | 45 | 2 |
| elafin | 0 | low | 3 | 0 |
| piperidines | 0 | medium | 171 | 24 |
| bryostatin 1 | 0 | medium | 9 | 4 |
| thymosin | 0 | medium | 27 | 4 |
| 5-hydroxymethyl-2'-deoxyuridine | 0 | medium | 1 | 1 |
| interleukin-8 | 0 | medium | 169 | 9 |
| vpc32183 | 0 | low | 1 | 0 |
| dufulin | 0 | low | 1 | 0 |
| dabrafenib | 0 | medium | 507 | 80 |
| pki 587 | 0 | low | 1 | 0 |
| cblc137 | 0 | low | 1 | 0 |
| geoditin a | 0 | low | 1 | 0 |
| physalin a | 0 | low | 1 | 0 |
| saucerneol d | 0 | low | 1 | 0 |
| kahalalide f | 0 | medium | 1 | 1 |
| gardiquimod | 0 | low | 2 | 0 |
| 3-(1,3-benzodioxol-5-yl)-5-(3-bromophenyl)-1h-pyrazole | 0 | low | 1 | 0 |
| ribociclib | 0 | low | 6 | 0 |
| yk 4-279 | 0 | low | 1 | 0 |
| clavosolide a | 0 | low | 1 | 0 |
| palmostatin b | 0 | low | 1 | 0 |
| apatinib | 0 | medium | 7 | 4 |
| formylchromone | 0 | low | 1 | 0 |
| gx 15-070 | 0 | low | 7 | 0 |
| colistin | 0 | low | 1 | 0 |
| sofosbuvir | 0 | low | 3 | 0 |
| exenatide | 0 | low | 1 | 0 |
| tak-632 | 0 | low | 2 | 0 |
| gsk 2334470 | 0 | low | 1 | 0 |
| abemaciclib | 0 | low | 1 | 0 |
| wzb117 | 0 | low | 2 | 0 |
| gsk 1070916 | 0 | low | 1 | 0 |
| 1-palmitoyl-2-glutaroyl-sn-glycero-3-phosphorylcholine | 0 | low | 1 | 0 |
| jnj38877605 | 0 | low | 1 | 0 |
| vs-5584 | 0 | low | 1 | 0 |
| dinaciclib | 0 | low | 4 | 0 |
| 1-(5-((2,4-difluorophenyl)thio)-4-nitrothiophen-2-yl)ethanone | 0 | low | 1 | 0 |
| fructose-1,6-diphosphate | 0 | low | 1 | 0 |
| abi-274 | 0 | low | 1 | 0 |
| calcipotriene | 0 | low | 3 | 0 |
| birinapant | 0 | low | 3 | 0 |
| abt-199 | 0 | low | 2 | 0 |
| tubastatin a | 0 | low | 2 | 0 |
| encorafenib | 0 | medium | 67 | 10 |
| spautin-1 | 0 | low | 1 | 0 |
| gsk2141795 | 0 | medium | 2 | 2 |
| methylcellulose | 0 | medium | 10 | 1 |
| isoquercitrin | 0 | low | 1 | 0 |
| gsk1210151a | 0 | low | 3 | 0 |
| apr-246 | 0 | low | 3 | 0 |
| 3-(2,6-dichloro-3,5-dimethoxyphenyl)-1-(6-(4-(4-ethylpiperazin-1-yl)-phenylamino)pyrimidin-4-yl)-1-methylurea | 0 | low | 1 | 0 |
| nvp-cgm097 | 0 | low | 1 | 0 |
| vasoactive intestinal peptide | 0 | low | 7 | 0 |
| phosphomannopentaose sulfate | 0 | medium | 2 | 2 |
| natriuretic peptide, brain | 0 | low | 1 | 0 |
| acy-1215 | 0 | low | 3 | 0 |
| rg7388 | 0 | low | 2 | 0 |
| 3-amino-4-(3-hexylphenylamino)-4-oxobutylphosphonic acid | 0 | low | 1 | 0 |
| 3,3',4,4',5,5'-hexahydroxystilbene | 0 | low | 1 | 0 |
| ll z1640-2 | 0 | low | 1 | 0 |
| sar405838 | 0 | medium | 1 | 1 |
| chondroitin | 0 | medium | 9 | 1 |
| heparitin sulfate | 0 | low | 44 | 0 |
| tuftsin | 0 | low | 7 | 0 |
| putreanine | 0 | low | 1 | 0 |
| ascorbic acid | 0 | medium | 76 | 2 |
| novobiocin | 0 | medium | 3 | 1 |
| tetracycline | 0 | medium | 24 | 1 |
| chlortetracycline | 0 | low | 2 | 0 |
| oxytetracycline, anhydrous | 0 | low | 3 | 0 |
| minocycline | 0 | low | 10 | 0 |
| salicylates | 0 | low | 5 | 0 |
| dicumarol | 0 | low | 1 | 0 |
| piroxicam | 0 | medium | 5 | 1 |
| roquinimex | 0 | medium | 4 | 1 |
| mobiflex | 0 | low | 1 | 0 |
| warfarin | 0 | medium | 50 | 2 |
| dihydroxyfumarate | 0 | low | 1 | 0 |
| metastat | 0 | low | 1 | 0 |
| ascorbate-2-phosphate | 0 | low | 2 | 0 |
| citrinin | 0 | low | 1 | 0 |
| zilascorb | 0 | medium | 2 | 1 |
| teriflunomide | 0 | low | 1 | 0 |
| 3-deazauridine | 0 | low | 2 | 0 |
| tigecycline | 0 | low | 4 | 0 |
| vulpinic acid | 0 | low | 1 | 0 |
| ascorbic acid 2-o-glucoside | 0 | low | 1 | 0 |
| kijanimicin | 0 | low | 1 | 0 |
| almagate | 0 | low | 1 | 0 |
| byl719 | 0 | medium | 3 | 1 |
| nk 121 | 0 | low | 1 | 0 |
| epidermal growth factor | 0 | low | 88 | 0 |
| pf 3512676 | 0 | medium | 15 | 10 |
| zhengguangmycin | 0 | low | 1 | 0 |
| gastrin-releasing peptide | 0 | low | 4 | 0 |
| calca protein, human | 0 | medium | 2 | 1 |
| clay | 0 | low | 1 | 0 |
| charybdotoxin | 0 | low | 2 | 0 |
| holothurin | 0 | low | 1 | 0 |
| lead radioisotopes | 0 | low | 1 | 0 |
| transforming growth factor beta | 0 | medium | 231 | 7 |
| okadaic acid | 0 | low | 3 | 0 |
| methylglyoxal bis(cyclopentylamidinohydrazone) | 0 | low | 1 | 0 |
| glycyl-arginyl-glycyl-glutamyl-seryl-proline | 0 | low | 1 | 0 |
| ceritinib | 0 | low | 1 | 0 |
| sybr green i | 0 | low | 3 | 0 |
| wnt-c59 | 0 | low | 1 | 0 |
| cc-115 | 0 | low | 1 | 0 |
| xl 888 | 0 | low | 6 | 0 |
| pyrethrins | 0 | low | 1 | 0 |
| vo-ohpic | 0 | low | 1 | 0 |
| globotriaosylceramide | 0 | low | 1 | 0 |
| ledipasvir | 0 | low | 1 | 0 |
| gsk-2816126 | 0 | low | 4 | 0 |
| lys01 | 0 | low | 1 | 0 |
| ponicidin | 0 | low | 1 | 0 |
| bgp 15 | 0 | low | 1 | 0 |
| gsk2830371 | 0 | low | 1 | 0 |
| men 4901 | 0 | low | 1 | 0 |
| thymic factor, circulating | 0 | low | 6 | 0 |
| kiss1 protein, human | 0 | low | 17 | 0 |
| timosaponin aiii | 0 | low | 1 | 0 |
| fti 277 | 0 | low | 1 | 0 |
| rome | 0 | low | 7 | 0 |
| 4-((1-butyl-3-phenylureido)methyl)-n-hydroxybenzamide | 0 | low | 2 | 0 |
| verdinexor | 0 | low | 1 | 0 |
| agar | 0 | low | 52 | 0 |
| cb-839 | 0 | low | 1 | 0 |
| arsenic trisulfide | 0 | low | 1 | 0 |
| saquinavir-no | 0 | low | 2 | 0 |
| phleomycin d1 | 0 | low | 2 | 0 |
| atglistatin | 0 | low | 1 | 0 |
| ly3009120 | 0 | low | 2 | 0 |
| pf-06463922 | 0 | low | 1 | 0 |
| 3,7-dioxolanosta-8,24-dien-26-oic acid | 0 | low | 1 | 0 |
| hirudin | 0 | low | 7 | 0 |
| ephrin-a5 | 0 | low | 3 | 0 |
| glutaminase | 0 | medium | 11 | 1 |
| cyclin d1 | 0 | medium | 166 | 3 |
| unc2025 | 0 | low | 1 | 0 |
| qs 21 | 0 | medium | 10 | 7 |
| onc201 | 0 | low | 1 | 0 |
| caseins | 0 | low | 7 | 0 |
| thearubigin | 0 | low | 1 | 0 |
| technetium tc 99m sulfur colloid | 0 | medium | 126 | 13 |
| nov 002 | 0 | low | 1 | 0 |
| saf-m | 0 | medium | 1 | 1 |
| gamma2-msh | 0 | low | 1 | 0 |
| hp 228 | 0 | low | 1 | 0 |
| oligomycins | 0 | low | 8 | 0 |
| nonachlor | 0 | low | 1 | 0 |
| crotamine | 0 | low | 2 | 0 |
| illite | 0 | low | 1 | 0 |
| phthalocyanine | 0 | low | 11 | 0 |
| carubicin | 0 | low | 5 | 0 |
| g(m3) ganglioside | 0 | medium | 55 | 3 |
| benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone | 0 | low | 20 | 0 |
| nitrophenols | 0 | low | 26 | 0 |
| bassianolide | 0 | low | 1 | 0 |
| plx7904 | 0 | low | 1 | 0 |
| glaucarubin | 0 | low | 1 | 0 |
| lewis x antigen | 0 | low | 15 | 0 |
| calpastatin | 0 | low | 1 | 0 |
| gadoxetic acid disodium | 0 | medium | 2 | 1 |
| hyaluronoglucosaminidase | 0 | low | 21 | 0 |
| adrenomedullin | 0 | low | 1 | 0 |
| epoetin alfa | 0 | medium | 4 | 1 |
| ebc-46 | 0 | medium | 1 | 1 |
| lipofectamine | 0 | low | 3 | 0 |
| d-ala(2),mephe(4),met(0)-ol-enkephalin | 0 | low | 1 | 0 |
| oridonin | 0 | low | 3 | 0 |
| ailanthone | 0 | low | 2 | 0 |
| voacamine | 0 | low | 1 | 0 |
| t-2 toxin | 0 | low | 2 | 0 |
| vitamin b 12 | 0 | low | 9 | 0 |
| ferric ammonium citrate | 0 | low | 3 | 0 |
| oblimersen | 0 | medium | 28 | 4 |
| roussin's black salt | 0 | low | 1 | 0 |
| norgestrel | 0 | low | 2 | 0 |
| sermorelin | 0 | low | 1 | 0 |
| transforming growth factor alpha | 0 | low | 12 | 0 |
| as 1411 | 0 | low | 2 | 0 |
| dodecaborate | 0 | low | 1 | 0 |
| cyclosporine | 0 | medium | 37 | 2 |
| alpha1-purothionin protein, wheat | 0 | low | 2 | 0 |
| flavin mononucleotide | 0 | low | 1 | 0 |
| silybin | 0 | low | 5 | 0 |
| cytochalasin d | 0 | low | 12 | 0 |
| siomycin a | 0 | low | 1 | 0 |
| lactoferrin | 0 | medium | 11 | 1 |
| insulin, (2-nitro-4-azidophenylacetyl)(b2)-des-phe(b1)- | 0 | low | 1 | 0 |
| gracillin | 0 | low | 2 | 0 |
| icg 001 | 0 | low | 2 | 0 |
| alpha-solanine | 0 | low | 1 | 0 |
| orabase | 0 | medium | 8 | 3 |
| technetium tc 99m medronate | 0 | low | 12 | 0 |
| technetium tc-99m tetrofosmin | 0 | low | 5 | 0 |
| apyrase | 0 | low | 14 | 0 |
| thromboplastin | 0 | low | 39 | 0 |
| muramidase | 0 | low | 17 | 0 |
| cord factors | 0 | low | 1 | 0 |
| chromomycins | 0 | low | 1 | 0 |
| nedaplatin | 0 | low | 2 | 0 |
| lewis y antigen | 0 | low | 1 | 0 |
| chondroitin sulfates | 0 | medium | 48 | 1 |
| exudates | 0 | low | 11 | 0 |
| angiogenin | 0 | medium | 12 | 1 |
| ganglio-n-triaosylceramide | 0 | low | 1 | 0 |
| plicamycin | 0 | low | 1 | 0 |
| bixin | 0 | low | 2 | 0 |
| lupane | 0 | low | 2 | 0 |
| protopanaxatriol | 0 | low | 1 | 0 |
| technetium tc 99m dimercaptosuccinic acid | 0 | low | 1 | 0 |
| mrk 003 | 0 | low | 1 | 0 |
| 11-dehydrosinulariolide | 0 | low | 1 | 0 |
| 68ga-dotanoc | 0 | low | 1 | 0 |
| tetra(4-n-methylpyridyl)porphine | 0 | low | 2 | 0 |
| sb-590885 | 0 | low | 3 | 0 |
| acyclovir | 0 | medium | 6 | 1 |
| osi 027 | 0 | low | 1 | 0 |
| levoleucovorin | 0 | medium | 17 | 2 |
| cyclic gmp | 0 | low | 28 | 0 |
| deoxyguanosine | 0 | low | 13 | 0 |
| deoxyinosine | 0 | low | 3 | 0 |
| 2'-deoxyguanosine 5'-phosphate | 0 | low | 1 | 0 |
| deoxyguanosine triphosphate | 0 | low | 2 | 0 |
| dihydrofolate | 0 | low | 1 | 0 |
| guanosine diphosphate | 0 | low | 3 | 0 |
| guanosine monophosphate | 0 | low | 2 | 0 |
| guanosine triphosphate | 0 | low | 16 | 0 |
| guanine | 0 | medium | 34 | 3 |
| guanosine | 0 | low | 10 | 0 |
| hypoxanthine | 0 | low | 3 | 0 |
| inosine | 0 | medium | 16 | 1 |
| sapropterin | 0 | low | 5 | 0 |
| folic acid | 0 | low | 33 | 0 |
| 3-methyladenine | 0 | low | 8 | 0 |
| guanosine 5'-o-(3-thiotriphosphate) | 0 | low | 5 | 0 |
| 7-methylguanine | 0 | low | 2 | 0 |
| isoxanthopterin | 0 | low | 1 | 0 |
| neopterin | 0 | medium | 22 | 12 |
| rifampin | 0 | medium | 4 | 1 |
| dacarbazine | 0 | medium | 1,361 | 416 |
| ganciclovir | 0 | medium | 26 | 4 |
| olanzapine | 0 | low | 1 | 0 |
| zaprinast | 0 | low | 2 | 0 |
| inosine dialdehyde | 0 | low | 1 | 0 |
| allopurinol | 0 | low | 6 | 0 |
| 2,2'-(hydroxynitrosohydrazono)bis-ethanamine | 0 | low | 1 | 0 |
| azaguanine | 0 | low | 3 | 0 |
| guanylyl imidodiphosphate | 0 | low | 3 | 0 |
| xanthopterin | 0 | low | 1 | 0 |
| hematein | 0 | low | 1 | 0 |
| diazeniumdiolate | 0 | low | 1 | 0 |
| 2-amino-5-bromo-6-(3-fluorophenyl)-4(3h)pyrimidinone | 0 | low | 2 | 0 |
| 8-hydroxyguanosine | 0 | low | 1 | 0 |
| alanosine | 0 | medium | 3 | 1 |
| forodesine | 0 | low | 1 | 0 |
| pyridoxal isonicotinoyl hydrazone | 0 | low | 2 | 0 |
| guanosine 5'-o-(2-thiodiphosphate) | 0 | low | 2 | 0 |
| pemetrexed | 0 | low | 3 | 0 |
| 2-amino-5-iodo-6-phenyl-4-pyrimidinone | 0 | low | 1 | 0 |
| bropirimine | 0 | low | 3 | 0 |
| pcf 39 | 0 | low | 1 | 0 |
| tirapazamine | 0 | medium | 7 | 3 |
| sildenafil citrate | 0 | low | 14 | 0 |
| aprepitant | 0 | low | 1 | 0 |
| pyrazofurin | 0 | medium | 3 | 1 |
| vardenafil dihydrochloride | 0 | low | 3 | 0 |
| u 25166 | 0 | low | 1 | 0 |
| quazinone | 0 | low | 1 | 0 |
| 5(4'-hydroxybenzylidenoimino)-3-methylisothiazolo(5,4-d)pyrimidine-(7h)-4,6-dione | 0 | low | 1 | 0 |
| xav939 | 0 | low | 3 | 0 |
| 8-bromocyclic gmp | 0 | low | 4 | 0 |
| 8-hydroxyguanine | 0 | medium | 2 | 1 |
| sb-590885 | 0 | low | 1 | 0 |
| trypan blue | 0 | low | 10 | 0 |
| 2-azahypoxanthine | 0 | low | 1 | 0 |
| nintedanib | 0 | medium | 2 | 1 |
| methylnitronitrosoguanidine | 0 | low | 12 | 0 |
| 5,10,15,20-tetra(4-hydroxyphenyl)porphyrin | 0 | low | 1 | 0 |
| 8-hydroxy-2'-deoxyguanosine | 0 | low | 7 | 0 |
| guanosine 5'-(alpha,beta-methylene)triphosphate | 0 | low | 1 | 0 |
| coelenterazine | 0 | low | 1 | 0 |
| inosine pranobex | 0 | medium | 3 | 1 |
| prodigiosin | 0 | low | 4 | 0 |
| 5,10,15,20-tetra(3-hydroxyphenyl)porphyrin | 0 | low | 1 | 0 |
| 8-methylguanosine | 0 | low | 1 | 0 |
| 5-methyltetrahydrofolate | 0 | low | 4 | 0 |
| 9-(4-fluoro-3-hydroxymethylbutyl)guanine | 0 | low | 1 | 0 |
| cytidylyl-3'-5'-guanosine | 0 | low | 4 | 0 |
| enng | 0 | low | 1 | 0 |
| imidacloprid | 0 | low | 1 | 0 |
| cyclic guanosine monophosphate-adenosine monophosphate | 0 | low | 6 | 0 |
| sta 9090 | 0 | medium | 4 | 1 |
| bmn 673 | 0 | low | 2 | 0 |
| bay 80-6946 | 0 | low | 2 | 0 |
| nms-e973 | 0 | low | 1 | 0 |
| dibutyryl cyclic gmp | 0 | low | 2 | 0 |
| sparstolonin b | 0 | low | 1 | 0 |
| liproxstatin-1 | 0 | low | 1 | 0 |
| prodiginine | 0 | low | 2 | 0 |
| cyanine dye 3 | 0 | low | 1 | 0 |
| alcian blue | 0 | low | 1 | 0 |
| cycloprodigiosin | 0 | low | 1 | 0 |
| 4-imino-1,3-diazabicyclo(3.1.0)hexan-2-one | 0 | medium | 3 | 1 |
| lipoteichoic acid | 0 | low | 1 | 0 |
| disodium isostearyl 2-o-l-ascorbyl phosphate | 0 | low | 1 | 0 |
| eye | 0 | medium | 234 | 5 |
| zinc(ii) phthalocyanine trisulfonic acid | 0 | low | 1 | 0 |
| chromomycin a3 | 0 | low | 3 | 0 |
| n-glycolylneuraminyllactosylceramide | 0 | medium | 5 | 1 |
| batumin | 0 | low | 1 | 0 |
| carbidopa | 0 | low | 9 | 0 |
| chaetocin | 0 | low | 1 | 0 |
| vinzolidine | 0 | low | 1 | 0 |
| pseudolaric acid b | 0 | low | 4 | 0 |
| concanavalin a | 0 | medium | 66 | 1 |
| nisin z | 0 | low | 1 | 0 |
| chlorotoxin | 0 | low | 1 | 0 |
| trypsinogen | 0 | low | 2 | 0 |
| gq1b ganglioside | 0 | low | 2 | 0 |
| metallothionein | 0 | low | 27 | 0 |
| antimony sodium gluconate | 0 | medium | 4 | 1 |
| yo-pro 1 | 0 | low | 1 | 0 |
| beta, beta-dimethylacrylshikonin | 0 | low | 2 | 0 |
| id-6105 | 0 | low | 1 | 0 |
| dinitrobenzenes | 0 | medium | 16 | 2 |
| chloroaluminum tetrasulfophthalocyanine | 0 | low | 1 | 0 |
| aluminum tetrasulfophthalocyanine | 0 | low | 7 | 0 |
| aluminum phthalocyanine disulfonate | 0 | low | 5 | 0 |
| 2',7'-bis(carboxyethyl)-5(6)-carboxyfluorescein | 0 | low | 2 | 0 |
| phosphorus radioisotopes | 0 | medium | 121 | 1 |
| galanin-like peptide | 0 | low | 1 | 0 |
| octaarginine | 0 | low | 1 | 0 |
| leptin | 0 | medium | 21 | 1 |
| 20-hydroxyvitamin d3 | 0 | low | 3 | 0 |
| pyrimidinones | 0 | medium | 444 | 72 |
| sc-2001 | 0 | low | 1 | 0 |
| filipin | 0 | low | 3 | 0 |
| phenanthrenes | 0 | low | 18 | 0 |
| pa22-2 | 0 | low | 1 | 0 |